10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark one)
☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 1, 2023

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to                 .

Commission File Number 0-21272

Sanmina Corporation

(Exact name of registrant as specified in its charter)

DE	77-0228183
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification Number)
2700 N. First St., San Jose, CA	95134
(Address of principal executive offices)	(Zip Code)
(408) 964-3500
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒    No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large Accelerated Filer	☒	Accelerated filer ☐	Non-accelerated filer ☐	Smaller reporting company	☐
				Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐  No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock	SANM	NASDAQ Global Select Market

As of May 3, 2023, there were 58,168,859 shares outstanding of the issuer’s common stock, $0.01 par value per share.

SANMINA CORPORATION

INDEX

		Page
	PART I. FINANCIAL INFORMATION
Item 1.	Interim Financial Statements (Unaudited)	3
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Income	4
	Condensed Consolidated Statements of Comprehensive Income	5
	Condensed Consolidated Statements of Stockholders’ Equity	6
	Condensed Consolidated Statements of Cash Flows	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	33
Item 4.	Controls and Procedures	33
	PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	35
Item 1A.	Risk Factors	36
Item 5.	Other Information	48
Item 6.	Exhibits	49
Signatures		50

2

SANMINA CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

	As of
	April 1,		October 1,
	2023		2022
			(Restated)
	(Unaudited)
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	718,203	$	529,857
Accounts receivable, net of allowances of approximately $8 million as of April 1, 2023 and October 1, 2022		1,208,808		1,138,894
Contract assets		486,290		475,721
Inventories		1,552,568		1,684,099
Prepaid expenses and other current assets		69,091		62,044
Total current assets		4,034,960		3,890,615
Property, plant and equipment, net		616,998		575,170
Deferred tax assets		196,191		209,554
Other		181,307		160,192
Total assets	$	5,029,456	$	4,835,531
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	1,828,699	$	2,041,434
Accrued liabilities		282,414		281,599
Accrued payroll and related benefits		126,373		130,892
Short-term debt, including current portion of long-term debt		17,500		17,500
Total current liabilities		2,254,986		2,471,425
Long-term liabilities:
Long-term debt		320,779		329,237
Other		235,697		215,333
Total long-term liabilities		556,476		544,570
Contingencies (Note 8)
Stockholders’ equity		2,217,994		1,819,536
Total liabilities and stockholders’ equity	$	5,029,456	$	4,835,531

See accompanying notes to condensed consolidated financial statements.

3

SANMINA CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(Unaudited)
	(In thousands, except per share data)
Net sales	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396
Cost of sales		2,128,914		1,768,575		4,289,336		3,383,604
Gross profit		191,189		146,495		386,575		287,792
Operating expenses:
Selling, general and administrative		63,390		61,817		124,120		123,292
Research and development		6,394		5,472		11,993		10,249
Restructuring and other		804		2,932		1,435		4,346
Gain on sale of long-lived assets		—		—		—		(4,610)
Total operating expenses		70,588		70,221		137,548		133,277
Operating income		120,601		76,274		249,027		154,515
Interest income		2,539		349		5,472		658
Interest expense		(9,286)		(4,870)		(17,967)		(9,747)
Other income (expense), net		(2,768)		(1,408)		(9,480)		664
Interest and other, net		(9,515)		(5,929)		(21,975)		(8,425)
Income before income taxes		111,086		70,345		227,052		146,090
Provision for income taxes		25,779		21,724		46,631		41,292
Net income before noncontrolling interest		85,307		48,621	$	180,421	$	104,798
Less: Net income attributable to noncontrolling interest		5,686		—		8,786		—
Net income attributable to common shareholders	$	79,621	$	48,621	$	171,635	$	104,798
Net income attributable to common shareholders per share:
Basic	$	1.37	$	0.77	$	2.96	$	1.65
Diluted	$	1.33	$	0.76	$	2.87	$	1.60
Weighted average shares used in computing per share amounts:
Basic		58,269		62,845		57,999		63,622
Diluted		59,819		64,271		59,863		65,365

See accompanying notes to condensed consolidated financial statements.

4

SANMINA CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(Unaudited)
	(In thousands)
Net income before noncontrolling interest	$	85,307	$	48,621	$	180,421	$	104,798
Other comprehensive income (loss), net of tax:
Change in foreign currency translation adjustments		1,060		(1,069)		7,243		(3,116)
Derivative financial instruments:
Change in net unrealized amount		2,938		7,776		7,407		9,740
Amount reclassified into net income before noncontrolling interest		(6,203)		337		(9,499)		2,400
Defined benefit plans:
Changes in unrecognized net actuarial losses and unrecognized transition costs		(157)		183		(908)		661
Amortization of actuarial losses and transition costs		217		242		562		480
Total other comprehensive income (loss)		(2,145)		7,469		4,805		10,165
Comprehensive income before noncontrolling interest	$	83,162	$	56,090	$	185,226	$	114,963
Less: Net income attributable to noncontrolling interest		5,686		—		8,786		—
Comprehensive income attributable to common shareholders	$	77,476	$	56,090	$	176,440	$	114,963

See accompanying notes to condensed consolidated financial statements.

5

SANMINA CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(Unaudited)
	(In thousands)
Common Stock and Additional Paid-in Capital
Balance, beginning of period	$	6,471,299	$	6,349,588	$	6,381,348	$	6,339,506
Issuances under stock plans		122		352		295		1,402
Stock-based compensation expense		12,534		9,330		24,143		18,362
Sale of noncontrolling interest		—		—		78,169		—
Balance, end of period		6,483,955		6,359,270		6,483,955		6,359,270
Treasury Stock
Balance, beginning of period		(1,386,168)		(1,116,025)		(1,378,159)		(1,047,202)
Repurchases of treasury stock		(13,498)		(113,498)		(21,507)		(182,321)
Balance, end of period		(1,399,666)		(1,229,523)		(1,399,666)		(1,229,523)
Accumulated Other Comprehensive Income
Balance, beginning of period		63,275		43,386		56,325		40,690
Other comprehensive income (loss)		(2,145)		7,469		4,805		10,165
Balance, end of period		61,130		50,855		61,130		50,855
Accumulated Deficit
Balance, beginning of period		(3,147,964)		(3,424,185)		(3,239,978)		(3,480,362)
Net income attributable to common shareholders		79,621		48,621		171,635		104,798
Balance, end of period		(3,068,343)		(3,375,564)		(3,068,343)		(3,375,564)
Noncontrolling Interest
Balance, beginning of period		135,232		—		—		—
Sale of noncontrolling interest		—		—		132,132		—
Net income attributable to noncontrolling interest		5,686		—		8,786		—
Balance, end of period		140,918		—		140,918		—
Total stockholders’ equity	$	2,217,994	$	1,805,038	$	2,217,994	$	1,805,038
Common Stock Shares Outstanding
Number of shares, beginning of period		110,502		109,518		110,160		108,734
Issuances under stock plans		783		393		1,125		1,177
Number of shares, end of period		111,285		109,911		111,285		109,911
Treasury Shares
Number of shares, beginning of period		(52,902)		(46,198)		(52,766)		(44,427)
Repurchases of treasury stock		(225)		(2,926)		(361)		(4,697)
Number of shares, end of period		(53,127)		(49,124)		(53,127)		(49,124)

See accompanying notes to condensed consolidated financial statements.

6

SANMINA CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

	Six Months Ended
	April 1,		April 2,
	2023		2022
			(Restated)
	(Unaudited)
	(In thousands)
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income before noncontrolling interest	$	180,421	$	104,798
Adjustments to reconcile net income before noncontrolling interest to cash provided by (used in) operating activities:
Depreciation and amortization		57,818		55,032
Stock-based compensation expense		24,143		18,362
Deferred income taxes		13,558		9,173
Other, net		101		(1,903)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable		(66,479)		(79,308)
Contract assets		(10,569)		(67,092)
Inventories		136,447		(403,783)
Prepaid expenses and other assets		(25,381)		(11,334)
Accounts payable		(213,168)		362,191
Accrued liabilities		4,911		161,137
Cash provided by operating activities		101,802		147,273
CASH FLOWS PROVIDED BY (USED IN) INVESTING ACTIVITIES:
Purchases of property, plant and equipment		(100,978)		(52,650)
Proceeds from sales of property, plant and equipment		990		8,025
Purchases of investments		(1,500)		(1,000)
Cash used in investing activities		(101,488)		(45,625)
CASH FLOWS PROVIDED BY (USED IN) FINANCING ACTIVITIES:
Repayments of long-term debt		(8,750)		(9,376)
Proceeds from revolving credit facility borrowings		1,471,700		202,800
Repayments of revolving credit facility borrowings		(1,471,700)		(202,800)
Net proceeds from stock issuances		295		1,402
Repurchases of common stock		(21,507)		(182,321)
Proceeds from sale of noncontrolling interest		215,799		—
Cash provided by (used in) financing activities		185,837		(190,295)
Effect of exchange rate changes		2,195		(1,486)
Increase (decrease) in cash and cash equivalents		188,346		(90,133)
Cash and cash equivalents at beginning of period		529,857		650,026
Cash and cash equivalents at end of period	$	718,203	$	559,893
Cash paid during the period for:
Interest, net of capitalized interest	$	15,264	$	7,533
Income taxes, net of refunds	$	28,247	$	17,052
Unpaid purchases of property, plant and equipment at the end of period	$	34,973	$	18,264

See accompanying notes to condensed consolidated financial statements.

7

SANMINA CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Restatement of Condensed Consolidated Financial Statements

Sanmina Corporation (the “Company”) identified misstatements in the unaudited condensed consolidated financial statements for the comparative periods of 2022 in conjunction with an independent investigation conducted by the Audit Committee of the Board of Directors, as further disclosed in the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on May 11, 2023. The comparative periods have been amended and restated to correct for such misstatements. More detailed information related to the amendment and restatement is contained in Amendment No. 1 to the Company’s Annual Report on Form 10-K for the fiscal year ended October 1, 2022 and Amendment No. 1 to the Company’s Form 10-Q for the quarter ended December 31, 2022 as filed with the Securities and Exchange Commission on May 19, 2023.

During the preparation of its unaudited consolidated financial statements for the fiscal quarter ended April 1, 2023, the Company determined that certain personnel in one of its divisions had failed to properly substantiate and update cost estimates for materials and other costs over the life of certain contracts. As a result, the Company conducted an independent investigation (the “Investigation”) under the direction of the Audit Committee of the Company’s Board of Directors (the “Audit Committee”). The division, like other Company divisions, has a stand-alone finance organization, which reports directly to the Company finance organization and indirectly to the management of the division. References in the findings below refer solely to this division unless otherwise noted. The Investigation found that:

● In connection with the preparation and review of quarterly contract cost and other estimates, an internal control in the Company’s accounting process for the division’s contracts with customers, certain division personnel made inappropriate and unsupported adjustments to reduce certain cost estimates and failed to appropriately evaluate and increase other cost estimates to reflect cost overruns and other costs associated with delays in completing certain contracts.

● The division had a culture that did not recognize or emphasize the importance of rigor in the division’s quarterly contract estimate review process or its significance to the Company’s internal control over financial reporting and accounting and financial reporting determinations with respect to the division’s contracts with customers. Instead, the division’s tone at the top and other control weaknesses enabled participants in the quarterly contract estimate review process to tolerate, place undue reliance on or otherwise fail to challenge unsupported adjustments and assumptions to contract cost estimates that had been made based on unsubstantiated optimism and/or a desire to avoid adverse outcomes.

● The division had an ineffective finance function that did not provide sufficient oversight on financial accounting and reporting matters or effectively challenge adjustments or other improper practices in the quarterly contract estimate review process.

● Certain division personnel lacked sufficient understanding of the division’s policies and procedures for the quarterly contract estimate review process as well as the relevant cost and contract accounting practices and requirements.

● Certain division personnel provided materially inaccurate and incomplete information to, including in response to inquiries from, Company management and the Company’s internal and independent auditors concerning contract cost estimates and related items.

The “Previously Reported” amounts in the following tables are amounts derived from the Form 10-Q for the period ended April 2, 2022. The amounts in columns labeled “Investigation Adjustments” represent the effect of adjustments resulting from an independent investigation conducted by the Audit Committee of the Board of Directors and the amounts in columns labeled “Other Adjustments” represent the effect of uncorrected misstatements in previously filed financial statements that were not material, individually or in the aggregate, to those previously filed financial statements. The effects of the restatement, including the related income tax effects, have been corrected in all impacted tables and footnotes throughout these condensed consolidated financial statements. The only impact to the Condensed Consolidated Statements of Comprehensive Income and Condensed Consolidated Statements of Stockholders’ Equity was to net income.

Investigation Adjustments correct misstatements that resulted primarily from 1) increases to estimated costs at completion of a contract that previously did not properly reflect estimated costs remaining to be incurred to complete a contract, 2) reductions in the

8

amount of transaction consideration expected to be received under a contract, and 3) segmentation of contracts that had previously been combined. The adjustments primarily affected net sales, cost of sales, contract assets and inventory.

Other Adjustments primarily correct balance sheet misstatements related to inventory cut-off and advance payments from customers.

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Statements of Income for the three and six months ended April 2, 2022.

	Three Months Ended								Six Months Ended
	April 2, 2022								April 2, 2022
	(Unaudited)								(Unaudited)
	Previously		Investigation		Other				Previously		Investigation		Other
	Reported		Adjustments		Adjustments		As Restated		Reported		Adjustments		Adjustments			As Restated
	(In thousands, except per share data)
Net sales	$	1,911,530	$	3,540	$	—	$	1,915,070	$	3,668,855	$	2,541	$	—	$	3,671,396
Cost of sales		1,759,083		9,492		—		1,768,575		3,371,919		11,685		—		3,383,604
Gross profit		152,447		(5,952)		—		146,495		296,936		(9,144)		—		287,792
Operating expenses:
Selling, general and administrative		61,817		—		—		61,817		123,292		—		—		123,292
Research and development		5,472		—		—		5,472		10,249		—		—		10,249
Restructuring and other		2,932		—		—		2,932		4,346		—		—		4,346
Gain on sale of long-lived assets		—		—		—		—		(4,610)		—		—		(4,610)
Total operating expenses		70,221		—		—		70,221		133,277		—		—		133,277
Operating income		82,226		(5,952)		—		76,274		163,659		(9,144)		—		154,515
Interest income		349		—		—		349		658		—		—		658
Interest expense		(4,870)		—		—		(4,870)		(9,747)		—		—		(9,747)
Other income (expense), net		(1,408)		—		—		(1,408)		664		—		—		664
Interest and other, net		(5,929)		—		—		(5,929)		(8,425)		—		—		(8,425)
Income before income taxes		76,297		(5,952)		—		70,345		155,234		(9,144)		—		146,090
Provision for income taxes		23,077		(1,353)		—		21,724		43,380		(2,088)		—		41,292
Net Income	$	53,220	$	(4,599)		—	$	48,621	$	111,854	$	(7,056)	$	—	$	104,798
Net income per share:
Basic	$	0.85	$	(0.08)	$	—	$	0.77	$	1.76	$	(0.11)	$	—	$	1.65
Diluted	$	0.83	$	(0.07)	$	—	$	0.76	$	1.71	$	(0.11)	$	—	$	1.60
Weighted average shares used in computing per share amounts:
Basic		62,845		—		—		62,845		63,622		—		—		63,622
Diluted		64,271		—		—		64,271		65,365		—		—		65,365

9

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Balance Sheet as of October 1, 2022.

	As of
	October 1, 2022
	(Unaudited)
	Previously		Investigation		Other
	Reported		Adjustments		Adjustments		As Restated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	529,857	$	—	$	—	$	529,857
Accounts receivable, net of allowances		1,138,894		—		—		1,138,894
Contract assets		503,674		(27,953)		—		475,721
Inventories		1,691,081		(21,705)		14,723		1,684,099
Prepaid expenses and other current assets		62,044		—		—		62,044
Total current assets		3,925,550		(49,658)		14,723		3,890,615
Property, plant and equipment, net		575,170		—		—		575,170
Deferred tax assets		198,588		10,966		—		209,554
Other		160,192		—		—		160,192
Total assets	$	4,859,500	$	(38,692)	$	14,723	$	4,835,531
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	2,029,534	$	—	$	11,900	$	2,041,434
Accrued liabilities		275,735		1,441		4,423		281,599
Accrued payroll and related benefits		130,892		—		—		130,892
Short-term debt, including current portion of long-term debt		17,500		—		—		17,500
Total current liabilities		2,453,661		1,441		16,323		2,471,425
Long-term liabilities:
Long-term debt		329,237		—		—		329,237
Other		215,333		—		—		215,333
Total long-term liabilities		544,570		—		—		544,570
Contingencies (Note 8)
Stockholders’ equity		1,861,269		(40,133)		(1,600)		1,819,536
Total liabilities and stockholders’ equity	$	4,859,500	$	(38,692)	$	14,723	$	4,835,531

10

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Statements of Cash Flows for the six month period ended April 2, 2022. There were no adjustments to cash flows provided by (used in) investing or financing activities for the six month period ended April 2, 2022.

	Six Months Ended
	April 2, 2022
	(Unaudited)
	Previously		Investigation		Other
	Reported		Adjustments		Adjustments		As Restated
	(In thousands)
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income before noncontrolling interest	$	111,854	$	(7,056)	$	—	$	104,798
Adjustments to reconcile net income before noncontrolling interest to cash provided by (used in) operating activities:
Depreciation and amortization		55,032		—		—		55,032
Stock-based compensation expense		18,362		—		—		18,362
Deferred income taxes		11,071		(1,898)		—		9,173
Other, net		(1,903)		—		—		(1,903)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable		(79,705)		—		397		(79,308)
Contract assets		(68,545)		4,804		(3,351)		(67,092)
Inventories		(403,396)		4,628		(5,015)		(403,783)
Prepaid expenses and other assets		(11,334)		—		—		(11,334)
Accounts payable		357,176		—		5,015		362,191
Accrued liabilities		158,661		(478)		2,954		161,137
Cash provided by operating activities	$	147,273	$	—	$	—	$	147,273

Note 2. Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been omitted pursuant to those rules or regulations. The interim condensed consolidated financial statements are unaudited, but reflect all adjustments, consisting primarily of normal recurring adjustments, that are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended October 1, 2022, included in Amendment No. 1 on Form 10-K/A to the Company’s Annual Report on Form 10-K for such fiscal year filed with the SEC on May 19, 2023.

The unaudited condensed consolidated financial statements include all accounts of the Company, its wholly-owned subsidiaries and subsidiaries in which it has control. All intra-company accounts and transactions have been eliminated. Noncontrolling interest represents a noncontrolling investor’s interest in the results of operations of subsidiaries that the Company controls and consolidates.

The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates.

Results of operations for the second quarter of 2023 are not necessarily indicative of the results that may be expected for other interim periods or for the full fiscal year.

The Company operates on a 52 or 53 week year ending on the Saturday nearest September 30. Fiscal 2023 and 2022 are each 52-week years. All references to years relate to fiscal years unless otherwise noted.

11

Note 3. Revenue Recognition

The Company is a leading global provider of integrated manufacturing solutions, components, products and repair, logistics and after-market services. For purposes of determining when to recognize revenue, and in what amount, the Company applies a 5-step model: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the Company satisfies a performance obligation. Each of these steps may involve the use of significant judgments, as discussed below.

Step 1 - Identify the Contract with a Customer

A contract is defined as an agreement between two parties that creates enforceable rights and obligations. The Company generally enters into a master supply agreement (“MSA”) with its customers that provides the framework under which business will be conducted, and pursuant to which a customer will issue purchase orders or other binding documents to specify the quantity, price and delivery requirements for products or services the customer wishes to purchase. The Company generally considers its contract with a customer to be a firm commitment, consisting of the combination of an MSA and a purchase order or any other similar binding document.

Step 2 - Identify the Performance Obligations in the Contract

A performance obligation is a promised good or service that is material in the context of the contract and is both capable of being distinct (customer can benefit from the good or service on its own or together with other readily available resources) and distinct within the context of the contract (separately identifiable from other promises). The Company reviews its contracts to identify promised goods or services and then evaluates such items to determine which of those items are performance obligations. The majority of the Company’s contracts have a single performance obligation since the promise to transfer an individual good or service is not separately identifiable from other promises in the contract. The Company’s performance obligations generally have an expected duration of one year or less.

Step 3 - Determine the Transaction Price

The Company’s contracts with its customers may include certain forms of variable consideration such as early payment discounts, volume discounts and shared cost savings. The Company includes an estimate of variable consideration when determining the transaction price and the appropriate amount of revenue to be recognized. This estimate is limited to an amount which will not result in a significant reversal of revenue in a future period. Factors considered in the Company’s estimate of variable consideration are the potential amount subject to these contract provisions, historical experience and other relevant facts and circumstances.

Step 4 - Allocate the Transaction Price to the Performance Obligations in the Contract

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. In the event that more than one performance obligation is identified in a contract, the Company is required to allocate a portion of the transaction price to each performance obligation. This allocation would generally be based on the relative standalone price of each performance obligation, which most often would represent the price at which the Company would sell similar goods or services separately.

Step 5 - Recognize Revenue When (or as) a Performance Obligation is Satisfied

The Company is required to assess whether control of a product or services promised under a contract is transferred to the customer at a point-in-time or over time as the product is being manufactured or the services are being provided. If the criteria in ASC 606 for recognizing revenue on an over time basis are not met, revenue must be recognized at the point-in-time determined by the Company at which its customer obtains control of a product or service.

12

The Company has determined that revenue for the majority of its contracts is required to be recognized on an over time basis. This determination is based on the fact that 1) the Company does not have an alternative use for the end products it manufactures for its customers and has an enforceable right to payment, including a reasonable profit, for work-in-progress upon a customer’s cancellation of a contract for convenience or 2) the Company’s customer simultaneously receives and consumes the benefits provided by the Company’s services. For these contracts, revenue is recognized on an over time basis using the cost-to-cost method (ratio of costs incurred to date to total estimated costs at completion) which the Company believes best depicts the transfer of control to the customer. At least 95% of the Company’s revenue is recognized on an over time basis, which is as products are manufactured or services are performed. Because of this, and the fact that there is no work-in-process or finished goods inventory associated with contracts for which revenue is recognized on an over-time basis, 99% or more of the Company’s inventory at the end of a given period is in the form of raw materials. For contracts for which revenue is required to be recognized at a point-in-time, the Company recognizes revenue when it has transferred control of the related goods, which generally occurs upon shipment or delivery of the goods to the customer.

Application of the cost-to-cost method for government contracts in the Company’s Defense and Aerospace division requires the use of significant judgments with respect to estimated materials, labor and subcontractor costs included in the total estimated costs at completion. Additionally, the Company evaluates whether contract modifications for claims have been approved and, if so, estimates the amount, if any, of variable consideration that can be included in the transaction price of the contract. This division is an operating segment whose results are combined with eleven other operating segments and reported under Components, Products and Services (“CPS”) for segment reporting purposes. During the first half of 2023, CPS revenue and gross profit were $830 million and $118 million, respectively.

Estimates of materials, labor and subcontractor costs expected to be incurred to satisfy a performance obligation are updated on a quarterly basis. These estimates consider costs incurred to date and estimated costs to be incurred over the remaining expected period of performance to satisfy a performance obligation. Such estimates are reviewed each quarter by a group of employees that includes representatives from numerous functions such as engineering, materials, contracts, manufacturing, program management, finance and senior management. If a change in estimate is deemed necessary, the impact of the change is recognized in the period of change. Additionally, contract modifications for claims are assessed each quarter to determine whether the claims have been approved. If it is determined that a claim has been approved, the amount of the claim, if any, that can be included in transaction price is estimated considering a number of factors such as the length of time expected to lapse until uncertainty about the claim has been resolved and the extent to which our experience with claims for similar contracts has predictive value.

Contract Assets

A contract asset is recognized when the Company has recognized revenue, but has not issued an invoice to its customer for payment. Contract assets are classified separately on the unaudited condensed consolidated balance sheets and transferred to accounts receivable when rights to payment become unconditional. Because of the Company’s short manufacturing cycle times, the transfer from contract assets to accounts receivable generally occurs within the next fiscal quarter.

Other

Taxes assessed by governmental authorities that are both imposed on and concurrent with a specific revenue-producing transaction, and are collected by the Company from a customer, are excluded from revenue.

Shipping and handling costs associated with outbound freight after control of a product has transferred to a customer are accounted for as fulfillment costs and are included in cost of sales.

The Company applies the following practical expedients or policy elections under ASC 606:

● The promised amount of consideration under a contract is not adjusted for the effects of a significant financing component because, at inception of a contract, the Company expects the period between when a good or service is transferred to a customer and when the customer pays for that good or service will generally be one year or less.

● The Company has elected not to disclose information about remaining performance obligations that have original expected durations of one year or less, which is substantially all of the Company’s remaining performance obligations.

13

● Incremental costs of obtaining a contract are not capitalized if the period over which such costs would be amortized to expense is less than one year.

Disaggregation of Revenue

In the following table, revenue is disaggregated by segment, market sector and geography.

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(In thousands)
Segments:
IMS	$	1,919,158	$	1,549,416	$	3,846,270	$	2,966,327
CPS		400,945		365,654		829,641		705,069
Total	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396
End Markets:
Industrial, Defense, Medical and Automotive	$	1,361,843	$	1,158,260	$	2,701,871	$	2,212,232
Communications Networks and Cloud Infrastructure		958,260		756,810		1,974,040		1,459,164
Total	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396
Geography:
Americas (1)	$	1,112,778	$	902,111	$	2,248,529	$	1,698,132
APAC		853,492		714,379		1,767,833		1,405,450
EMEA		353,833		298,580		659,549		567,814
Total	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396

(1) Mexico represents approximately 70% and 60% of the Americas revenue and the U.S. represents approximately 30% and 40% of the Americas revenue for the six months ended April 1, 2023 and April 2, 2022, respectively.

Note 4. Financial Instruments

Fair Value Measurements

Fair Value of Financial Instruments

The fair values of cash equivalents (represents 21% of cash and cash equivalents), accounts receivable, accounts payable and short-term debt approximate carrying values due to the short-term duration of these instruments. Additionally, the fair value of variable rate long-term debt approximates carrying value as of April 1, 2023.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

The Company’s primary financial assets and financial liabilities measured at fair value on a recurring basis are deferred compensation plan assets and defined benefit plan assets, which are both measured using Level 1 inputs. Deferred compensation plan assets were $38 million and $37 million as of April 1, 2023 and October 1, 2022, respectively. Defined benefit plan assets were $17 million as of October 1, 2022 and are measured at fair value only in the fourth quarter of each year. Other financial assets and financial liabilities measured at fair value on a recurring basis include foreign exchange contracts and interest rate swaps, which are both measured using Level 2 inputs. Foreign exchange contracts were not material as of April 1, 2023 or October 1, 2022. Interest rate swaps had values of $3 million and $6 million as of April 1, 2023 and October 1, 2022, respectively.

Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis

Other non-financial assets, such as goodwill and other long-lived assets, are measured at fair value as of the date such assets are acquired or in the period an impairment is recorded.

14

Offsetting Derivative Assets and Liabilities

The Company has entered into master netting arrangements with each of its derivative counterparties that allows net settlement of derivative assets and liabilities under certain conditions, such as multiple transactions with the same currency maturing on the same date. The Company presents its derivative assets and derivative liabilities on a gross basis on the unaudited condensed consolidated balance sheets. The amount that the Company had the right to offset under these netting arrangements was not material as of April 1, 2023 or October 1, 2022.

Derivative Instruments

Foreign Exchange Rate Risk

The Company is exposed to certain risks related to its ongoing business operations. The primary risk managed by using derivative instruments is foreign currency exchange risk.

Forward contracts on various foreign currencies are used to manage foreign currency risk associated with forecasted foreign currency transactions and certain monetary assets and liabilities denominated in non-functional currencies. The Company’s primary foreign currency cash flows are in certain Asian and European countries, Israel and Mexico.

The Company had the following outstanding foreign currency forward contracts that were entered into to hedge foreign currency exposures:

	As of
	April 1,		October 1,
	2023		2022
Derivatives Designated as Accounting Hedges:
Notional amount (in thousands)	$	126,383	$	123,172
Number of contracts		50		50
Derivatives Not Designated as Accounting Hedges:
Notional amount (in thousands)	$	434,005	$	531,558
Number of contracts		42		43

The Company utilizes foreign currency forward contracts to hedge certain operational (“cash flow”) exposures resulting from changes in foreign currency exchange rates. Such exposures generally result from (1) forecasted non-functional currency sales and (2) forecasted non-functional currency materials, labor, overhead and other expenses. These contracts are designated as cash flow hedges for accounting purposes and are generally one to two months in duration but, by policy, may be up to twelve months in duration.

For derivative instruments that are designated and qualify as cash flow hedges, the Company excludes time value from its assessment of hedge effectiveness and recognizes the amount of time value in earnings over the life of the derivative instrument. Gains or losses on the derivative not caused by changes in time value are recorded in Accumulated Other Comprehensive Income (“AOCI”), a component of equity, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The amount of gain or loss recognized in Other Comprehensive Income on derivative instruments and the amount of gain or loss reclassified from AOCI into income were not material for any period presented herein.

The Company enters into short-term foreign currency forward contracts to hedge currency exposures associated with certain monetary assets and liabilities denominated in non-functional currencies. These contracts have maturities of up to two months and are not designated as accounting hedges. Accordingly, these contracts are marked-to-market at the end of each period with unrealized gains and losses recorded in other income (expense), net, in the unaudited condensed consolidated statements of income. The amount of gains or losses associated with these forward contracts was not material for any period presented herein. From an economic perspective, the objective of the Company’s hedging program is for gains and losses on forward contracts to substantially offset gains and losses on the underlying hedged items. In addition to the contracts disclosed in the table above, the Company has numerous contracts that have been closed from an economic and financial accounting perspective and will settle early in the first month of the following quarter. Since these offsetting contracts do not expose the Company to risk of fluctuations in exchange rates, these contracts have been excluded from the above table.

15

Interest Rate Risk

The Company enters into forward interest rate swap agreements with independent counterparties to partially hedge the variability in cash flows due to changes in the Secured Overnight Financing Rate (“SOFR”), which is the benchmark interest rate associated with anticipated variable rate borrowings. These interest rate swaps have maturity dates of December 1, 2023 and September 27, 2027 and effectively convert a portion of the Company’s variable interest rate obligations to fixed interest rate obligations. These swaps are accounted for as cash flow hedges under ASC Topic 815, Derivatives and Hedging. Interest rate swaps with an aggregate notional amount of $600 million and $350 million were outstanding as of April 1, 2023 and October 1, 2022, respectively. The aggregate effective interest rate of these swaps as of April 1, 2023 was approximately 4.4%. The interest rate swaps portfolio had a value of $3 million and $6 million as of April 1, 2023 and October 1, 2022, respectively, of which the majority is included in prepaid expenses and other current assets and the remaining amount is included in other long-term liabilities on the unaudited condensed consolidated balance sheets.

Note 5. Debt

Long-term debt consisted of the following:

	As of
	April 1,		October 1,
	2023		2022
	(In thousands)
Term loan due 2027, net of issuance costs	$	338,279	$	346,737
Less: Current portion of Term Loan due 2027		17,500		17,500
Long-term debt	$	320,779	$	329,237

Term Loan maturities as of April 1, 2023 by fiscal year are as follows:

	(In Thousands)
Remainder of 2023	$	8,750
2024		13,125
2025		17,500
2026		21,875
2027		280,000
	$	341,250

Revolving Credit Facility

During the fourth quarter of 2022, the Company entered into a Fifth Amended and Restated Credit Agreement (the “Credit Agreement”), that provides for an $800 million revolving credit facility and a $350 million secured term loan (“Term Loan Due 2027”). Subject to the satisfaction of certain conditions, including obtaining additional commitments from existing and/or new lenders, the Company may increase the revolving commitment up to an additional $200 million. The Term Loan Due 2027 was fully drawn upon on the closing date.

Loans under the Credit Agreement bear interest, at the Company’s option, at either the SOFR or a base rate, in each case plus a spread determined based on the Company’s credit rating. Interest on the loans is payable quarterly in arrears with respect to base rate loans and at the end of an interest period (or at three-month intervals if the interest period exceeds three months) in the case of SOFR loans. The outstanding principal amount of all loans under the Credit Agreement, including, the Term Loan Due 2027, together with accrued and unpaid interest, is due on September 27, 2027. The Company is required to repay a portion of the principal amount of the Term Loan Due 2027 equal to 1.25% of the principal in quarterly installments.

On May 17, 2023, as a result of the Company’s failure to timely file its Form 10-Q for the quarter ended April 1, 2023, the Company was in technical default with respect to certain covenants within its Credit Agreement. Because the Company is filing this Form 10-Q on May 19, 2023, which is within the stated cure period of 15 calendar days, the Company is no longer in default.

Certain of the Company’s domestic subsidiaries are guarantors under the Credit Agreement. The Company and the subsidiary guarantors’ obligations under the Credit Agreement are secured by a lien on substantially all of their respective assets (excluding real property), including cash, accounts receivable and the shares of certain Company subsidiaries, subject to certain exceptions.

16

As of April 1, 2023, there were no borrowings and $13 million of letters of credit outstanding under the Credit Agreement.

Foreign Short-term Borrowing Facilities

As of April 1, 2023, certain foreign subsidiaries of the Company had a total of $74 million of uncommitted short-term borrowing facilities available, under which no borrowings were outstanding.

Debt Covenants

The Credit Agreement requires the Company to comply with certain financial covenants, namely a maximum consolidated leverage ratio and a minimum interest coverage ratio, in both cases measured on the basis of a trailing 12-month look-back period. In addition, the Company’s debt agreements contain a number of restrictive covenants, including restrictions on incurring additional debt, making investments and other restricted payments, selling assets and paying dividends, subject to certain exceptions. The Company was in compliance with these covenants as of April 1, 2023.

Note 6. Leases

The Company’s leases consist primarily of operating leases for buildings and land and have initial lease terms of up to 44 years. Certain of these leases contain an option to extend the lease term for additional periods or to terminate the lease after an initial non-cancelable term. Renewal options are considered in the measurement of the Company’s initial lease liability and corresponding right-of-use (“ROU”) assets only if it is reasonably certain that the Company will exercise such options. Leases with lease terms of twelve months or less are not recorded on the Company’s balance sheet.

ROU assets and lease liabilities recorded in the unaudited condensed consolidated balance sheet are as follows:

	As of
	April 1,			October 1,
	2023			2022
	(In thousands)
Other assets	$	98,541		$	79,495
Accrued liabilities	$	20,960		$	16,695
Other long-term liabilities		65,602			48,566
Total lease liabilities	$	86,562		$	65,261
Weighted average remaining lease term (in years)		11.02			15.74
Weighted average discount rate		3.68	%		2.40	%

Lease expense and supplemental cash flow information related to operating leases are as follows:

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
	(In thousands)
Operating lease expense (1)	$	8,198	$	5,860	$	17,565	$	11,770

	Six Months Ended
	April 1,		April 2,
	2023		2022
	(In thousands)
Cash paid for operating lease liabilities	$	11,629	$	9,752

(1) Includes immaterial amounts of short term leases, variable lease costs and sublease income.

17

Future lease payments under non-cancelable operating leases as of April 1, 2023, by fiscal year, are as follows:

	Operating
	Leases
	(In thousands)
Remainder of 2023	$	12,268
2024		22,789
2025		19,976
2026		15,759
2027		12,502
2028		3,498
Thereafter		9,030
Total lease payments		95,822
Less: imputed interest		9,260
Total	$	86,562

Note 7. Accounts Receivable Sale Program

The Company is a party to a Receivable Purchase Agreement (the “RPA”) with certain third-party banking institutions for the sale of trade receivables generated from sales to certain customers, subject to acceptance by, and a funding commitment from, the banks that are party to the RPA. Trade receivables sold pursuant to the RPA are serviced by the Company.

In addition to the RPA, the Company has the option to participate in trade receivables sales programs that have been implemented by certain of the Company’s customers, as in effect from time to time. The Company does not service trade receivables sold under these other programs.

Under each of the programs noted above, the Company sells its entire interest in a trade receivable for 100% of face value, less a discount. During the six months ended April 1, 2023 and April 2, 2022, the Company sold approximately $1.7 billion and $371 million, respectively, of accounts receivable under these programs. Upon sale, these receivables are removed from the unaudited condensed consolidated balance sheets and cash received is presented as cash provided by operating activities in the unaudited condensed consolidated statements of cash flows. Discounts on sold receivables were $12 million and $0.4 million for the six months ended April 1, 2023 and April 2, 2022, respectively. As of April 1, 2023 and October 1, 2022, $238 million and $194 million, respectively, of accounts receivable sold under the RPA and subject to servicing by the Company remained outstanding and had not yet been collected. The Company’s sole risk with respect to receivables it services is with respect to commercial disputes regarding such receivables. Commercial disputes include billing errors, returns and similar matters. To date, the Company has not been required to repurchase any receivable it has sold due to a commercial dispute. Additionally, the Company is required to remit amounts collected as servicer under the RPA on a weekly basis to the financial institutions that purchased the receivables. As of April 1, 2023 and October 1, 2022, $75 million and $49 million, respectively, had been collected but not yet remitted. This amount is classified in accrued liabilities on the unaudited condensed consolidated balance sheets.

Note 8. Contingencies

From time to time, the Company is a party to litigation, claims and other contingencies, including environmental, regulatory and employee matters and examinations and investigations by governmental agencies, which arise in the ordinary course of business. The Company records a contingent liability when it is probable that a loss has been incurred and the amount of loss is reasonably estimable in accordance with ASC Topic 450, Contingencies, or other applicable accounting standards. As of April 1, 2023 and October 1, 2022, the Company had estimated liabilities of $36 million and $38 million, respectively, for environmental matters, warranty, litigation and other contingencies (excluding reserves for uncertain tax positions), which the Company believes are adequate. However, there can be no assurance that the Company’s reserves will be sufficient to settle these contingencies. Such reserves are included in accrued liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets.

18

Legal Proceedings

Environmental Matters

The Company is subject to various federal, state, local and foreign laws and regulations and administrative orders concerning environmental protection, including those addressing the discharge of pollutants into the environment, the management and disposal of hazardous substances, the cleanup of contaminated sites, the materials used in products, and the recycling, treatment and disposal of hazardous waste. As of April 1, 2023, the Company had been named in a lawsuit and several administrative orders alleging certain of its current and former sites contributed to groundwater contamination. One such order demands that the Company and other alleged defendants remediate groundwater contamination at four landfills located in Northern California to which the Company may have sent wastewater in the past. The Company is participating in a working group of other alleged defendants to better understand its potential exposure in this action and has reserved its estimated exposure for this matter as of April 1, 2023. However, there can be no assurance that the Company’s reserve will ultimately be sufficient.

In June 2008, the Company was named by the Orange County Water District in a suit alleging that a predecessor company’s actions at a plant the Company sold in 1998 contributed to polluted groundwater managed by the plaintiff. The complaint seeks recovery of compensatory and other damages, as well as declaratory relief, for the payment of costs necessary to investigate, monitor, remediate, abate and contain contamination of groundwater. In April 2013, all claims against the Company were dismissed. The plaintiff appealed this dismissal and the Court of Appeal reversed the judgment in August 2017, remanding the case back to the Superior Court of California for trial. The trial against the Company and several other defendants commenced in April 2021 and the submission of evidence concluded in May 2022. On April 3, 2023, the Court published a statement of decision finding the Company and other remaining defendants liable for certain past investigation costs incurred by the plaintiff. The Company believes a loss in this matter is probable and has recorded an estimated loss. There will be subsequent proceedings to assess the Company’s and other defendants’ liability for the plaintiff’s future remediation and other costs. It is probable that the Company will record additional losses in connection with this matter, and it is reasonably possible that the amount of such additional losses will be material. However, at the current time, the Company is unable to estimate the amount of such additional losses or a range of losses. The Company intends to continue defending the case vigorously and to seek appellate review at the appropriate time.

Other Matters

In October 2018, a contractor who had been retained by the Company through a third party temporary staffing agency filed a lawsuit against the Company in the Santa Clara County Superior Court on behalf of himself and all other similarly situated Company contractors and employees in California, alleging violations of California Labor Code provisions governing overtime, meal and rest periods, wages, wage statements and reimbursement of business expenses. The complaint sought certification of a class of all non-exempt employees. Although the Company continued to deny any wrongdoing, on November 19, 2020, the Company reached an agreement to resolve all claims, including claims under California’s Private Attorneys General Act of 2004 (the “Settlement”), which also resulted in the dismissal of a suit alleging substantially similar claims filed in the Santa Clara County Superior Court in June 2021. The final amount of the judicially approved Settlement was approximately $4 million and was paid during the first quarter of fiscal 2022.

In December 2019, the Company sued a former customer, Dialight plc (“Dialight”), in the United States District Court for the Southern District of New York to collect approximately $10 million in unpaid accounts receivable and net obsolete inventory obligations. Later the same day, Dialight commenced its own action in the same court. Dialight’s complaint, which asserts claims for fraudulent inducement, breach of contract and willful misconduct, alleges that the Company fraudulently misrepresented its capabilities to induce Dialight to enter into a Manufacturing Services Agreement (the “Dialight MSA”), and then breached its obligations contained in the Dialight MSA relating to quality, on-time delivery and supply chain management. Dialight seeks compensatory and punitive damages that it contends exceed $200 million, but which the Company believes are vastly overstated and subject to a contractual limitation of liability that limits any Dialight recovery to less than $2 million. In an Opinion and Order dated March 14, 2023, the Court granted in part the Company's motion for partial summary judgment and dismissed Dialight's willful misconduct claim. The Company continues to vigorously prosecute its claims against Dialight. Further, the Company strongly disagrees with Dialight’s allegations and is defending against them vigorously. No trial date has been set in this matter.

In May 2023, the Company and its SCI Technology, Inc. subsidiary (“SCI”) received Civil Investigative Demands (“CIDs”) from the United States Department of Justice (“DOJ") pursuant to the civil False Claims Act (“FCA”). The stated purpose of the CIDs—a form of subpoena requiring responses to written interrogatories and the production of documents relating to certain contracts, projects, proposals and business activities of SCI going back to 2010—is to determine whether there is or has been a violation of the

19

FCA with respect to the provision of products and services to the government. These CIDs supplement several CIDs relating to the same subject matter served upon SCI and certain current and former SCI and Sanmina employees beginning in August 2020 pursuant to which SCI has been producing documents and information and the current and former employees have provided or will provide oral testimony. To date, neither the Company nor SCI has been served with a complaint in this matter. The Company has been, and is, cooperating with the DOJ and continues to produce documents and other information responsive to the CIDs. The Company is unable to predict the ultimate outcome in this matter, although a loss currently is not considered to be probable or estimable.

For each of the pending matters noted above, the Company is unable to reasonably estimate a range of possible loss at this time.

Note 9. Income Tax

The Company estimates its annual effective income tax rate at the end of each quarterly period. The estimate takes into account the geographic mix of expected pre-tax income (loss), expected total annual pre-tax income (loss), enacted changes in tax laws, implementation of tax planning strategies and possible outcomes of audits and other uncertain tax positions. To the extent there are fluctuations in any of these variables during a period, the provision for income taxes may vary.

The Company’s provision for income taxes for the three months ended April 1, 2023 and April 2, 2022 was $26 million (23% of income before taxes) and $22 million (31% of income before taxes), respectively. The tax rate was lower for the three months ended April 1, 2023 due to $5 million of favorable discrete items related to excess tax benefit from stock compensation and adjustments to tax reserves.

The provision for income taxes for the six months ended April 1, 2023 and April 2, 2022 was $47 million (21% of income before taxes) and $41 million (28% of income before taxes), respectively. The tax rate was lower for the six months ended April 1, 2023 due to various discrete items, including the recognition of an $8 million tax benefit that resulted from the release of certain foreign tax reserves due to lapse of time and expiration of statutes of limitations.

Note 10. Stockholders’ Equity

Accumulated Other Comprehensive Income

Accumulated other comprehensive income, net of tax as applicable, consisted of the following:

	As of
	April 1,		October 1,
	2023		2022
	(In thousands)
Foreign currency translation adjustments	$	71,172	$	63,929
Unrealized holding gains on derivative financial instruments		2,020		4,112
Unrecognized net actuarial losses and transition costs for benefit plans		(12,062)		(11,716)
Total	$	61,130	$	56,325

Stock Repurchase Program

During the six months ended April 1, 2023 and April 2, 2022, the Company repurchased 3,800 and 4.4 million shares of its common stock for $0.2 million and $169 million, respectively, under stock repurchase programs authorized by the Board of Directors. There were no repurchases during the three months ended April 1, 2023. These programs have no expiration dates and the timing of repurchases will depend upon capital needs to support the growth of the Company’s business, market conditions and other factors. Although stock repurchases are intended to increase stockholder value, they also reduce the Company’s liquidity. As of April 1, 2023, an aggregate of $164 million remained available under these programs.

In addition to the repurchases discussed above, the Company withheld 0.4 million and 0.3 million shares of its common stock during the six months ended April 1, 2023 and April 2, 2022, respectively, in settlement of employee tax withholding obligations due upon the vesting of restricted stock units. The Company paid $21 million and $13 million for the six months ended April 1, 2023 and April 2, 2022, respectively, to applicable tax authorities in connection with these repurchases.

20

Note 11. Business Segment, Geographic and Customer Information

ASC Topic 280, Segment Reporting, establishes standards for reporting information about operating segments, products and services, geographic areas of operations and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker or decision making group in deciding how to allocate resources and in assessing performance.

The Company’s operations are managed as two businesses: Integrated Manufacturing Solutions (“IMS”) and CPS. The Company’s CPS business consists of multiple operating segments which do not meet the quantitative threshold for being presented individually as reportable segments. Therefore, financial information for these operating segments is presented in a single category entitled “CPS” and the Company has only one reportable segment - IMS.

The following table presents revenue and a measure of segment gross profit used by management to allocate resources and assess performance of operating segments:

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(In thousands)
Gross sales:
IMS	$	1,929,945	$	1,558,125	$	3,867,613	$	2,983,135
CPS		431,077		393,407		889,170		759,685
Intersegment revenue		(40,919)		(36,462)		(80,872)		(71,424)
Net sales	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396
Gross profit:
IMS	$	144,459	$	108,660	$	277,796	$	215,289
CPS		51,004		41,046		117,528		80,592
Total		195,463		149,706		395,324		295,881
Unallocated items (1)		(4,274)		(3,211)		(8,749)		(8,089)
Total	$	191,189	$	146,495	$	386,575	$	287,792

(1) For purposes of evaluating segment performance, management excludes certain items from its measure of gross profit. These items consist of stock-based compensation expense, amortization of intangible assets and litigation settlements

Net sales by geographic segment, determined based on the country in which a product is manufactured, were as follows:

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(In thousands)
Net sales:
Americas (1)	$	1,112,778	$	902,111	$	2,248,529	$	1,698,132
APAC		853,492		714,379		1,767,833		1,405,450
EMEA		353,833		298,580		659,549		567,814
Total	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396

(1) Mexico represents approximately 70% and 60% of the Americas revenue and the U.S. represents approximately 30% and 40% of the Americas revenue for the six months ended April 1, 2023 and April 2, 2022, respectively.

Percentage of net sales represented by ten largest customers	49	%	50	%	50	%	49	%
Number of customers representing 10% or more of net sales	1		2		1		2

21

Note 12. Earnings Per Share

Basic and diluted per share amounts are calculated by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during the period, as follows:

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(In thousands, except per share data)
Numerator:
Net income attributable to common shareholders	$	79,621	$	48,621	$	171,635	$	104,798
Denominator:
Weighted average common shares outstanding		58,269		62,845		57,999		63,622
Effect of dilutive stock options and restricted stock units		1,550		1,426		1,864		1,743
Denominator for diluted earnings per share		59,819		64,271		59,863		65,365
Net income attributable to common shareholders per share:
Basic	$	1.37	$	0.77	$	2.96	$	1.65
Diluted	$	1.33	$	0.76	$	2.87	$	1.60

Weighted-average dilutive securities that were excluded from the above calculation because their inclusion would have had an anti-dilutive effect under ASC Topic 260, Earnings per Share, due to application of the treasury stock method were not material for any period presented.

Note 13. Stock-Based Compensation

Stock-based compensation expense was recognized as follows:

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
	(In thousands)
Cost of sales	$	4,025	$	2,948	$	8,267	$	6,731
Selling, general and administrative		8,304		6,276		15,446		11,411
Research and development		205		106		430		220
Total	$	12,534	$	9,330	$	24,143	$	18,362

During the second quarter of 2023, the Company's stockholders approved the reservation of an additional 1.2 million shares of common stock for future issuance under the Company's 2019 Equity Incentive Plan. As of April 1, 2023, an aggregate of 6 million shares of common stock were authorized for future issuance under the Company’s stock plans, of which 3 million of such shares were issuable upon exercise of outstanding options and delivery of shares upon vesting of restricted stock units and 3 million shares of common stock were available for future grant.

Restricted and Performance Stock Units

The Company grants restricted stock units (“RSUs”) and restricted stock units with performance conditions (“PSUs”) to executive officers, directors and certain other employees. These units vest over periods ranging from one year to four years and/or upon achievement of specified performance criteria, with associated compensation expense recognized ratably over the vesting period.

22

The Company’s PSUs vest contingent on achievement of cumulative non-GAAP earnings per share measured over three fiscal years. If a minimum threshold is not achieved during the measurement period, the PSUs will be cancelled. If the minimum threshold is achieved or exceeded, the number of shares of common stock that will be issued will range from 70% to 130% of the number of PSUs granted, depending on the extent of performance. Additionally, the number of shares that vest may be adjusted up or down by up to 15% based on the Company’s total shareholder return relative to that of its peer group over this same period.

Activity with respect to the Company’s RSUs and PSUs was as follows:

			Weighted-
		Weighted-	Average
		Average Grant	Remaining	Aggregate
		Date	Contractual	Intrinsic
	Number of	Fair Value	Term	Value
	Shares	($)	(Years)	($)
	(In thousands)			(In thousands)
Outstanding as of October 1, 2022	3,280	37.11	1.35	155,049
Granted	922	60.07
Vested/Forfeited/Cancelled	(1,199)	35.25
Outstanding as of April 1, 2023	3,003	44.90	1.60	174,278
Expected to vest as of April 1, 2023	2,581	44.33	1.55	149,815

As of April 1, 2023, unrecognized compensation expense of $95 million is expected to be recognized over a weighted average period of 1.6 years.

Note 14. Strategic Transaction

India Joint Venture

On October 3, 2022, the Company completed a joint venture transaction pursuant to a Share Subscription and Purchase Agreement (the “SSPA”) and a Joint Venture and Shareholders’ Agreement (the “Shareholders’ Agreement”) previously entered into with Reliance Strategic Business Ventures Limited (“RSBVL”), a wholly owned subsidiary of Reliance Industries Limited. Pursuant to the SSPA and the Shareholders’ Agreement, the parties established Sanmina SCI India Private Limited (“SIPL”), the Company’s existing Indian manufacturing entity, as a joint venture to engage in manufacturing in India of telecommunications equipment, data center and internet equipment, medical equipment, clean technology equipment and other high-tech equipment. This partnership leverages the Company’s advanced manufacturing experience and RSBVL’s expertise and leadership in the Indian business ecosystem. In addition to supporting the Company’s current customer base, the joint venture will create a state-of-the-art ‘Manufacturing Technology Center of Excellence’ that will serve as an incubation center to support the product development and hardware start-up ecosystem in India, as well as promote research and innovation of leading-edge technologies.

As a result of the transaction, RSBVL acquired shares of SIPL for approximately $216 million of cash such that RSBVL holds 50.1% of the outstanding shares of SIPL and the Company holds the remaining 49.9% of the outstanding shares of SIPL. In connection with RSBVL’s investment, Sanmina and RSBVL entered into a management services contract pursuant to which Sanmina has the unilateral ability to make the significant financial and operating decisions made in the ordinary course of SIPL’s business.

In accordance with ASC 810, Consolidation, the Company is required to consolidate entities in which it has a controlling financial interest. The Company determined the voting interest model was applicable under ASC 810 and concluded that, despite not having a majority ownership interest, the Company has a controlling financial interest in SIPL through the management services contract. Therefore, the Company has, by contract, the unilateral ability to control the significant decisions made in the ordinary course of SIPL’s business. Because the Company has a controlling financial interest in SIPL, the Company continues to consolidate SIPL. However, the Company periodically assesses whether any changes in facts and circumstances have occurred that could require the Company to deconsolidate SIPL.

The Company recognized a noncontrolling interest of $132 million and an increase in additional paid-in-capital of $84 million in the unaudited condensed consolidated financial statements in connection with the sale of shares of SIPL to RSBVL. SIPL’s cash and cash equivalents balance of $171 million as of April 1, 2023, is not available for general corporate purposes and must be retained in SIPL to fund SIPL’s operations.

23

Note 15. Subsequent Event

On May 18, 2023, the Company received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) as a result of its failure to file this Quarterly Report on Form 10-Q for the fiscal quarter ended April 1, 2023 (the “Form 10-Q”) with the SEC by the required due date of May 16, 2023. The Notice stated that, under the Nasdaq Listing Rules, the Company has 60 calendar days, or until July 17, 2023, to submit a plan to regain compliance with Nasdaq’s continued listing requirements.

On May 19, 2023 the Company filed Amendment No. 1 to the Company’s Annual Report on Form 10-K for the fiscal year ended October 1, 2022, Amendment No. 1 to the Company’s Form 10-Q for the quarter ended December 31, 2022 and this Form 10-Q with the SEC. As a result of these filings, the Company believes it has regained compliance with Nasdaq Listing Rule 5250(c)(1) and that no further action will be taken with respect to the Notice.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This quarterly report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements relate to our expectations for future events and time periods. All statements other than statements of historical fact are statements that could be deemed to be forward-looking statements, including any statements regarding trends in future revenue or results of operations, gross margin, operating margin, expenses, earnings or losses from operations, or cash flow; any statements of the plans, strategies and objectives of management for future operations and the anticipated benefits of such plans, strategies and objectives; any statements regarding future economic conditions or performance; any statements regarding litigation or pending investigations, claims or disputes; any statements regarding the timing of closing of, future cash outlays for, and benefits of acquisitions and other strategic transactions, including our Indian joint venture; any statements regarding expected restructuring costs and benefits; any statements concerning the adequacy of our current liquidity and the availability of additional sources of liquidity; any statements regarding the potential impact of the COVID-19 pandemic on our business, results of operations and financial condition; any statements regarding the potential impact of supply chain shortages and inflation on our business; any statements regarding the future impact of tariffs and export controls on our business; any statements relating to the expected impact of accounting pronouncements not yet adopted; any statements regarding future repurchases of our common stock; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing. Generally, the words “anticipate,” “believe,” “plan,” “expect,” “future,” “intend,” “may,” “will,” “should,” “estimate,” “predict,” “potential,” “continue” and similar expressions identify forward-looking statements. Our forward-looking statements are based on current expectations, forecasts and assumptions and are subject to risks and uncertainties, including those contained in Part II, Item 1A of this report. As a result, actual results could vary materially from those suggested by the forward-looking statements. We undertake no obligation to publicly disclose any revisions to these forward-looking statements to reflect events or circumstances occurring subsequent to filing this report with the Securities and Exchange Commission (the “SEC”). Investors and others should note that Sanmina announces material financial information to our investors using our investor relations website (http://ir.sanmina.com/investor-relations/overview/default.aspx), SEC filings, press releases, public conference calls and webcasts. We use these channels to communicate with our investors and the public about Sanmina, its products and services and other issues. It is possible that the information we post on our investor relations website could be deemed to be material information. Therefore, we encourage investors, the media, and others interested in Sanmina to review the information we post on our investor relations website. The contents of our investor relations website are not incorporated by reference into this quarterly report on Form 10-Q or in any other report or document we file with the SEC.

Sanmina Corporation and its subsidiaries (“Sanmina”, the “Company”, “we” or “us”) operate on a 52 or 53 week year ending on the Saturday nearest September 30. Fiscal 2023 and 2022 are each 52-week years. All references to years relate to fiscal years unless otherwise noted.

Overview

We are a leading global provider of integrated manufacturing solutions, components, products and repair, logistics and after-market services. Our revenue is generated from sales of our products and services primarily to original equipment manufacturers (OEMs) that serve the industrial, medical, defense and aerospace, automotive, communications networks and cloud solutions industries.

24

Our operations are managed as two businesses:

1. Integrated Manufacturing Solutions (IMS). Our IMS segment consists of printed circuit board assembly and test, high-level assembly and test and direct-order-fulfillment.

2. Components, Products and Services (CPS). Components include printed circuit boards, backplanes and backplane assemblies, cable assemblies, fabricated metal parts, precision machined parts, and plastic injected molded parts. Products include memory solutions from our Viking Technology division; high-performance storage platforms for hyperscale and enterprise solutions from our Viking Enterprise Solutions (VES) division; optical, radio frequency (RF) and microelectronic (microE) design and manufacturing services from Advanced Microsystems Technologies; defense and aerospace products from SCI Technology; and cloud-based manufacturing execution software from our 42Q division. Services include design, engineering and logistics and repair.

Our only reportable segment for financial reporting purposes is IMS, which represented approximately 80% of our total revenue in the first half of 2023. Our CPS business consists of multiple operating segments which do not individually meet the quantitative thresholds for being presented as reportable segments. Therefore, financial information for these operating segments is combined and presented in a single category entitled “Components, Products and Services”.

Our strategy is to leverage our comprehensive product and service offerings, advanced technologies and global capabilities to further penetrate diverse end markets that we believe offer significant growth opportunities and have complex products that require higher value-added services. We believe this strategy differentiates us from our competitors and will help drive more sustainable revenue growth and provide opportunities for us to ultimately achieve operating margins that exceed industry standards.

There are many challenges to successfully executing our strategy. For example, we compete with a number of companies in each of our key end markets, including companies that are much larger than we are and smaller companies that focus on a particular niche. Although we believe we are well-positioned in each of our key end markets and seek to differentiate ourselves from our competitors, competition remains intense and profitably growing our revenues has been challenging. Additionally, the COVID-19 pandemic created a unique and challenging environment in which our revenue and profitability in 2021 and 2020 were significantly and negatively impacted. Although conditions have improved, our business continues to be impacted by ongoing supply chain constraints directly and indirectly caused by the pandemic. Thus, we believe it is possible that pandemic-related supply chain disruptions could continue to have a negative impact on our business, results of operations and financial condition for the foreseeable future.

A small number of customers have historically generated a significant portion of our net sales. Sales to our ten largest customers have typically represented approximately 50% of our net sales. One customer represented 10% or more of our net sales for the three and six months ended April 1, 2023. Two customers represented 10% or more of our net sales for the three and six months ended April 2, 2022.

We typically generate about 80% of our net sales from products manufactured in our foreign operations. The concentration of foreign operations has resulted primarily from a desire on the part of many of our customers to manufacture in lower cost locations in Asia, Latin America and Eastern Europe.

Historically, we have had substantial recurring sales to existing customers. We typically enter into supply agreements with our major OEM customers. These agreements generally have terms ranging from three to five years and cover the manufacture of a range of products. Under these agreements, a customer typically purchases its requirements for specific products in particular geographic areas from us. However, these agreements generally do not obligate the customer to purchase minimum quantities of products, which can have the effect of reducing revenue and profitability. In addition, some customer contracts contain cost reduction objectives, which can also have the effect of reducing revenue from such customers.

Over the past several years, the U.S., China, the E.U. and several other countries imposed tariffs impacting certain imported products. Although our customers are generally liable to us for reimbursement of tariffs we pay on components imported for the manufacture of their products, there can be no assurance that we will be successful in recovering all of the tariffs that are owed to us. Unrecovered tariffs paid on behalf of our customers reduce our gross margins. Also, although we are required to pay tariffs upon importation of components, we may not recover these amounts from customers until sometime later, which adversely impacts our operating cash flow in a given period. However, the net impact of tariffs, after recovery from customers, has not been, and is not expected to be, material to us.

25

Critical Accounting Policies and Estimates

Management’s discussion and analysis of our financial condition and results of operations are based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). We review the accounting policies used in reporting our financial results on a regular basis. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, net sales and expenses and related disclosure of contingent liabilities. On an ongoing basis, we evaluate the process used to develop estimates related to accounts receivable, inventories, income taxes, environmental matters, litigation and other contingencies, as well as estimates related to costs expected to be incurred to satisfy performance obligations under long-term contracts and variable consideration related to such contracts. We base our estimates on historical experience and on various other assumptions that we believe are reasonable for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Our actual results may differ materially from these estimates.

A complete description of our critical accounting policies and estimates is contained in Amendment No. 1 on Form 10-K/A to our Annual Report on Form 10-K for such fiscal year filed with the SEC on May 16, 2023.

Results of Operations

Key Operating Results

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(In thousands)
Net sales	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396
Gross profit	$	191,189	$	146,495	$	386,575	$	287,792
Operating income	$	120,601	$	76,274	$	249,027	$	154,515
Net income attributable to common shareholders	$	79,621	$	48,621	$	171,635	$	104,798

Net Sales

Sales by end market were as follows (dollars in thousands):

	Three Months Ended								Six Months Ended
	April 1,		April 2,						April 1,		April 2,
	2023		2022		Increase/(Decrease)				2023		2022		Increase/(Decrease)
			(Restated)								(Restated)
Industrial, Medical, Defense and Automotive	$	1,361,843	$	1,158,260	$	203,583	17.6	%	$	2,701,871	$	2,212,232	$	489,639	22.1	%
Communications Networks and Cloud Infrastructure		958,260		756,810		201,450	26.6	%		1,974,040		1,459,164		514,876	35.3	%
Total	$	2,320,103	$	1,915,070	$	405,033	21.1	%	$	4,675,911	$	3,671,396	$	1,004,515	27.4	%

Net sales increased 21.1% in the three months ended April 1, 2023 compared to the three months ended April 2, 2022 and 27.4% in the six months ended April 1, 2023 compared to the six months ended April 2, 2022. Sales in our communications networks and cloud infrastructure end market increased in both periods primarily due to improved material availability, strong demand and a new program in our telecommunications end market. Sales in our industrial, medical, defense and automotive end market increased in both periods primarily as a result of new programs, continued program ramps, improved material availability and strong demand.

Gross Margin

Gross margin increased to 8.2% for the three months ended April 1, 2023 from 7.6% for the three months ended April 2, 2022. IMS gross margin increased to 7.5% for the three months ended April 1, 2023, from 7.0% for the three months ended April 2, 2022 primarily due to increased volume. CPS gross margin increased to 11.8% for the three months ended April 1, 2023 from 10.4% for the three months ended April 2, 2022 primarily due to increased volume.

26

Gross margin increased to 8.3% for the six months ended April 1, 2023 from 7.8% for the six months ended April 2, 2022, primarily due to increased volume. IMS gross margin was 7.2% for the six months ended April 1, 2023 and the six months ended April 2, 2022. CPS gross margin increased to 13.2% for the six months ended April 1, 2023 from 10.6% for the six months ended April 2, 2022, primarily due to increased volume and improved operating efficiencies.

We have experienced fluctuations in gross margin in the past and may continue to do so in the future. Fluctuations in our gross margins may also be caused by a number of other factors, including:

● the impacts of supply chain constraints on our operations, the operations of our suppliers and on our customers’ businesses;

● capacity utilization which, if lower, results in lower margins due to fixed costs being absorbed by lower volumes;

● changes in the mix of high and low margin products demanded by our customers;

● competition in the EMS industry and pricing pressures from OEMs due to greater focus on cost reduction;

● the amount of our provisions for excess and obsolete inventory, including those associated with distressed customers;

● levels of operational efficiency and production yields; and

● our ability to transition the location of and ramp manufacturing and assembly operations when requested by a customer in a timely and cost-effective manner.

Selling, General and Administrative

Selling, General and Administrative expenses increased $1.6 million, from $61.8 million, or 3.2% of net sales, in the three months ended April 2, 2022 to $63.4 million, or 2.7% of net sales, in the three months ended April 1, 2023. The increase in absolute dollars was primarily due to an increase in our deferred compensation liability resulting from an increase in the market value of participant accounts in the second quarter of 2023, partially offset by reduced incentive compensation.

Selling, General and Administrative expenses increased $0.8 million, from $123.3 million, or 3.4% of net sales, in the six months ended April 2, 2022 to $124.1 million, or 2.7% of net sales, in the six months ended April 1, 2023.

Interest Income

Interest income for the three months ended April 1, 2023 and April 2, 2022 was $3 million and $0.3 million, respectively. Interest income for the six months ended April 1, 2023 and April 2, 2022 was $5 million and $0.7 million, respectively. The increases for the three and six months ended April 1, 2023 were primarily due to interest earned on investments purchased with a portion of the cash proceeds received from the sale of an equity interest related to a joint venture transaction that closed on October 3, 2022.

Interest Expense

Interest expense for the three months ended April 1, 2023 and April 2, 2022 was $9 million and $5 million, respectively. Interest expense for the six months ended April 1, 2023 and April 2, 2022 was $18 million and $10 million, respectively. The increases for the three and six months ended April 1, 2023 were primarily due to higher utilization of our revolving credit facility and higher interest rates during the three and six months ended April 1, 2023 compared to the same periods in 2022.

Other Income (Expense), Net

Other income (expense), net for the three months ended April 1, 2023 and April 2, 2022, was $(3) million and $(1) million, respectively. The increase in the three months ended April 1, 2023 was primarily due to a $6 million increase in fees relating to accounts receivable factoring due to increased amounts factored compared to the same period in 2022, the impact of a strengthening of the US dollar against other key currencies in which our expenses are denominated compared to the same period in 2022, and an increase in exposure to the Indian Rupee, which strengthened in the three months ended April 1, 2023 compared to the period in 2022,

27

as a result of our receipt of consideration in that currency from a joint venture transaction that closed in the first quarter of 2023. These increases were partially offset by a $4 million increase in the market value of participant investment accounts in our deferred compensation plan compared to the same period in 2022.

Other income (expense), net for the six months ended April 1, 2023 and April 2, 2022 was $(9) million and $0.7 million, respectively. The increase in the six months ended April 1, 2023 was primarily due to a $12 million increase in fees relating to accounts receivable factoring due to increased amounts factored compared to the same period in 2022, and the other factors listed above. These increases were partially offset by a $3 million increase in the market value of participant investment accounts in our deferred compensation plan compared to the same period in 2022.

Provision for Income Taxes

Our provision for income taxes for the three months ended April 1, 2023 and April 2, 2022 was $26 million (23% of income before taxes) and $22 million (31% of income before taxes), respectively. The tax rate was lower for the three months ended April 1, 2023 due to favorable discrete tax items.

Our provision for income taxes for the six months ended April 1, 2023 and April 2, 2022 was $47 million (21% of income before taxes) and $41 million (28% of income before taxes), respectively. The tax rate was lower for the six months ended April 1, 2023 due to favorable discrete tax items, including the recognition of an $8 million tax benefit that resulted from the release of certain foreign tax reserves due to lapse of time and expiration of statutes of limitations.

Net Income Attributable to Noncontrolling Interest

On October 3, 2022, we completed a joint venture transaction pursuant to a Share Subscription and Purchase Agreement (the “SSPA”) and a Joint Venture and Shareholders’ Agreement (the “Shareholders’ Agreement”) previously entered into with Reliance Strategic Business Ventures Limited (“RSBVL”), a wholly owned subsidiary of Reliance Industries Limited. Pursuant to the SSPA and the Shareholders’ Agreement, the parties established Sanmina SCI India Private Limited (“SIPL”), our existing Indian manufacturing entity, as a joint venture to engage in manufacturing in India of telecommunications equipment, data center and internet equipment, medical equipment, clean technology equipment and other high-tech equipment. This partnership leverages our advanced manufacturing experience and RSBVL’s expertise and leadership in the Indian business ecosystem. In addition to supporting our current customer base, the joint venture will create a state-of-the-art ‘Manufacturing Technology Center of Excellence’ that will serve as an incubation center to support the product development and hardware start-up ecosystem in India, as well as promote research and innovation of leading-edge technologies.

As a result of the transaction, RSBVL acquired shares of SIPL for approximately $216 million of cash such that RSBVL holds 50.1% of the outstanding shares of SIPL and we hold the remaining 49.9% of the outstanding shares of SIPL. In connection with RSBVL’s investment, Sanmina and RSBVL entered into a management services contract pursuant to which Sanmina has the unilateral ability to make the significant financial and operating decisions made in the ordinary course of SIPL’s business.

In accordance with ASC 810, Consolidation, we are required to consolidate entities in which we have a controlling financial interest. We determined the voting interest model was applicable under ASC 810 and concluded that, despite not having a majority ownership interest, we have a controlling financial interest in SIPL through the management services contract. Therefore, we have, by contract, the unilateral ability to control the significant decisions made in the ordinary course of SIPL’s business. Because we have a controlling financial interest in SIPL, we continue to consolidate SIPL. However, we periodically assess whether any changes in facts and circumstances have occurred that could require us to deconsolidate SIPL.

Net income attributable to noncontrolling interest for the three and six months ended April 1, 2023 was $6 million and $9 million, respectively.

28

Liquidity and Capital Resources

	Six Months Ended
	April 1,		April 2,
	2023		2022
		(In thousands)
Net cash provided by (used in):
Operating activities	$	101,802	$	147,273
Investing activities		(101,488)		(45,625)
Financing activities		185,837		(190,295)
Effect of exchange rate changes on cash and cash equivalents		2,195		(1,486)
Increase (Decrease) in cash and cash equivalents	$	188,346	$	(90,133)

Key Working Capital Management Measures

	As of
	April 1,	October 1,
	2023	2022
		(Restated)
Days sales outstanding (1)	49	48
Contract asset days (2)	18	19
Inventory turns (3)	5.2	5.0
Days inventory on hand (4)	70	73
Accounts payable days (5)	85	90
Cash cycle days (6)	52	50

(1) Days sales outstanding (a measure of how quickly we collect our accounts receivable), or “DSO”, is calculated as the ratio of average accounts receivable, net, to average daily net sales for the quarter.

(2) Contract asset days (a measure of how quickly we transfer contract assets to accounts receivable) are calculated as the ratio of average contract assets to average daily net sales for the quarter.

(3) Inventory turns (annualized) (a measure of how quickly we sell inventory) are calculated as the ratio of four times our cost of sales for the quarter to average inventory.

(4) Days inventory on hand (a measure of how quickly we turn inventory into sales) is calculated as the ratio of average inventory for the quarter to average daily cost of sales for the quarter.

(5) Accounts payable days (a measure of how quickly we pay our suppliers), or “DPO”, is calculated as the ratio of 365 days divided by accounts payable turns, in which accounts payable turns is calculated as the ratio of four times our cost of sales for the quarter to average accounts payable.

(6) Cash cycle days (a measure of how quickly we convert investments in inventory to cash) is calculated as days inventory on hand plus days sales outstanding and contract assets days minus accounts payable days.

Cash and cash equivalents were $718 million at April 1, 2023 and $530 million at October 1, 2022. This increase was driven largely by our receipt of approximately $216 million from the sale of shares of SIPL to RSBVL subsequent to our 2022 fiscal year end. Our cash levels vary during any given quarter depending on the timing of collections from customers and payments to suppliers, borrowings under our credit facilities, sales of accounts receivable under numerous programs we utilize, repurchases of common stock and other factors. Our working capital was $1.8 billion and $1.4 billion as of April 1, 2023 and October 1, 2022, respectively.

Net cash provided by operating activities was $102 million and $147 million for the six months ended April 1, 2023 and April 2, 2022, respectively. Cash flows from operating activities consist of: (1) net income before noncontrolling interest adjusted to exclude non-cash items such as depreciation and amortization, deferred income taxes and stock-based compensation expense, and (2) changes in net operating assets, which are comprised of accounts receivable, contract assets, inventories, prepaid expenses and other assets, accounts payable, accrued liabilities and other long-term liabilities. Our working capital metrics tend to fluctuate from quarter-to-quarter based on factors such as the linearity of our shipments to customers and purchases from suppliers, customer and supplier

29

mix, the extent to which we factor customer receivables and the negotiation of payment terms with customers and suppliers. These fluctuations can significantly affect our cash flows from operating activities.

During the six months ended April 1, 2023, we generated $276 million of cash primarily from earnings, excluding non-cash items, and used $174 million of cash due primarily to an increase in accounts receivable and a decrease in accounts payable, partially offset by a decrease in inventory. Individual components of operating assets and liabilities fluctuate for a number of reasons, including linearity of purchases and sales, the mix of customer and supplier payment terms within our accounts receivable and accounts payable, and the amount and timing of sales of accounts receivable. The increase in accounts receivable is primarily attributable to an increase in sales and billings to customers for their inventory obligations. The decrease in inventory is primarily due to improved availability of supply-constrained parts which reduced the need for us to carry other inventory while waiting for these supply-constrained parts to become available and the impact of other inventory reduction initiatives such as working more closely with our customers to ensure their demand forecasts properly consider the current supply chain environment to the extent possible. The decrease in accounts payable was primarily attributable to lower inventory receipts and unfavorable supplier payment terms mix.

Net cash used in investing activities was $101 million and $46 million for the six months ended April 1, 2023 and April 2, 2022, respectively. During the six months ended April 1, 2023, we used $101 million of cash for capital expenditures. During the six months ended April 2, 2022, we used $53 million of cash for capital expenditures, purchased $1 million of long-term investments and received proceeds of $8 million primarily from the sale of a certain property.

Net cash provided by (used in) financing activities was $186 million and $(190) million for the six months ended April 1, 2023 and April 2, 2022, respectively. During the six months ended April 1, 2023, we received $216 million from sale of shares of SIPL to RSBVL and used $22 million of cash to repurchase common stock primarily related to employee tax withholding on vested restricted stock units and repaid $9 million of long-term debt. During the six months ended April 2, 2022, we used $182 million of cash to repurchase common stock (including $13 million related to employee tax withholding on vested restricted stock units), repaid an aggregate of $9 million of long-term debt and received $1 million of net proceeds from issuances of common stock pursuant to stock option exercises.

Other Liquidity Matters

On May 17, 2023, as a result of our failure to timely file our Form 10-Q for the quarter ended April 1, 2023, we were in technical default with respect to certain covenants within our Credit Agreement. Because we are filing this Form 10-Q on May 19, 2023, which is within the stated cure period of 15 calendar days, we are no longer in default.

During the six months ended April 1, 2023 and April 2, 2022, we repurchased 3,800 and 4.4 million shares of our common stock for $0.2 million and $169 million, respectively, under stock repurchase programs authorized by the Board of Directors. There were no repurchases during the three months ended April 1, 2023. These programs have no expiration dates and the timing of repurchases will depend upon capital needs to support the growth of our business, market conditions and other factors. Although stock repurchases are intended to increase stockholder value, they also reduce our liquidity. As a result, the timing of future repurchases depends upon our future capital needs, market conditions and other factors. As of April 1, 2023, an aggregate of $164 million remained available under these programs.

We are a party to a Receivable Purchase Agreement (the “RPA”) with certain third-party banking institutions for the sale of trade receivables generated from sales to certain customers, subject to acceptance by, and a funding commitment from, the banks that are party to the RPA. As of April 1, 2023, a maximum of $542 million of sold receivables can be outstanding at any point in time under this program, as amended, as required by our Fifth Amended Credit Agreement (the “Credit Agreement”). Additionally, the amount available under the RPA is uncommitted and, as such, is available at the discretion of our third-party banking institutions. Under the Credit Agreement, the percentage of our total accounts receivable that can be sold and outstanding at any time is 50%. Trade receivables sold pursuant to the RPA are serviced by us.

In addition to the RPA, we participate in trade receivables sales programs that have been implemented by certain of our customers, as in effect from time to time. We do not service trade receivables sold under these other programs.

The sale of receivables under all of these programs is subject to the approval of the banks or customers involved and there can be no assurance that we will be able to sell the maximum amount of receivables permitted by these programs when desired.

30

Under each of the programs noted above, we sell our entire interest in a trade receivable for 100% of face value, less a discount. During the six months ended April 1, 2023 and April 2, 2022, we sold approximately $1.7 billion and $371 million, respectively, of accounts receivable under these programs. Upon sale, these receivables are removed from the unaudited condensed consolidated balance sheets and cash received is presented as cash provided by operating activities in the unaudited condensed consolidated statements of cash flows. Discounts on sold receivables were not material for any period presented. As of April 1, 2023 and October 1, 2022, $238 million and $194 million, respectively, of accounts receivable sold under the RPA and subject to servicing by us remained outstanding and had not yet been collected. Our sole risk with respect to receivables we service is with respect to commercial disputes regarding such receivables. Commercial disputes include billing errors, returns and similar matters. To date, we have not been required to repurchase any receivable we have sold due to a commercial dispute. Additionally, we are required to remit amounts collected as servicer on a weekly basis to the financial institutions that purchased the receivables. As of April 1, 2023 and October 1, 2022, $75 million and $49 million, respectively, had been collected but not yet remitted. This amount is classified in accrued liabilities on the unaudited condensed consolidated balance sheets.

We enter into forward interest rate swap agreements with independent counterparties to partially hedge the variability in cash flows due to changes in the Secured Overnight Financing Rate (“SOFR”), which is the benchmark interest rate associated with anticipated variable rate borrowings. These interest rate swaps have maturity dates of December 1, 2023 and September 27, 2027 and effectively convert a portion of our variable interest rate obligations to fixed interest rate obligations. These swaps are accounted for as cash flow hedges under ASC Topic 815, Derivatives and Hedging. Interest rate swaps with an aggregate notional amount of $600 million and $350 million were outstanding as of April 1, 2023 and October 1, 2022, respectively. The aggregate effective interest rate of these swaps as of April 1, 2023 was approximately 4.4%. The interest rate swaps portfolio had a value of $3 million and $6 million as of April 1, 2023 and October 1, 2022, respectively, of which the majority is included in prepaid expenses and other current assets and the remaining amount is included in other long-term liabilities on the unaudited condensed consolidated balance sheets.

In the ordinary course of business, we are or may become party to legal proceedings, claims and other contingencies, including environmental, regulatory, warranty and employee matters and examinations by government agencies. As of April 1, 2023, we had accrued liabilities of $36 million related to such matters. We cannot accurately predict the outcome of these matters or the amount or timing of cash flows that may be required to defend ourselves or to settle such matters or that these reserves will be sufficient to fully satisfy our contingent liabilities.

As of April 1, 2023, we had a liability of $53 million for uncertain tax positions. Our estimate of liabilities for uncertain tax positions is based on a number of subjective assessments, including the likelihood of a tax obligation being assessed, the amount of taxes (including interest and penalties) that would ultimately be payable, and our ability to settle any such obligations on favorable terms. Therefore, the amount of future cash flows associated with uncertain tax positions may be significantly higher or lower than our recorded liability and we are unable to reliably estimate when cash settlement may occur.

Our liquidity is largely dependent on changes in our working capital, including sales of accounts receivable under our receivables sales programs and the extension of trade credit by our suppliers, investments in manufacturing inventory, facilities and equipment, repayments of obligations under outstanding indebtedness and repurchases of common stock. We generated $102 million of cash from operations in the second quarter of 2023. Our primary sources of liquidity as of April 1, 2023 consisted of (1) cash and cash equivalents of $718 million (an aggregate of $171 million of our cash is held by our Indian joint venture and may not be used for general corporate purposes); (2) our Credit Agreement, under which $787 million, net of outstanding borrowings and letters of credit, was available; (3) our uncommitted foreign short-term borrowing facilities of $74 million, all of which was available; (4) proceeds from the sale of accounts receivable under our receivables sales programs and (5) cash generated from operations. Subject to satisfaction of certain conditions, including obtaining additional commitments from existing and/or new lenders, we may increase the revolving commitments under the Credit Agreement up to an additional $200 million.

We believe our existing cash resources and other sources of liquidity, together with cash generated from operations, will be sufficient to meet our working capital requirements through at least the next 12 months. However, should demand for our services decrease significantly over the next 12 months, should we be unable to recover on inventory obligations owed to us by our customers or should we experience significant increases in delinquent or uncollectible accounts receivable for any reason, our cash provided by operations could decrease significantly and we could be required to seek additional sources of liquidity to continue our operations at their current level.

We distribute our cash among a number of financial institutions that we believe to be of high quality. However, there can be no assurance that one or more of such institutions will not become insolvent in the future, in which case all or a portion of our uninsured funds on deposit with such institutions could be lost.

31

As of April 1, 2023, 43% of our cash balance was held in the United States. Should we choose or need to remit cash to the United States from our foreign locations, we may incur tax obligations which would reduce the amount of cash ultimately available to the United States. We believe that cash held in the United States, together with liquidity available under our Credit Agreement and cash from foreign subsidiaries that could be remitted to the United States without tax consequences, will be sufficient to meet our United States liquidity needs for at least the next twelve months.

Off-Balance Sheet Arrangements

As of April 1, 2023, we did not have any off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K promulgated by the SEC, that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues, or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.

32

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk

Our primary exposure to market risk for changes in interest rates relates to our Term Loan Due 2027 of $341 million under our Credit Agreement under which $341 million is currently outstanding and for which the interest rate we pay is based on a floating index. As of April 1, 2023, we had interest rate swaps with an aggregate notional amount of $600 million that effectively convert the $341 million of our floating rate debt outstanding to fixed rate debt. An immediate 10 percent change in interest rates would not have a significant impact on our results of operations.

Foreign Currency Exchange Risk

We transact business in foreign currencies. Our foreign exchange policy requires that we take certain steps to limit our foreign exchange exposures resulting from certain assets and liabilities and forecasted cash flows. However, our policy does not require us to hedge all foreign exchange exposures. Furthermore, our foreign currency hedges are based on forecasted transactions and estimated balances, the amount of which may differ from that actually incurred. As a result, we can experience foreign exchange gains and losses in our results of operations.

Our primary foreign currency cash flows are in certain Asian and European countries, Israel and Mexico. We enter into short-term foreign currency forward contracts to hedge currency exposures associated with certain monetary assets and liabilities denominated in non-functional currencies. These contracts generally have maturities of up to two months and these forward contracts are not designated as part of a hedging relationship for accounting purposes. Accordingly, all outstanding foreign currency forward contracts are marked-to-market at the end of the period with unrealized gains and losses included in other income (expense), net, in the unaudited condensed consolidated statements of income. From an economic perspective, the objective of our hedging program is for gains or losses on forward contracts to substantially offset gains and losses on the underlying hedged items. As of April 1, 2023, we had outstanding foreign currency forward contracts to exchange various foreign currencies for U.S. dollars in an aggregate notional amount of $434 million.

We also utilize foreign currency forward contracts to hedge certain operational (“cash flow”) exposures resulting from changes in foreign currency exchange rates. Such exposures result from (1) forecasted non-functional currency sales and (2) forecasted non-functional currency materials, labor, overhead and other expenses. These contracts may be up to twelve months in duration and are designated as cash flow hedges for accounting purposes. The effective portion of changes in the fair value of the contracts is recorded in stockholders’ equity as a separate component of accumulated other comprehensive income and recognized in earnings when the hedged item affects earnings. We had forward contracts related to cash flow hedges in various foreign currencies in the aggregate notional amount of $126 million as of April 1, 2023.

The net impact of an immediate 10 percent change in exchange rates would not be material to our unaudited condensed consolidated financial statements, provided we accurately forecast and estimate our foreign currency exposure. If such forecasts are materially inaccurate, we could incur significant gains or losses.

Item 4. Controls and Procedures

(a)Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures will prevent all errors and all fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that their objectives are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits of disclosure controls and procedures must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of disclosure controls and procedures can provide absolute assurance that all disclosure control issues and instances of fraud, if any, have been detected. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of April 1, 2023. Based on their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of April 1, 2023 because of the material weaknesses in our internal control over financial reporting discussed below.

33

(b)Material Weaknesses in Internal Control Over Financial Reporting

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected in a timely basis.

We identified material weaknesses in the control environment at one of our divisions due to the division maintaining an inappropriate tone at the top. Specifically, division management did not sufficiently promote, monitor or enforce appropriate accounting policies and procedures, thereby resulting in inappropriate and unsupported adjustments to the quarterly contract cost estimate process. Additionally, we did not maintain a sufficient complement of finance personnel at the division with an appropriate level of expertise, knowledge and training in internal control over financial reporting commensurate with our financial reporting requirements. These material weaknesses contributed to an additional material weakness that the division did not design and maintain effective controls over the quarterly contract estimate review process, which lead to the failure to timely and appropriately record adjustments to quarterly estimates.

These material weaknesses resulted in the restatement of our consolidated financial statements for the fiscal years ended October 3, 2020, October 2, 2021 and October 1, 2022 and for the quarterly fiscal periods included in such fiscal years and for the first fiscal quarter ended December 31, 2022. Additionally, these material weaknesses could result in misstatements of the accounts and disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected.

Management intends to remediate the material weaknesses described above primarily by ensuring that relevant program management and finance personnel possess sufficient knowledge and experience and are sufficiently engaged to identify, escalate and drive closure of matters that could impact estimated long-term customer program costs and require the recording of additional expenses in the Company’s financial statements. This is expected to be achieved through replacements or new hires and organizational realignment, whereby financial analysts whose duties include assessing these estimates will report to senior finance personnel rather than program management. In addition, management believes the recent hiring of a senior division controller for the affected division with significant experience in accounting for the long-term contracts at issue will assist in the remediation of the controls in question.

We believe these measures, and others that may be implemented, will remediate the material weaknesses in internal control over financial reporting described above.

The material weaknesses will not be considered formally remediated until the controls have operated effectively for a sufficient period of time and management has concluded, through testing, that the controls are operating effectively.

(c)Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that occurred during the quarter ended April 1, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

34

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

In June 2008, we were named by the Orange County Water District in a suit alleging that a predecessor company’s actions at a plant we sold in 1998 contributed to polluted groundwater managed by the plaintiff. The complaint seeks recovery of compensatory and other damages, as well as declaratory relief, for the payment of costs necessary to investigate, monitor, remediate, abate and contain contamination of groundwater. In April 2013, all claims against us were dismissed. The plaintiff appealed this dismissal and the Court of Appeal reversed the judgment in August 2017, remanding the case back to the Superior Court of California for trial. The trial commenced in April 2021 and the submission of evidence concluded in May 2022. On April 3, 2023, the Court published a statement of decision finding us and the other remaining defendants liable for certain past investigation costs incurred by the plaintiff. We believe a loss in this matter is probable and have recorded an estimated loss. There will be subsequent proceedings to assess our and other defendants’ liability for the plaintiff’s future remediation and other costs. It is probable that we will record additional losses in connection with this matter, and it is reasonably possible that the amount of such additional losses will be material. However, at the current time, we are unable to estimate the amount of such additional losses or a range of losses. We intend to continue defending the case vigorously and to seek appellate review at the appropriate time.

On December 20, 2019, we sued our former customer, Dialight plc (“Dialight”), in the United States District Court for the Southern District of New York to collect approximately $10 million in unpaid accounts receivable and net obsolete inventory obligations. Later the same day, Dialight commenced its own action in the same court. Dialight’s complaint, which asserts claims for fraudulent inducement, breach of contract and willful misconduct, alleges that we fraudulently misrepresented our capabilities to induce Dialight to enter into a Manufacturing Services Agreement (“Dialight MSA”), and then breached our obligations under the Dialight MSA relating to quality, on-time delivery and supply chain management. Dialight seeks compensatory and punitive damages that it contends exceed $200 million, but which we believe are vastly overstated and subject to a contractual limitation of liability that limits any Dialight recovery to less than $2 million. In an Opinion and Order dated March 14, 2023, the Court granted in part our motion for partial summary judgment and dismissed Dialight’s willful misconduct claim. We continue to vigorously prosecute our claims against Dialight. Further, we strongly disagree with Dialight’s allegations and are defending against them vigorously. No trial date has been set in this matter.

In May 2023, Sanmina and its SCI Technology, Inc. subsidiary (“SCI”) received Civil Investigative Demands (“CIDs”) from the United States Department of Justice (“DOJ”) pursuant to the civil False Claims Act (“FCA”). The stated purpose of the CIDs—a form of subpoena requiring responses to written interrogatories and the production of documents relating to certain contracts, projects, proposals and business activities of SCI going back to 2010—is to determine whether there is or has been a violation of the FCA with respect to the provision of products and services to the government. These CIDs supplement several CIDs relating to the same subject matter served upon SCI and certain current and former SCI and Sanmina employees beginning in August 2020 pursuant to which SCI has been producing documents and information and the current and former employees have provided or will provide oral testimony. To date, neither Sanmina nor SCI has been served with a complaint in this matter. We have been, and are, cooperating with the DOJ and continue to produce documents and other information responsive to the CIDs. We are unable to predict the ultimate outcome in this matter, although a loss currently is not considered to be probable or estimable.

In addition, from time to time, we may become involved in routine legal proceedings, demands, claims, threatened litigation and regulatory inquiries and investigations that arise in the normal course of our business. We record liabilities for such matters when a loss becomes probable and the amount of loss can be reasonably estimated. The ultimate outcome of any litigation is uncertain and unfavorable outcomes could have a negative impact on our results of operations and financial condition. Regardless of outcome, litigation can have an adverse impact on us as a result of incurrence of litigation costs, diversion of management resources, and other factors.

Refer also to Note 8 to the Condensed Consolidated Financial Statements.

35

Item 1A. Risk Factors

End Market and Operational Risks

Worldwide supply chain shortages caused by the COVID-19 pandemic, the resumption of strong worldwide demand for electronic products and components and geopolitical events have collectively limited our ability to manufacture and ship all of the products for which we have demand; our profitability will be reduced if we are unable to continue to pass on increasing component costs.

Over the past three years, our supply chain has been significantly impacted by interruptions in supplier and port operations resulting from the COVID-19 pandemic, the resumption of strong worldwide demand for electronic products and components following the easing of COVID-19 restrictions, and geopolitical events, such as the war in Ukraine. As a result, we have experienced and continue to experience delays in delivery and shortages of certain components, particularly certain types of capacitors, resistors and discrete semiconductors needed for many of the products we manufacture. These conditions limited our ability to manufacture and ship all of the products for which we have demand and that require these components and have resulted in an increase in our inventories of other components that cannot be assembled into finished products without these components. These factors are exacerbated by the fact that we are dependent on a number of limited and sole source suppliers to provide key components, which we incorporate into our products. Although conditions have recently improved we expect some level of delays and shortages to persist through at least the first half of calendar year 2023 and that such shortages could result in delays in shipments to our customers during the period of such shortages. Any such delays would reduce our revenue, margins and operating cash flow for the periods affected.

In addition, inflationary pressures resulting from supply chain constraints and generally improved economic conditions are leading to sustained increases in the prices we pay for components and materials used in production and in our labor and transportation costs. While we seek to pass on to our customers the increased prices for components and shipping, plus a margin, our gross margins and profitability could decrease, perhaps significantly, over a sustained period of time if we are unable to do so.

The COVID-19 pandemic has had, and may continue to have, a significant impact on our results of operations and financial condition by reducing demand from our customers, interrupting the flow of components needed for our customers’ products, limiting the operations or productivity of our manufacturing facilities and creating health risks to our employees.

Our business, operations and results of operations were significantly and negatively impacted by the COVID-19 pandemic over the past three years. Among other impacts, the pandemic:

● Resulted in the temporary closure of certain of our facilities;

● Temporarily reduced the amount of staffing at certain of our plants;

● Required us in some cases to pay staff who are not able to work due to government orders or illness;

● Limited the capacity of logistics providers to deliver the components we use and ship the products we manufacture;

● Reduced demand for certain of our customers’ products;

● Resulted in interruptions in supply of components, either because our suppliers have themselves been prevented from operating or because major distribution channels (e.g., sea transport) were disrupted by the pandemic; and

● Resulted in certain of our customers and suppliers experiencing financial difficulties, which in some cases have impacted their ability or willingness to satisfy their payment or delivery obligations.

Although conditions have generally improved, we cannot predict when the COVID-19 pandemic will cease to present risks to our business due to a large number of uncertainties, including the duration of ongoing supply chain constraints directly and indirectly caused by the pandemic, the extent of the impact of the pandemic on our customers’ businesses, the number of our employees who may become infected, the continued efficacy and availability of COVID-19 vaccines and treatments, the geographic locations of any future outbreaks, including outbreaks caused by variants of COVID-19, such as the Omicron variant of COVID-19 and its subvariants, and actions that government authorities may take in response. For example, China previously maintained a “zero tolerance” policy towards COVID-19 infections, which disrupted our operations and our suppliers’ operations there. Thus, we believe that the pandemic could continue to have a negative impact on our business, results of operations and financial condition for the foreseeable future.

36

Adverse changes in the key end markets we target could harm our business by reducing our sales.

We provide products and services to companies that serve the industrial, medical, defense and aerospace, automotive, communications networks and cloud infrastructure industries. Adverse changes in any of these end markets could reduce demand for our customers’ products or make these customers more sensitive to the cost of our products and services, either of which could reduce our sales, gross margins and net income. A number of factors could affect these industries in general and our customers in particular, leading to reductions in net sales. These factors include:

● intense competition among our customers and their competitors, leading to reductions in prices for their products and increases in pricing pressure placed on us;

● failure of our customers’ products to gain widespread commercial acceptance, which could decrease the volume of orders our customers place with us;

● changes in regulatory requirements affecting the products we build for our customers, leading to product redesigns or obsolescence and potentially causing us to lose business; and

● the negative effects of inflation, rising interest rates and any potential resultant recession on customers’ end markets and their demand for our products and services.

We realize a substantial portion of our revenues from communications equipment customers. This market is highly competitive, particularly in the area of price. Should any of our larger customers in this market fail to effectively compete with their competitors, they could reduce their orders to us or experience liquidity difficulties, either of which could have the effect of substantially reducing our revenue and net income. There can be no assurance that we will not experience declines in demand in this or in other end markets in the future.

Our operating results are subject to significant uncertainties, which can cause our future sales, net income and cash generated from operations to be variable.

Our operating results can vary due to a number of significant uncertainties, including:

● our ability to replace declining sales from end-of-life programs and customer disengagements with new business wins;

● conditions in the global economy as a whole and in the industries we serve, which have been significantly impacted by the COVID-19 pandemic, inflationary pressures and rising interest rates;

● fluctuations in component prices, component shortages and extended component lead times caused by high demand and supply chain constraints, disruptions relating to the COVID-19 pandemic, geopolitical events, such as the war in Ukraine, natural disasters or otherwise;

● timing and success of new product developments and ramps by our customers, which create demand for our services, but which can also require us to incur start-up costs relating to new tooling and processes;

● levels of demand in the end markets served by our customers;

● timing of orders from customers and the accuracy of their forecasts;

● our inventory levels, which have been driven higher as a result of ongoing supply chain disruptions, with higher levels of inventory reducing our operating cash flow;

● customer payment terms and the extent to which we factor customer receivables during the quarter;

● increasing labor costs in the regions in which we operate;

● mix of products ordered by and shipped to major customers, as high volume and low complexity manufacturing services typically have lower gross margins than more complex and lower volume services;

● our ability to pass tariffs and price increases of components through to our customers;

● resolution of quality or other claims made by our customers;

● the degree to which we are able to fully utilize our available manufacturing capacity;

● customer insolvencies resulting in bad debt or inventory exposures that are in excess of our reserves;

● our ability to efficiently move manufacturing operations to lower cost regions when requested by our customers;

● changes in our tax provision due to changes in our estimates of pre-tax income in the jurisdictions in which we operate, uncertain tax positions and our continued ability to utilize our deferred tax assets; and

● political and economic developments in countries in which we or our customers or our suppliers have operations, which could restrict our operations or those of our suppliers and/or customers or increase our costs.

37

Variability in our operating results may also lead to variability in cash generated by operations, which can adversely affect our ability to make capital expenditures, engage in strategic transactions and repurchase stock.

We are subject to risks arising from our international operations.

The substantial majority of our net sales are generated through our non-U.S. operations. As a result, we are or can be negatively impacted by economic, political and other conditions in the foreign countries in which we do business, including:

● changes in trade and tax laws that may result in us or our customers being subject to increased taxes, duties and tariffs and import and export restrictions, which could increase our costs and/or reduce our customers’ willingness to use our services in countries in which we are currently manufacturing their products;

● compliance with foreign laws, including labor laws that generally provide for increased notice, severance and consultation requirements compared to U.S. labor laws;

● labor unrest, including strikes;

● difficulties in staffing due to immigration or travel restrictions imposed by national governments, including the U.S.;

● security concerns;

● political instability and/or regional military tension or hostilities, such as the war in Ukraine, the possibility of such conflict broadening to areas outside of Ukraine, and the actions taken by national governments in response to such hostilities, such as sanctions and export bans;

● fluctuations in currency exchange rates, which may either increase or decrease our operating costs and for which we have significant exposure;

● the imposition of currency controls, which would have the effect of preventing us from repatriating profits from our foreign subsidiaries;

● exposure to heightened corruption risks;

● aggressive, selective or lax enforcement of laws and regulations by national governmental authorities; and

● potentially increased risk of misappropriation of intellectual property.

We operate in countries that have experienced labor unrest, political instability or conflict and strife in the past, including China, India, Israel, Malaysia, Mexico and Thailand, and we have experienced work stoppages and similar disruptions at our plants in these countries. To the extent these factors prevent us from adequately staffing our plants and manufacturing and shipping products in those jurisdictions, our margins and net income could be reduced and our reputation as a reliable supplier could be negatively impacted.

We rely on a relatively small number of customers for a substantial portion of our sales, and declines in sales to these customers could significantly reduce our net sales and net income.

Sales to our ten largest customers have historically represented approximately half of our net sales. We expect to continue to depend upon a relatively small number of customers for a significant percentage of our sales for the foreseeable future. The loss of a significant reduction in sales or pricing to, or an inability to recover components liabilities from our largest customers could therefore substantially reduce our revenue and margins.

Current U.S. trade policy could increase the cost of using both our onshore and offshore manufacturing services for our U.S. customers, leading them to reduce their orders to us.

Although we maintain significant manufacturing capacity in the U.S., the majority of our manufacturing operations are located outside the U.S. The U.S., China, the E.U. and several other countries have imposed tariffs on certain imported products. In particular, the U.S. has imposed tariffs impacting certain components and products imported from China by us into the U.S. These tariffs apply to both components imported into the U.S. from China for use in the manufacture of products at our U.S. plants and to certain of our customers’ products that we manufacture for them in China and that are then imported into the U.S. Any decision by a large number of our customers to cease using our manufacturing services due to the application of tariffs would materially reduce our revenue and net income. In addition, our gross margins would be reduced in the event we are for any reason unable to pass on any tariffs that we incurred to our customers. Although our customers are generally liable for tariffs we pay on their behalf on importation of components used in the manufacture of their products, our gross margins would be reduced in the event we were for any reason unable to recover tariffs or duties from our customers. Further, although we are required to pay tariffs upon importation of the components, we may not be able to recover these amounts from customers until sometime later, if at all, which would adversely impact our operating cash flow in a given period.

38

Customer order cancellations, push-outs and reduced forecasts could reduce our sales, net income and liquidity.

We generally do not obtain firm, long-term purchase commitments from our customers and our bookings may generally be canceled prior to the scheduled shipment date. Although customers are generally liable for components we procure on their behalf, finished goods and work-in-process at the time of cancellation, customers may fail to honor this commitment or we may be unable to, or, for other business reasons, choose not to enforce our contractual rights. Cancellations, reductions or push-outs of orders by customers and reduced customer forecasts customers could cause our inventory levels to increase, consume working capital, lead to write-offs of inventory that customers fail to purchase for any reason, which could reduce our sales, net income and liquidity.

Our strategy to pursue higher margin business depends in part on the success of our CPS businesses, which, if not successful, could cause our future gross margins and operating results to be lower.

A key part of our strategy of providing end-to-end manufacturing solutions is to grow our CPS businesses, which supplies printed circuit boards, backplane and backplane assemblies, cable assemblies, fabricated metal parts, precision machined parts, and plastic injected molded parts, memory, RF, optical and microelectronic solutions, and data storage solutions and design, engineering, logistics and repair services and our SCI defense and aerospace products. A decrease in orders for these components, products and services can have a disproportionately adverse impact on our profitability since these components, products and services generally yield higher margins than our core IMS business. In addition, in order to grow this portion of our business profitably, we must continue to make substantial investments in the development of our product development capabilities, research and development activities, test and tooling equipment and skilled personnel, all of which reduce our operating results in the short term. The success of our CPS businesses also depends on our ability to increase sales of our proprietary products, convince our customers to purchase our components rather than those of third parties for use in the manufacture of their products, and expand the number of our customers who contract for our design, engineering, logistics and repair services. We may face challenges in achieving commercially viable yields and difficulties in manufacturing components in the quantities and to the specifications and quality standards required by our customers, as well as in qualifying our components for use in our customers’ designs. Our proprietary products and design, engineering, logistics and repair services must compete with products and services offered by established vendors which focus solely on development of similar technologies or the provision of similar services. Any of these factors could reduce the revenue and margins of our CPS businesses, which in turn would have an adverse and potentially disproportionate effect on our overall revenues and profitability.

Transfers of business or operations may increase our costs and cause disruptions in our ability to service our customers.

Our customers sometimes require that we transfer the manufacturing of their products from one of our facilities to another to achieve cost reductions, tariff reductions and other objectives. These transfers have resulted in increased costs to us due to facility downtime, less than optimal utilization of our manufacturing capacity and delays and complications related to the transition of manufacturing programs to new locations. These transfers, and any decision by a significant customer to terminate manufacturing services in a particular facility, could require us to close or reduce operations at certain facilities and, as a result, we may incur in the future significant costs for the closure of facilities, employee severance and related matters. We may be required to relocate additional manufacturing operations in the future and, accordingly, we may incur additional costs that decrease our net income.

In addition, certain of our foreign manufacturing facilities are leased from third parties. To the extent we are unable to renew the leases covering such facilities as they expire on reasonable terms, or are forced to move our operations at those facilities to other locations as a result of a failure to agree upon renewal terms, production for our customers may be interrupted, we may breach our customer agreements, we could incur significant start-up costs at new facilities and our lease expense may increase, potentially significantly.

39

Regulatory, Compliance and Litigation Risks

We are subject to a number of U.S. export control and regulatory requirements relating to our defense business, with which the failure to comply could result in fines and reduction of future revenue.

We are subject to a number of laws and regulations relating to the export of U.S. technology, anti-corruption and the award, administration and performance of U.S. government contracts and subcontracts. In particular, our activities must comply with the restrictions relating to the export of controlled technology and sales to denied or sanctioned parties contained in the International Traffic in Arms Regulations (“ITAR”), the U.S. Export Administration Regulations and sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”). The U.S. Commerce Department recently released rules that in some cases significantly restrict the export of U.S. technology to or from China. These laws could negatively impact our operations in China by making it more difficult to import components containing U.S. technology into China and to export finished products containing such components out of China. Any failure to comply with export control laws could result in significant fines or penalties. We must also comply with regulations relating to the award, administration and performance of U.S. government contracts and subcontracts with respect to our defense business, including regulations that govern price negotiations, cost accounting standards, procurement practices, termination at the election of the government and many other aspects of performance under government contracts and subcontracts. These laws and regulations are complex, require extensive compliance efforts and expenditures in the form of additional systems and personnel, and, in some cases, require us to ensure that our suppliers adhere to such regulations. Furthermore, our compliance with such regulations is subject to audit or investigation by governmental authorities. From time to time, we receive formal and informal inquiries from government agencies and regulators regarding our compliance. For example, we have received and are responding to several Civil Investigative Demands from the U.S. Department of Justice relating to certain contracts, projects, proposals, and business activities of our SCI subsidiary. Should we be found to have violated one or more government contracting laws or regulations, we could become subject to civil damages (which in some cases could be trebled) or criminal penalties and administrative sanctions, including appointment of government monitors, termination of our government contracts and, ultimately, debarment from doing further business with the U.S. government. Any of such results would increase our expenses, reduce our revenue and damage our reputation as both a commercial and government supplier.

If we manufacture or design defective products, if there are manufacturing defects in the components we incorporate into customer products or if our manufacturing processes do not comply with applicable statutory and regulatory requirements and standards, we could be subject to claims, damages and fines and lose customers.

We manufacture products to our customers’ specifications, and in some cases our manufacturing processes and facilities need to comply with various statutory and regulatory requirements and standards. For example, many of the medical products that we manufacture, as well as the facilities and manufacturing processes that we use to produce them, must comply with standards established by the U.S. Food and Drug Administration and products we manufacture for the automotive end market are generally subject to the IATF 16949:2016 standard. In addition, our customers’ products and the manufacturing processes that we use to produce them often are highly complex. As a result, products that we design or manufacture may at times contain design or manufacturing defects, and our manufacturing processes may be subject to errors or may not be in compliance with applicable statutory and regulatory requirements and standards. Finally, customer products can experience quality problems or failures as a result of defects in the components customers specify to be included in the products we manufacture for them. Defects in the products we design or manufacture, even if caused by components specified by the customer, may result in product recalls, warranty claims by customers, including liability for repair costs, delayed shipments to customers or reduced or canceled customer orders. The failure of the products that we design or manufacture or of our manufacturing processes and facilities to comply with applicable statutory and regulatory requirements and standards may subject us to legal fines or penalties, cause us to lose business and, in some cases, require us to shut down or incur considerable expense to correct a manufacturing program or facility. In addition, these defects may result in product liability claims against us by third parties. The risk and magnitude of such claims may increase as we continue to expand our presence in the medical and automotive end markets since defects in these types of products can result in death or significant injury to end users of these products. Even when our customers or suppliers are contractually responsible for defects in the design of a product and defects in components used in the manufacture of such products, there is no guarantee that any indemnities provided by such parties will be adequate to cover all damages to which we may become subject or that these parties will have the financial resources to indemnify us for such liabilities, in which case we could be required to expend significant resources to defend ourselves if named in a product liability suit over such defects.

40

If we are unable to protect our intellectual property or if we infringe, or are alleged to infringe, upon the intellectual property of others, we could be required to pay significant amounts in costs or damages.

We rely on a combination of copyright, patent, trademark and trade secret laws and contractual restrictions to protect our intellectual property rights. However, a number of our patents covering certain aspects of our manufacturing processes or products have expired and will continue to expire in the future. Such expirations reduce our ability to assert claims against competitors or others who use or sell similar technology. Any inability to protect our intellectual property rights could diminish or eliminate the competitive advantages that we derive from our proprietary technology. In addition, should a current or former employee use or disclose any of our or our customers’ proprietary information, we could become subject to legal action by our customers or others, our key technologies could become compromised and our ability to compete could be adversely impacted.

In addition, we may become involved in administrative proceedings, lawsuits or other proceedings if others allege that the products we manufacture for our customers or our own manufacturing processes and products infringe on their intellectual property rights. If successful, such claims could force our customers and us to stop importing or producing products or components of products that use the challenged intellectual property, to pay up to treble damages and to obtain a license to the relevant technology or to redesign those products or services so as not to use the infringed technology. The costs of defense and potential damages and/or impact on production of patent litigation could be significant and have a materially adverse impact on our financial results. In addition, although our customers typically indemnify us against claims that the products we manufacture for them infringe others’ intellectual property rights, there is no guaranty that these customers will have the financial resources to stand behind such indemnities should the need arise, nor is there any guarantee that any such indemnity could be fully enforced. We sometimes design products on a contract basis or jointly with our customers. In such situations, we may become subject to claims that products we design infringe third party intellectual property rights and may also be required to indemnify our customer against liability caused by such claims.

Any of these events could reduce our revenue, increase our costs and damage our reputation with our customers.

Allegations of failures to comply with domestic or international employment and related laws could result in the payment of significant damages, which would reduce our net income.

We are subject to a variety of domestic and foreign employment laws, including those related to safety, wages and overtime, discrimination, harassment, organizing, whistleblowing, classification of employees, privacy and severance payments. We may be required to defend against allegations that we have violated such laws. Allegations that we have violated labor laws could lead to damages being awarded to employees or fines from or settlements with plaintiffs or federal, state or foreign regulatory authorities, the amounts of which could be substantial, and which would reduce our net income. For example, in the first quarter of 2022, we paid approximately $4 million in a judicially approved settlement in connection with a lawsuit against the Company alleging violations of California Labor Code provisions governing overtime, meal and rest periods, wages, wage statements and reimbursements of business expenses.

41

Cyberattacks and other disruptions of our information technology network and systems could interrupt our operations, lead to loss of our customer and employee data and subject us to damages.

We rely on internal and cloud-based networks and systems furnished by third parties for worldwide financial reporting, inventory management, procurement, invoicing, employee payroll and benefits administration and email communications, among other functions. In addition, our 42Q manufacturing execution solutions software used by us and certain of our customers operates in the cloud. Despite our business continuity planning, including maintaining redundant data sites and network availability, both our internal and cloud-based infrastructure may be susceptible to outages due to fire, floods, power loss, telecommunications failures, terrorist attacks and similar events. In addition, our systems, like those of other large companies, are regularly subject to third party hacking attempts. Despite the implementation of numerous network security measures, both our internal and our cloud-based infrastructure may also be vulnerable to such hacking attempts, the installation of computer viruses, malware or similar disruptions either by third parties or employees with access to key IT infrastructure. Cybersecurity attacks can come in many forms, including distributed denial of service attacks, advanced persistent threat, phishing, business email compromise efforts and ransomware attacks. For example, a cyberattack in 2020 involving malware delivered through network monitoring software sold by SolarWinds resulted in the penetration of the systems of a multitude of governmental and commercial entities. While we were not affected by this cyberattack, there can be no assurance that a future malware attack will not be successful in breaching our systems. Hacking, malware and other cybersecurity attacks, if not prevented, could lead to the collection and disclosure of sensitive personal or confidential information relating to our customers, employees or others, exposing us to legal liability and causing us to suffer reputational damage. In addition, our SCI defense and aerospace business is subject to U.S. government regulations requiring the safeguarding of certain unclassified government information and to report to the U.S. government certain cyber incidents that affect such information. The increasing sophistication of cyberattacks requires us to continually evaluate new technologies and processes intended to detect and prevent these attacks. Our insurance coverage for cyberattacks is limited. There can be no assurance that our cybersecurity measures will be sufficient to protect the data we manage. If we and our cloud infrastructure vendors are not successful in preventing such outages and cyberattacks, our operations could be disrupted, we could incur losses, including losses relating to claims by our customers, employees or privacy regulators relating to loss of personal or confidential business information, the willingness of customers to do business with us may be damaged and, in the case of our defense business, we could be barred from future participation in U.S. government programs.

Global, national and corporate initiatives addressing climate change could increase our costs.

Concern over climate change may lead to state, federal and international legislative and regulatory initiatives aimed at reducing carbon dioxide and other greenhouse gas emissions through incentives, taxes or mandates and there is increased stockholder interest generally in voluntary corporate commitments to reduce the generation of greenhouse gases. Collectively, such initiatives and commitments could lead to an increase in both the price of energy and our operating costs. A sustained increase in energy prices for any reason could increase our raw material, components, operations and transportation costs, which we may not be able to pass on to our customers and which would therefore reduce our profitability, as would increased operating costs and investments due to our adoption, whether voluntary or mandatory, of measures to reduce our carbon footprint. We could also suffer reputational damage if our sustainability practices are perceived to be inadequate.

Any failure to comply with applicable environmental laws could adversely affect our business by causing us to pay significant amounts for cleanup of hazardous materials or for damages or fines.

We are subject to various federal, state, local and foreign environmental laws and regulations, including those governing the use, generation, storage, discharge and disposal of hazardous substances and waste in the ordinary course of our manufacturing operations. If we violate environmental laws or if we own or operate, or owned or operated in the past, a site at which we or a predecessor company caused contamination, we may be held liable for damages and the costs of remedial actions. For example, in April 2023, a court issued a ruling finding us and other defendants liable for certain investigation costs relating to a site owned by a predecessor company in Southern California at which a disposal was alleged to have occurred. Although we estimate and regularly reassess our potential liability with respect to violations or alleged violations and accrue for such liability, our accruals may not be sufficient. Any increase in existing reserves or establishment of new reserves for environmental liability would reduce our net income. Our failure or inability to comply with applicable environmental laws and regulations could also limit our ability to expand facilities or could require us to acquire costly equipment or to incur other significant expenses to comply with these laws and regulations.

42

Partly as a result of certain of our acquisitions, we have incurred liabilities associated with environmental contamination. These liabilities include ongoing investigation and remediation activities at a number of current and former sites. The time required to perform environmental remediation can be lengthy and there can be no assurance that the scope, and therefore cost, of these activities will not increase as a result of the discovery of new contamination or contamination on adjoining landowners’ properties or the adoption of more stringent regulatory standards covering sites at which we are currently performing remediation activities.

We cannot assure that past disposal activities will not result in liability that will materially affect us in the future, nor can we provide assurance that we do not have environmental exposures of which we are unaware and which could adversely affect our future operating results. Changes in or restrictions on discharge limits, emissions levels, permitting requirements and material storage or handling could require a higher than anticipated level of remediation activities, operating expenses and capital investment or, depending on the severity of the impact of the foregoing factors, costly plant relocation, any of which would reduce our net income.

Changes in financial accounting standards or policies have affected, and in the future may affect, our reported financial condition or results of operations; there are inherent limitations to our system of internal controls; changes in corporate governance policies and practices may impact our business.

We prepare our consolidated financial statements in conformity with GAAP. The preparation of our financial statements in accordance with GAAP requires that we make estimates and assumptions that affect the recorded amounts of assets, liabilities and net income during the reporting period. A change in the facts and circumstances surrounding those estimates could result in a change to our estimates and could impact our future operating results. GAAP is subject to interpretation by the Financial Accounting Standards Board (“FASB”), the SEC and various bodies formed to interpret and create accounting policies. A change in those policies can have a significant effect on our reported results and may affect our reporting of transactions which are completed before a change is announced. For example, in fiscal 2019, we implemented the new revenue recognition standard, which is complex and requires significant management judgment. Although we believe the judgments we applied in implementation of the new revenue recognition standard are appropriate, there can be no assurance that we will not be required to change our judgments relating to implementation of such standard in the future, whether as a result of new guidance or otherwise. A significant change in our accounting judgments could have a significant impact on our reported revenue, gross profit, assets and liabilities. In general, changes to accounting rules or challenges to our interpretation or application of the rules by regulators may have a material adverse effect on our reported financial results or on the way we conduct business.

Our system of internal and disclosure controls and procedures was designed to provide reasonable assurance of achieving its objectives. However, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been or will be detected. As a result, there can be no assurance that our system of internal and disclosure controls and procedures will be successful in preventing all errors, theft and fraud, or in informing management of all material information in a timely manner. For example, we have reported material weaknesses in this Quarterly Report on Form 10-Q.

Finally, corporate governance, public disclosure and compliance practices continue to evolve based upon continuing legislative action, SEC rulemaking and policy positions taken by large institutional stockholders and proxy advisors. As a result, the number of rules, regulations and standards applicable to us may become more burdensome to comply with, could increase scrutiny of our practices and policies by these or other groups and increase our legal and financial compliance costs and the amount of time management must devote to governance and compliance activities. For example, the SEC has recently proposed rules requiring that issuers provide significantly increased disclosures concerning cybersecurity matters and the impact of climate changes on their business and has adopted rules requiring public companies to adopt more stringent executive compensation clawback policies. Increasing regulatory burdens and corporate governance requirements could also make it more difficult for us to attract and retain qualified members of our Board of Directors and qualified executive officers.

Liquidity and Credit Risks

Our customers could experience credit problems, which could reduce our future revenues and net income.

Certain of our customers have experienced significant financial difficulties in the past, with a few filing for bankruptcy. Financial difficulties experienced by one or more of our customers, could negatively affect our business by decreasing demand from such customers and through the potential inability of these companies to make full payment on amounts owed to us. Customer bankruptcies also entail the risk of potential recovery by the bankruptcy estate of amounts previously paid to us that are deemed a preference under bankruptcy laws. There can be no assurance that additional customers will not declare bankruptcy or suffer financial distress, in which case our future revenues, net income and cash flow could be reduced.

43

We may be unable to generate sufficient liquidity to maintain or expand our operations, which would reduce the amount of business our customers and vendors are able to do with us and impact our ability to continue operations at current levels without seeking additional funding; we could experience losses if one or more financial institutions holding our cash or other financial counterparties were to fail; repatriation of foreign cash could increase our taxes.

Our liquidity is dependent on a number of factors, including profitability, business volume, inventory levels, the extension of trade credit by our suppliers, the degree of alignment of payment terms from our suppliers with payment terms granted to our customers, the amount we invest in our facilities and equipment, the timing of acquisitions and divestitures, the schedule for repayment of our outstanding indebtedness, the timing of stock repurchases, the amount available to borrow under the Credit Agreement and the amount of accounts receivable eligible for sale under our factoring programs. In the event we need or desire additional liquidity beyond the sources described above to maintain or expand our business levels, make acquisitions or repurchase stock, there can be no assurance that such additional liquidity will be available on acceptable terms or at all. The sale of receivables under our factoring programs is subject to the approval of the banks or customers involved and there can be no assurance that we will be able to sell the maximum amount of receivables permitted by these programs when desired.

Any failure to maintain adequate liquidity would prevent us from maintaining operations at current or desired levels, which in turn would reduce both our revenue and profitability.

Although we believe our existing cash resources and sources of liquidity, together with cash generated from operations, will be sufficient to meet our working capital requirements for at least the next 12 months, should demand for our services increase significantly over the next 12 months or should we experience significant increases in delinquent or uncollectible accounts receivable for any reason, including recessionary economic conditions, our cash provided by operations could decrease significantly and we could be required to seek additional sources of liquidity to continue our operations at their current level. In such a case, there can be no assurance that such additional sources of financing would be available.

A principal source of our liquidity is our cash and cash equivalents, which are held with various financial institutions. Although we distribute such funds among a number of financial institutions that we believe to be of high quality, there can be no assurance that one or more of such institutions will not become insolvent in the future. For example, in Spring of 2023, three mid-sized regional banks failed and were placed under the temporary control of federal regulators. Although the Company’s cash and cash equivalents were not deposited in any of such banks, should the financial institutions in which the Company’s cash and cash equivalents are deposited fail and not be backstopped by the federal government or otherwise guaranteed, all or a portion of our uninsured funds on deposit with such institutions could be lost. Similarly, should the financial institutions holding the cash and cash equivalents of our customers fail and not be backstopped or otherwise guaranteed, our customers may become unable to satisfy their obligations to us. Finally, if one or more counterparties to our interest rate or foreign currency hedging instruments were to fail, we could suffer losses and our hedging of risk could become less effective.

More than 50% of our cash is held in foreign jurisdictions. Some of these jurisdictions restrict the amount of cash that can be transferred to the U.S. or impose taxes and penalties on such transfers of cash. To the extent we have excess cash in foreign locations that could be used in, or is needed by, our U.S. operations, we may incur significant foreign taxes to repatriate these funds which would reduce the net amount ultimately available for such purposes.

Our Credit Agreement contains covenants that may adversely impact our business; the failure to comply with such covenants or the occurrence of an event of default could cause us to be unable to borrow additional funds and cause our outstanding debt to become immediately payable.

Our Credit Agreement contains a maximum leverage and minimum interest coverage ratio and a number of restrictive covenants, including restrictions on incurring additional debt, making investments and other restricted payments, selling assets and paying dividends, subject to certain exceptions, with which we must comply. Collectively, these covenants could constrain our ability to grow our business through acquisition or engage in other strategic transactions. Such facility also contains customary events of default, including that a material business interruption or cessation has not occurred. Finally, such facility includes covenants requiring, among other things, that we timely file quarterly and annual financial statements with the SEC, comply with all laws, pay all taxes and maintain casualty insurance. If we are not able to comply with these covenants or if an event of default were to occur and not be cured, all of our outstanding debt would become immediately due and payable and the incurrence of additional debt under our Credit Agreement would not be allowed, either of which would have a material adverse effect on our liquidity and ability to continue to conduct our business.

44

General Risk Factors

We are subject to intense competition in the EMS industry, which could cause us to lose sales and, therefore, harm our financial performance.

The EMS industry is highly competitive and the industry has experienced a surplus of manufacturing capacity. Our competitors include major global EMS providers, including Benchmark Electronics, Inc., Celestica, Inc., Flex Ltd., Hon Hai Precision Industry Co., Ltd. (Foxconn), Jabil Inc. and Plexus Corp., as well as other companies that have a regional, product, service or industry-specific focus. We also face competition from current and potential OEM customers who may elect to manufacture their own products internally rather than outsourcing to EMS providers.

Competition is based on a number of factors, including end markets served, price and quality. We may not be able to offer prices as low as some of our competitors for any number of reasons, including the willingness of competitors to provide EMS services at prices we are unable or unwilling to offer. There can be no assurance that we will win new business or maintain existing business due to competitive factors, which could decrease our sales and net income. In addition, due to the extremely price sensitive nature of our industry, business that we do win or maintain may have lower margins than our historical or target margins. As a result, competition may cause our gross and operating margins to fall.

Consolidation in the electronics industry may adversely affect our business by increasing customer buying power and increasing prices we pay for components.

Consolidation in the electronics industry among our customers, our suppliers and/or our competitors may increase, which could result in a small number of very large electronics companies offering products in multiple sectors of the electronics industry. If one of our customers is acquired by another company that does not rely on us to provide EMS services, we may lose that customer’s business. Similarly, consolidation among our suppliers could result in a sole or limited source for certain components used in our customers’ products. Any such consolidation could cause us to be required to pay increased prices for such components, which could reduce our gross margin and profitability if we are unable to pass on the corresponding cost to our customers.

Unanticipated changes in our income tax rates or exposure to additional tax liabilities could increase our taxes and decrease our net income; developments in pending audits could result in an increase in our tax expenses which would decrease our net income.

We are or may become subject to income, sales, value-added, goods and services, withholding and other taxes in the United States and various foreign jurisdictions. Significant judgment is required in determining our worldwide provision for taxes and, in the ordinary course of business, there are many transactions and calculations for which the ultimate tax determination is uncertain. Our effective income tax rates and liability for other taxes could increase as a result of changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in enacted tax laws, the effectiveness of our cash and tax management strategies, our ability to negotiate advance pricing agreements with foreign tax authorities, compliance with local trade laws and other factors. International initiatives require multinational enterprises, like ours, to report profitability on a country-by-country basis, which could increase scrutiny by foreign tax authorities. In addition, our tax determinations are regularly subject to audit by tax authorities. For example, we are currently undergoing audits of our tax returns for certain recent tax years in a number of jurisdictions, including the United States. Developments in these or future audits could adversely affect our tax provisions, including through the disallowance or reduction of deferred tax assets or the assessment of back taxes, interest and penalties, any of which could result in an increase to income tax expense and therefore a decrease in our net income.

45

We can experience losses due to foreign exchange rate fluctuations and currency controls, which could reduce our net income and impact our ability to repatriate funds.

Because we manufacture the majority of our products abroad, our operating results can be negatively impacted due to fluctuations in foreign currency exchange rates, particularly in volatile currencies to which we are exposed, such as the Euro, Mexican peso, Malaysian ringgit and Chinese renminbi. We use financial instruments, primarily short-term foreign currency forward contracts, to hedge our exposure to exchange rate fluctuations. However, the success of our foreign currency hedging activities in preventing foreign exchange losses depends largely upon the accuracy of our forecasts of future sales, expenses, capital expenditures and assets and liabilities. As such, our foreign currency hedging program may not fully cover all of our exposure to exchange rate fluctuations. If our hedging activities are not successful, our net income may be reduced. In addition, certain countries in which we operate have adopted currency controls requiring that local transactions be settled only in local currency rather than in our functional currency, which is generally different than the local currency. Such controls could require us to hedge larger amounts of local currency than we otherwise would and/or prevent us from repatriating cash generated by our operations in such countries.

We may not have sufficient insurance coverage for potential claims and losses, which could leave us responsible for certain costs and damages.

We carry various forms of business and liability insurance in types and amounts we believe are reasonable and customary for similarly situated companies in our industry. However, our insurance program does not generally cover losses due to failure to comply with typical customer warranties for workmanship, product and medical device liability, intellectual property infringement, product recall claims, or environmental contamination. In particular, our insurance coverage with respect to damages to or closure of our facilities, or damages to our customers’ products caused by cyberattacks and certain natural disasters, such as earthquakes, epidemics and pandemics (such as the COVID-19 pandemic), is limited and is subject to policy deductibles, coverage limits, and exclusions, and as a result, may not be sufficient to cover all of our losses. For example, our policies have very limited coverage for damages due to earthquakes or losses caused by business disruptions. In addition, such coverage may not continue to be available at commercially reasonable rates and terms. Our policies generally have deductibles and/or limits or may be limited to certain lines or business or customer engagements that reduce the amount of our potential recoveries from insurance. As a result, not all of our potential business losses are covered under our insurance policies. Should we sustain a significant uncovered loss, our net income will be reduced. Additionally, if one or more counterparties to our insurance coverage were to fail, we would bear the entire amount of an otherwise insured loss.

Recruiting and retaining our key personnel is critical to the continued growth of our business.

Our success depends upon the continued service of our key personnel, particularly our highly skilled sales and operations executives, managers and engineers with many years of experience in the EMS industry. Such individuals can be difficult to identify, recruit and retain and are heavily recruited by our competitors. As our key employees choose to retire or terminate their employment with us, we will be required to replace them with new employees with the required experience, which has become challenging in the U.S. recently due to the strong employment market. Should we be unable to recruit new employees to fill key positions with us, our operations and growth prospects could be negatively impacted.

46

We may not be successful in implementing and integrating strategic transactions or in divesting assets or businesses, which could harm our operating results; we could become required to book a charge to earnings should we determine that goodwill and other acquired assets are impaired.

From time to time, we may undertake strategic transactions that give us the opportunity to access new customers and new end markets, increase our proprietary product offerings, obtain new manufacturing and service capabilities and technologies, enter new geographic manufacturing locations, lower our manufacturing costs, increase our margins or further develop existing customer relationships. For example, in the first quarter of fiscal 2023, we entered into a joint venture with a wholly-owned subsidiary of Reliance Industries Limited intended to create a world-class electronic manufacturing hub in India. The success of this joint venture is subject to a number of risks and uncertainties including the timing of the joint venture obtaining “Trusted Source” designation under the India government’s “Make in India” initiative, adverse changes in the key markets the joint venture will target and the risks described above under the caption “We are subject to risks arising from our international operations.” Strategic transactions involve a number of risks, uncertainties and costs, including integrating acquired operations and workforce, businesses and products, resolving quality issues involving acquired products, incurring severance and other restructuring costs, diverting management attention from their normal operational duties, maintaining customer, supplier or other favorable business relationships of acquired operations, terminating unfavorable commercial arrangements, losing key employees, integrating the systems of acquired operations into our management information systems and satisfying the liabilities of acquired businesses, including liability for past violations of law and material environmental liabilities. Any of these risks could cause our strategic transactions not to be ultimately profitable. We may also choose to divest plants, businesses or products lines in the future. Divestitures reduce revenue and, potentially, margins and can involve the risk of retained liabilities from the operations divested, including environmental liabilities.

In addition, we have in the past recorded, and may be required to record in the future, goodwill and other intangible assets in connection with our acquisitions. We evaluate, at least on an annual basis, whether events or circumstances have occurred that indicate all, or a portion, of the carrying amount of our goodwill and other intangible assets may no longer be recoverable. Should we determine in the future that our goodwill or other intangible assets have become impaired, an impairment charge to earnings would become necessary, which could be significant. For example, during our fiscal 2018 annual goodwill impairment analysis, we fully impaired goodwill of $31 million associated with the acquisition of a storage software business we purchased in 2016.

We are subject to risks associated with natural disasters and global events.

Our activities, including manufacturing, administration and information technology management, can be adversely affected by natural disasters such as major earthquakes, hurricanes, floods, tsunamis, tornadoes, fires and epidemics or pandemics, such as the COVID-19 pandemic. Climate change may cause these events to become more severe and therefore more damaging. In the event of a major natural disaster affecting one or more of our facilities, our operations and management information systems, which control our worldwide procurement, inventory management, shipping and billing activities, could be significantly disrupted. Such events could delay or prevent product manufacturing for an extended period of time. Any extended inability to continue our operations at affected facilities following such an event could reduce our revenue.

Risks of Investing in Our Stock

The market price of our common stock is volatile and is impacted by factors other than our financial performance.

The stock market in recent years has experienced significant price and volume fluctuations that have affected our stock price. These fluctuations have often been unrelated to our operating performance. Factors that can cause such fluctuations include announcements by our customers, suppliers, competitors or other events affecting companies in the electronics industry, such as component shortages, currency fluctuations, the impact of natural disasters and global events, such as the COVID-19 pandemic, geopolitical tensions, such as the war in Ukraine, general market fluctuations and macroeconomic conditions, including concerns about inflation and recession, any of which may cause the market price of our common stock to fluctuate widely.

47

Item 5. Other Information

On May 18, 2023, the Company received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) as a result of its failure to file this Quarterly Report on Form 10-Q for the fiscal quarter ended April 1, 2023 (the “Form 10-Q”) with the SEC by the required due date of May 16, 2023. The Notice stated that, under the Nasdaq Listing Rules, the Company has 60 calendar days, or until July 17, 2023, to submit a plan to regain compliance with Nasdaq’s continued listing requirements.

On May 19, 2023 the Company filed Amendment No. 1 to the Company’s Annual Report on Form 10-K for the fiscal year ended October 1, 2022, Amendment No. 1 to the Company’s Form 10-Q for the quarter ended December 31, 2022 and this Form 10-Q with the SEC. As a result of these filings, the Company believes it has regained compliance with Nasdaq Listing Rule 5250(c)(1) and that no further action will be taken with respect to the Notice. In addition, as a result of making these filings with the SEC, the Company believes that it has cured a default that occurred with respect to the Credit Agreement due to the Company’s failure to file this Form 10-Q on or prior to May 16, 2023.

Please refer to Note 1 to Condensed Consolidated Financial Statements contained in this report for more details regarding the matter that caused the Company to not be able to file its Form 10-Q by the required due date.

48

Item 6. Exhibits

Exhibit Number	Description
10.29*	2019 Equity Incentive Plan, as amended (filed herewith)
31.1	Certification of the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
31.2	Certification of the Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
32.1 (1)	Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
32.2 (1)	Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Compensatory plan in which an executive officer or director participates.

(1) This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

49

SIGNATURES

Pursuant to the Requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		SANMINA CORPORATION
		(Registrant)
		By:	/s/ JURE SOLA
			Jure Sola
			Chief Executive Officer (Principal Executive Officer)
Date:	May 19, 2023
		By:	/s/ KURT ADZEMA
			Kurt Adzema
			Executive Vice President and
			Chief Financial Officer (Principal Financial Officer)
Date:	May 19, 2023

50

EX-10.29

EXHIBIT 10.29

SANMINA CORPORATION 2019 EQUITY INCENTIVE PLAN

(As of March 13, 2023)

1. Purposes of the Plan. The purposes of this Plan are:

· to attract and retain the best available personnel for positions of substantial responsibility,

· to provide additional incentive to Employees, Directors, and Consultants, and

· to promote the success of the Company’s business.

The Plan permits the grant of Incentive Stock Options, Nonstatutory Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Units, Performance Shares and other stock or cash awards as the Administrator may determine.

2. Definitions. As used herein, the following definitions will apply:

(a) “Administrator” means the Board or any of its Committees as will be administering the Plan, in accordance with Section 4 of the Plan.

(b) “Affiliate” means any corporation or any other entity (including, but not limited to, partnerships and joint ventures) controlling, controlled by, or under common control with the Company, including any Parent or Subsidiary of the Company.

(c) “Applicable Laws” means the legal and regulatory requirements relating to the administration of equity-based awards and the related issuance of Shares thereunder, including but not limited to U.S. federal and state corporate laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws of any non-U.S. country or jurisdiction where Awards are, or will be, granted under the Plan.

(d) “Award” means, individually or collectively, a grant under the Plan of Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Units (including Performance Units payable in cash), Performance Shares and other stock or cash awards as the Administrator may determine.

(e) “Award Agreement” means the written or electronic agreement setting forth the terms and provisions applicable to each Award granted under the Plan. The Award Agreement is subject to the terms and conditions of the Plan.

(f) “Board” means the Board of Directors of the Company.

(g) “Change in Control” means the occurrence of any of the following events:

A change in the ownership of the Company which occurs on the date that any one person, or more than one person acting as a group (“Person”), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than fifty percent (50%) of the total voting power of the stock of the Company; provided, however, that for purposes of this subsection, (A) the acquisition of additional stock by any one Person, who is considered to own more than fifty percent (50%) of the total voting power of the stock of the Company will not be considered a Change in Control, and (B) if the stockholders of the Company immediately before such change in ownership continue to retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares of the Company’s voting stock immediately prior to the change in ownership, the direct or indirect beneficial ownership of fifty percent (50%) or more of the total voting power of the stock of the Company or of the ultimate parent entity of the Company, such event will not be considered a Change in Control under this subsection (i). For this purpose, indirect beneficial ownership will include, without limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which own the Company, as the case may be, either directly or through one or more subsidiary corporations or other business entities; or a change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12)-month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election.

1

For purposes of this subsection (ii), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change in Control; or a change in the ownership of a substantial portion of the Company’s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12)-month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than fifty percent (50%) of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions; provided, however, that for purposes of this subsection (iii), the following will not constitute a change in the ownership of a substantial portion of the Company’s assets: (A) a transfer to an entity that is controlled by the Company’s stockholders immediately after the transfer, or (B) a transfer of assets by the Company to: (1) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company’s stock, (2) an entity, fifty percent (50%) or more of the total value or voting power of which is owned, directly or indirectly, by the Company, (3) a Person, that owns, directly or indirectly, fifty percent (50%) or more of the total value or voting power of all the outstanding stock of the Company, or (4) an entity, at least fifty percent (50%) of the total value or voting power of which is owned, directly or indirectly, by a Person described in this subsection (iii)(B)(3). For purposes of this subsection (iii), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.

For purposes of this definition, persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.

Notwithstanding the foregoing, a transaction will not be deemed a Change in Control unless the transaction qualifies as a change in control event within the meaning of Section 409A.

Further and for the avoidance of doubt, a transaction will not constitute a Change in Control if: (i) its sole purpose is to change the state of the Company’s incorporation, or (ii) its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction.

(h) “Code” means the Internal Revenue Code of 1986, as amended. Reference to a specific section of the Code or regulation thereunder will include such section or regulation, any valid regulation promulgated under such section, and any comparable provision of any future legislation or regulation amending, supplementing or superseding such section or regulation.

(i) “Committee” means a committee of Directors or of one or more other individuals satisfying Applicable Laws appointed by the Board, or a duly authorized committee of the Board, in accordance with Section 4 hereof.

(j) “Common Stock” means the common stock of the Company.

(k) “Company” means Sanmina Corporation, a Delaware corporation, or any successor thereto.

(l) “Consultant” means any natural person, including an advisor, engaged by the Company or an Affiliate to render bona fide services to such entity, provided the services (i) are not in connection with the offer or sale of securities in a capital raising transaction, and (ii) do not directly promote or maintain a market for the Company’s securities, in each case, within the meaning of Form S-8 promulgated under the Securities Act, and provided, further, that a Consultant will include only those persons to whom the issuance of Shares may be registered under Form S-8 promulgated under the Securities Act.

(m) “Director” means a member of the Board.

(n) “Disability” means total and permanent disability as defined in Code Section 22(e)(3), provided that in the case of Awards other than Incentive Stock Options, the Administrator in its discretion may determine whether a permanent and total disability exists in accordance with uniform and non-discriminatory standards adopted by the Administrator from time to time.

(o) “Employee” means any person, including Officers and Directors, employed by the Company or its Affiliates. Neither service as a Director nor payment of a director’s fee by the Company will be sufficient to constitute “employment” by the Company.

(p) “Exchange Act” means the Securities Exchange Act of 1934, as amended.

(q) “Exchange Program” means a program under which (i) outstanding Awards are surrendered or cancelled in exchange for awards of the same type (which may have higher or lower exercise prices and different terms), awards of a different type, and/or cash, (ii) Participants would have the opportunity to transfer any outstanding Awards to a financial institution or other person or entity selected by the Administrator, and/or (iii) the exercise price of an outstanding Award is increased or reduced. For the avoidance of doubt, as set forth in Section 6(a), the Administrator may not implement an Exchange Program.

2

(r) “Fair Market Value” means, as of any date the value of Common Stock determined as follows: The Fair Market Value will be the closing sales price for Common Stock as quoted on any established stock exchange or national market system (including without limitation the New York Stock Exchange, the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market of The Nasdaq Stock Market) on which the Common Stock is listed on the date of determination (or the closing bid, if no sales were reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable.

If the determination date for the Fair Market Value occurs on a non-trading day (i.e., a weekend or holiday), the Fair Market Value will be such price on the immediately preceding trading day, unless otherwise determined by the Administrator. In the absence of an established market for the Common Stock, the Fair Market Value thereof will be determined in good faith by the Administrator.

The determination of fair market value for purposes of tax withholding may be made in the Administrator’s discretion subject to Applicable Laws and is not required to be consistent with the determination of Fair Market Value for other purposes.

(s) “Fiscal Year” means the fiscal year of the Company.

(t) “Incentive Stock Option” means an Option that by its terms qualifies and is otherwise intended to qualify as an incentive stock option within the meaning of Code Section 422 and the regulations promulgated thereunder.

(u) “Nonstatutory Stock Option” means an Option that by its terms does not qualify or is not intended to qualify as an Incentive Stock Option.

(v) “Officer” means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder.

(w) “Option” means a stock option granted pursuant to Section 7 of the Plan.

(x) “Outside Director” means a Director who is not an Employee.

(y) “Parent” means a “parent corporation,” whether now or hereafter existing, as defined in Code Section 424(e).

(z) “Participant” means the holder of an outstanding Award.

(aa) “Performance Share” means an Award denominated in Shares which may be earned in whole or in part upon attainment of performance goals or other vesting criteria as the Administrator may determine pursuant to Section 11.

(bb) “Performance Unit” means an Award which may be earned in whole or in part upon attainment of performance goals or other vesting criteria as the Administrator may determine and which, in the Administrator’s sole discretion, may be settled for cash, Shares or other securities or a combination of the foregoing pursuant to Section 11, in the Administrator’s sole discretion.

(cc) “Period of Restriction” means the period during which the transfer of Shares of Restricted Stock are subject to restrictions and therefore, the Shares are subject to a substantial risk of forfeiture. Such restrictions may be based on the passage of time, the achievement of target levels of performance, or the occurrence of other events as determined by the Administrator.

(dd) “Plan” means this 2019 Equity Incentive Plan.

(ee) “Restricted Stock” means Shares issued pursuant to an Award of Restricted Stock under Section 9 of the Plan, or issued pursuant to the early exercise of an Option.

(ff) “Restricted Stock Unit” means a bookkeeping entry representing an amount equal to the Fair Market Value of one Share, granted pursuant to Section 10. Each Restricted Stock Unit represents an unfunded and unsecured obligation of the Company.

(gg) “Rule 16b-3” means Rule 16b-3 of the Exchange Act or any successor to Rule 16b-3, as in effect when discretion is being exercised with respect to the Plan.

(hh) “Section 16(b)” means Section 16(b) of the Exchange Act.

(ii) “Section 409A” means Code Section 409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and Internal Revenue Service guidance that has been promulgated or may be promulgated thereunder from time to time.

(jj) “Securities Act” means the Securities Act of 1933, as amended.

(kk) “Service Provider” means an Employee, Director or Consultant.

3

(ll) “Share” means a share of the Common Stock, as adjusted in accordance with Section 15 of the Plan.

(mm) “Stock Appreciation Right” means an Award, granted alone or in connection with an Option, that pursuant to Section 8 is designated as a Stock Appreciation Right.

(nn) “Subsidiary” means a “subsidiary corporation,” whether now or hereafter existing, as defined in Code Section 424(f).

3. Stock Subject to the Plan.

(a) Stock Subject to the Plan. Subject to the provisions of Section 15 of the Plan, the maximum aggregate number of Shares that may be awarded and sold under the Plan is 9,493,000 Shares, plus any Shares subject to stock options or similar awards granted under the Sanmina Corporation 2009 Stock Incentive Plan (the “2009 Plan”) that, after the date of stockholder approval of this Plan, expire or otherwise terminate without having been exercised in full and Shares issued pursuant to awards granted under the 2009 Plan that, after the date of stockholder approval of this Plan, are forfeited to or repurchased by the Company, with the maximum number of Shares to be added to the Plan pursuant to the 2009 Plan equal to 6,436,840 Shares. The Shares may be authorized, but unissued, or reacquired Common Stock.

(b) Full Value Awards. Any Shares subject to Awards other than Options or Stock Appreciation Rights will be counted against the numerical limits of this Section 3 as 1.36 Shares for every one Share subject thereto. Further, if Shares acquired pursuant to any such Award are forfeited or repurchased by the Company and would otherwise return to the Plan pursuant to Section 3(c), 1.36 times the number of Shares so forfeited or repurchased will return to the Plan and will again become available for issuance.

(c) Lapsed Awards. If an Award expires or becomes unexercisable without having been exercised in full, or, with respect to Restricted Stock, Restricted Stock Units, Performance Shares or Performance Units which are to be settled in Shares, is forfeited to or repurchased by the Company, the unpurchased Shares (or for Awards other than Options and Stock Appreciation Rights, the forfeited or repurchased Shares) which were subject thereto will become available for future grant or sale under the Plan (unless the Plan has terminated). Upon exercise of a Stock Appreciation Right settled in Shares, the gross number of Shares covered by the portion of the Award so exercised will cease to be available under the Plan. If unvested Shares of Restricted Stock, or unvested Shares issued pursuant to Awards of Restricted Stock Units, Performance Shares or Performance Units are repurchased by or forfeited to the Company, such Shares will become available for future grant under the Plan. Shares used to pay the tax and exercise price of an Award will not become available for future grant or sale under the Plan. To the extent an Award under the Plan is paid out in cash rather than Shares, such cash payment will not result in reducing the number of Shares available for issuance under the Plan. Notwithstanding the foregoing and, subject to adjustment provided in Section 15, the maximum number of Shares that may be issued upon the exercise of Incentive Stock Options will equal the aggregate Share number stated in Section 3(a), plus, to the extent allowable under Code Section 422, any Shares that become available for issuance under the Plan under this Section 3(c).

(d) Share Reserve. The Company, during the term of this Plan, will at all times reserve and keep available such number of Shares as will be sufficient to satisfy the requirements of the Plan.

4. Administration of the Plan.

(a) Procedure.

(i) Multiple Administrative Bodies. Different Committees with respect to different groups of Service Providers may administer the Plan.

(ii) Rule 16b-3. To the extent desirable to qualify transactions hereunder as exempt under Rule 16b-3, the transactions contemplated hereunder will be structured to satisfy the requirements for exemption under Rule 16b-3.

(iii) Delegation to an Officer. The Board may delegate to one or more Officers of the Company the authority to do one or both of the following (i) designate Employees or Consultants of the Company or any of its Subsidiaries who are not Officers to be recipients of Options, Restricted Stock and Restricted Stock Units and the terms thereof, and (ii) determine the number of shares of Common Stock to be subject to such Awards granted to such Employees and Consultants; provided, however, that the Board resolutions regarding such delegation shall specify the total number of shares of Common Stock that may be subject to the Awards granted by such Officer. Notwithstanding anything to the contrary in this Section 4(a), the Board may not delegate to an Officer authority to determine the Fair Market Value of the Common Stock pursuant to Section 4(b) below.

(iv) Other Administration. Other than as provided above, the Plan will be administered by (A) the Board or (B) a Committee, which committee will be constituted to satisfy Applicable Laws.

4

(b) Powers of the Administrator. Subject to the provisions of the Plan, and in the case of a Committee, subject to the specific duties delegated by the Board to such Committee, the Administrator will have the authority, in its discretion:

(i) to determine the Fair Market Value;

(ii) to select the Service Providers to whom Awards may be granted hereunder;

(iii) to determine the number of Shares to be covered by each Award granted hereunder;

(iv) to approve forms of Award Agreements for use under the Plan;

(v) to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder. Such terms and conditions include, but are not limited to, the exercise price, the time or times when Awards may be exercised (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions, and any restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Administrator will determine;

(vi) to construe and interpret the terms of the Plan and Awards granted pursuant to the Plan;

(vii) to prescribe, amend and rescind rules and regulations relating to the Plan, including rules and regulations relating to sub-plans established for the purpose of satisfying applicable non-U.S. laws or for qualifying for favorable tax treatment under applicable non-U.S. laws;

(viii) to modify or amend each Award (subject to 6(b) and Section 20(c) of the Plan) including but not limited to the discretionary authority to extend the post-termination exercisability period of Awards. Notwithstanding the previous sentence, the Administrator may not modify or amend an Option or Stock Appreciation Right to reduce the exercise price of such Option or Stock Appreciation Right after it has been granted (except for adjustments made pursuant to Section 15), and neither may the Administrator cancel any outstanding Option or Stock Appreciation Right in exchange for cash, other awards or an Option or Stock Appreciation Right with an exercise price that is less than the exercise price of the original Option or Stock Appreciation Right, or implement any other type of Exchange Program, unless such action is approved by stockholders prior to such action being taken;

(ix) to allow Participants to satisfy tax withholding obligations in such manner as prescribed in Section 16 of the Plan;

(x) to authorize any person to execute on behalf of the Company any instrument required to effect the grant of an Award previously granted by the Administrator;

(xi) to allow a Participant to defer the receipt of the payment of cash or the delivery of Shares that would otherwise be due to such Participant under an Award pursuant to such procedures as the Administrator may determine; and

(xii) to make all other determinations deemed necessary or advisable for administering the Plan.

(c) Effect of Administrator’s Decision. The Administrator’s decisions, determinations and interpretations will be final and binding on all Participants and any other holders of Awards.

5. Eligibility. Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Units, Performance Shares and such other cash or stock awards as the Administrator determines may be granted to Service Providers. Incentive Stock Options may be granted only to employees of the Company or any Parent or Subsidiary of the Company.

6. Limits.

(a) No Exchange Program or Repricing. The Administrator may not implement an Exchange Program.

(b) One-Year Vesting Requirement. Awards granted under the Plan shall vest no earlier than the one (1) year anniversary of the Award’s date of grant, provided that the Administrator, in its sole discretion, may provide an Award may accelerate vesting, including, without limitation, by reason of the Participant’s death, Disability or retirement, or a termination of the Participant’s service, and provided further, that, notwithstanding the foregoing one-year vesting requirement, Awards that result in the issuance of an aggregate of up to five percent (5%) of the Shares reserved for issuance under Section 3(a) may be granted to Service Providers without regard to such minimum vesting provisions.

(c) Dividends and Other Distributions. The Administrator will not be permitted to provide that dividends or other distributions with respect to Shares to be paid or issued to a Participant with respect to an Award, unless and

5

until the underlying Award has vested. Further, in no event may dividend equivalents be paid with respect to Awards of Stock Options or Stock Appreciation Rights.

(d) Outside Director Limitations. No Outside Director may be granted, in any Fiscal Year, Awards with a grant date fair value (determined in accordance with U.S. generally accepted accounting principles) of greater than $900,000. Any Awards granted to an individual for his or her services as an Employee, or for his or her services as a Consultant (other than as an Outside Director), will not count for purposes of the limitation under this Section 6(d).

(e) Chief Executive Officer Holding Requirement. Any Shares received by the Chief Executive Officer of the Company pursuant to the exercise, issuance or settlement of an Award granted to him or her while serving in the capacity of Chief Executive Officer, after satisfaction of any applicable tax obligations, may not be sold or otherwise transferred (other than for estate planning purposes) by the Chief Executive Officer prior to the one (1) year anniversary of the date the Chief Executive Officer received such Shares, or, if earlier, the termination of the Chief Executive Officer’s status as a Service Provider.

7. Stock Options.

(a) Limitations. Each Option will be designated in the Award Agreement as either an Incentive Stock Option or a Nonstatutory Stock Option. However, notwithstanding such designation, to the extent that the aggregate Fair Market Value of the Shares with respect to which Incentive Stock Options are exercisable for the first time by the Participant during any calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds $100,000, such Options will be treated as Nonstatutory Stock Options. For purposes of this Section 7(a), Incentive Stock Options will be taken into account in the order in which they were granted. The Fair Market Value of the Shares will be determined as of the time the Option with respect to such Shares is granted.

(b) Number of Shares. The Administrator will have complete discretion to determine the number of Shares subject to an Option granted to any Participant.

(c) Term of Option. The Administrator will determine the term of each Option in its sole discretion; provided, however, that the term will be no more than ten (10) years from the date of grant thereof. Moreover, in the case of an Incentive Stock Option granted to a Participant who, at the time the Incentive Stock Option is granted, owns stock representing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any Parent or Subsidiary, the term of the Incentive Stock Option will be five (5) years from the date of grant or such shorter term as may be provided in the Award Agreement.

(d) Option Exercise Price and Consideration.

(i) Exercise Price. The per share exercise price for the Shares to be issued pursuant to exercise of an Option will be determined by the Administrator, but will be no less than 100% of the Fair Market Value per Share on the date of grant. In addition, in the case of an Incentive Stock Option granted to an Employee who, at the time the Incentive Stock Option is granted, owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Parent or Subsidiary, the per Share exercise price will be no less than 110% of the Fair Market Value per Share on the date of grant. Notwithstanding the foregoing provisions of this Section 7(d), Options may be granted with a per Share exercise price of less than 100% of the Fair Market Value per Share on the date of grant pursuant to a transaction described in, and in a manner consistent with, Code Section 424(a).

(ii) Waiting Period and Exercise Dates. At the time an Option is granted, the Administrator will fix the period within which the Option may be exercised and will determine any conditions that must be satisfied before the Option may be exercised.

(iii) Form of Consideration. The Administrator will determine the acceptable form(s) of consideration for exercising an Option, including the method of payment, to the extent permitted by Applicable Laws, which forms of consideration shall be set forth in the Award Agreement at the time of grant.

(e) Exercise of Option.

(i) Procedure for Exercise; Rights as a Stockholder. Any Option granted hereunder will be exercisable according to the terms of the Plan and at such times and under such conditions as determined by the Administrator and set forth in the Award Agreement. An Option may not be exercised for a fraction of a Share. An Option will be deemed exercised when the Company receives: (i) notice of exercise (in such form as the Administrator specifies from time to time) from the person entitled to exercise the Option, and (ii) full payment for the Shares with respect to which the Option is exercised (together with any

6

applicable withholding taxes). No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 15 of the Plan.

(ii) Termination of Relationship as a Service Provider. If a Participant ceases to be a Service Provider, other than upon the Participant’s termination as the result of the Participant’s death or Disability, the Participant may exercise his or her Option within such period of time as is specified in the Award Agreement to the extent that the Option is vested on the date of termination (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement). In the absence of a specified time in the Award Agreement, the Option will remain exercisable for ninety (90) days following the Participant’s termination. Unless otherwise provided by the Administrator, if on the date of termination the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan. If after termination the Participant does not exercise his or her Option within the time specified by the Administrator, the Option will terminate, and the Shares covered by such Option will revert to the Plan.

(iii) Disability of Participant. If a Participant ceases to be a Service Provider as a result of the Participant’s Disability, the Participant may exercise his or her Option within such period of time as is specified in the Award Agreement to the extent the Option is vested on the date of termination (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement). In the absence of a specified time in the Award Agreement, the Option will remain exercisable for five (5) years following the Participant’s termination. Unless otherwise provided by the Administrator, if on the date of termination the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan. If after termination the Participant does not exercise his or her Option within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan.

(iv) Death of Participant. If a Participant dies while a Service Provider, the Option may be exercised following the Participant’s death within such period of time as is specified in the Award Agreement to the extent of all of the shares subject to the Option, including Shares that had not yet vested on the date of death (but in no event may the option be exercised later than the expiration of the term of such Option as set forth in the Award Agreement), by the Participant’s designated beneficiary, provided such beneficiary has been designated prior to Participant’s death in a form acceptable to the Administrator. If no such beneficiary has been designated by the Participant, then such Option may be exercised by the personal representative of the Participant’s estate or by the person(s) to whom the Option is transferred pursuant to the Participant’s will or in accordance with the laws of descent and distribution. In the absence of a specified time in the Award Agreement, the Option will remain exercisable for five (5) years following Participant’s death. If the Option is not so exercised within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan.

(v) Tolling Expiration. A Participant’s Award Agreement may also provide that:

(1) if the exercise of the Option following the termination of Participant’s status as a Service Provider (other than upon the Participant’s death or Disability) would result in liability under Section 16(b), then the Option will terminate on the earlier of (A) the expiration of the term of the Option set forth in the Award Agreement, or (B) the tenth (10th) day after the last date on which such exercise would result in such liability under Section 16(b); or

(2) if the exercise of the Option following the termination of the Participant’s status as a Service Provider (other than upon the Participant’s death or Disability) would be prohibited at any time solely because the issuance of Shares would violate the registration requirements under the Securities Act, then the Option will terminate on the earlier of (A) the expiration of the term of the Option, or (B) the expiration of a period of ninety (90) days after the termination of the Participant’s status as a Service Provider during which the exercise of the Option would not be in violation of such registration requirements.

8. Stock Appreciation Rights.

(a) Grant of Stock Appreciation Rights. Subject to the terms and conditions of the Plan, a Stock Appreciation Right may be granted to Service Providers at any time and from time to time as will be determined by the Administrator, in its sole discretion.

(b) Number of Shares. The Administrator will have complete discretion to determine the number of Stock Appreciation Rights granted to any Participant.

(c) Exercise Price and Other Terms. The Administrator, subject to the provisions of the Plan, will have complete discretion to determine the terms and conditions of Stock Appreciation Rights granted under the Plan,

7

provided, however, that the exercise price will be not less than 100% of the Fair Market Value of a Share on the date of grant. Notwithstanding the foregoing, any outstanding Stock Appreciation Rights held by a Participant who dies while a Service Provider will accelerate and fully vest upon the Participant’s death.

(d) Stock Appreciation Right Agreement. Each Stock Appreciation Right grant will be evidenced by an Award Agreement that will specify the exercise price, the term of the Stock Appreciation Right, the conditions of exercise, and such other terms and conditions as the Administrator, in its sole discretion, will determine.

(e) Expiration of Stock Appreciation Rights. A Stock Appreciation Right granted under the Plan will expire upon the date determined by the Administrator, in its sole discretion, and set forth in the Award Agreement; provided, however, that the term will be no more than ten (10) years from the date of grant thereof. Notwithstanding the foregoing, the rules of Section 7(c) also will apply to Stock Appreciation Rights.

(f) Payment of Stock Appreciation Right Amount. Upon exercise of a Stock Appreciation Right, a Participant will be entitled to receive payment from the Company in an amount determined by multiplying:

(i) The difference between the Fair Market Value of a Share on the date of exercise over the exercise price; by

(ii) The number of Shares with respect to which the Stock Appreciation Right is exercised. At the discretion of the Administrator, the payment upon the exercise of a Stock Appreciation Right may be in cash, in Shares of equivalent value, or in some combination thereof.

9. Restricted Stock.

(a) Grant of Restricted Stock. Subject to the terms and provisions of the Plan, the Administrator, at any time and from time to time, may grant Shares of Restricted Stock to Service Providers in such amounts as the Administrator, in its sole discretion, will determine.

(b) Restricted Stock Agreement. Each Award of Restricted Stock will be evidenced by an Award Agreement that will specify the Period of Restriction, the number of Shares granted, and such other terms and conditions as the Administrator, in its sole discretion, determines. Unless the Administrator determines otherwise, Shares of Restricted Stock will be held by the Company as escrow agent until the restrictions on such Shares have lapsed.

(c) Transferability. Except as provided in Section 14, Shares of Restricted Stock may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated until the end of the applicable Period of Restriction.

(d) Other Restrictions. The Administrator, in its sole discretion, may impose such other restrictions on Shares of Restricted Stock as it may deem advisable or appropriate and contained in the Award Agreement on the date of grant.

(e) Removal of Restrictions. Except as otherwise provided in this Section 9, Shares of Restricted Stock covered by each Restricted Stock grant made under the Plan will be released from escrow as soon as practicable after the last day of the Period of Restriction. Subject to the vesting limitations under Section 6(b), the Administrator, in its discretion, may accelerate the time at which any restrictions will lapse or be removed. Notwithstanding the foregoing, any outstanding Shares of Restricted Stock held by a Participant who dies while a Service Provider will accelerate and fully vest upon the Participant’s death.

(f) Voting Rights. During the Period of Restriction, Service Providers holding Shares of Restricted Stock granted hereunder may exercise full voting rights with respect to those Shares, unless the Administrator determines otherwise.

(g) Dividends and Other Distributions. During the Period of Restriction, Service Providers holding Shares of Restricted Stock will not be entitled to receive dividends or any other distributions paid with respect to such Shares.

(h) Return of Restricted Stock to Company. On the date set forth in the Award Agreement, the Restricted Stock for which restrictions have not lapsed will revert to the Company and become available for grant under the Plan.

10. Restricted Stock Units.

(a) Grant. Restricted Stock Units may be granted at any time and from time to time as determined by the Administrator. Each Restricted Stock Unit grant will be evidenced by an Award Agreement that will specify such other terms and conditions as the Administrator, in its sole discretion, determines, including all terms, conditions, and restrictions related to the grant, the number of Restricted Stock Units and the form of payout, which, subject to Section 10(d), may be left to the discretion of the Administrator.

8

(b) Vesting Criteria and Other Terms. Subject to Section 6(b), the Administrator will set vesting criteria in its discretion, which, depending on the extent to which the criteria are met, will determine the number of Restricted Stock Units that will be paid out to the Participant. Subject to Section 6(b), after the grant of Restricted Stock Units, the Administrator, in its sole discretion, may reduce or waive any restrictions for such Restricted Stock Units. Each Award of Restricted Stock Units will be evidenced by an Award Agreement that will specify the vesting criteria, and such other terms and conditions as the Administrator, in its sole discretion, determines. The Administrator may set vesting criteria based upon the achievement of Company-wide, divisional, business unit, or individual goals (including, but not limited to, continued employment or service), applicable federal or state securities laws or any other basis determined by the Administrator in its discretion. Notwithstanding the foregoing, any outstanding Restricted Stock Units held by a Participant who dies while a Service Provider will accelerate and fully vest upon the Participant’s death.

(c) Earning Restricted Stock Units. Upon meeting the applicable vesting criteria, the Participant will be entitled to receive a payout as determined by the Administrator. Notwithstanding the foregoing, subject to the vesting limitations under Section 6(b), at any time after the grant of Restricted Stock Units, the Administrator, in its sole discretion, may reduce or waive any vesting criteria that must be met to receive a payout.

(d) Form and Timing of Payment. Payment of earned Restricted Stock Units will be made as soon as practicable after the date(s) determined by the Administrator and set forth in the Award Agreement. The Administrator, in its sole discretion, may only settle earned Restricted Stock Units in cash, Shares, or a combination of both.

(e) Cancellation. On the date set forth in the Award Agreement, all unearned Restricted Stock Units will be forfeited to the Company and become available for grant under the Plan.

11. Performance Units and Performance Shares.

(a) Grant of Performance Units/Shares. Performance Units and Performance Shares may be granted to Service Providers at any time and from time to time, as determined by the Administrator, in its sole discretion. The Administrator will have complete discretion in determining the number of Performance Units and Performance Shares granted to each Participant.

(b) Value of Performance Units/Shares. Each Performance Unit will have an initial value that is established by the Administrator on or before the date of grant. Each Performance Share will have an initial value equal to the Fair Market Value of a Share on the date of grant.

(c) Performance Objectives and Other Terms. Subject to Section 6(b), the Administrator will set Performance Goals or other vesting provisions (including, without limitation, continued status as a Service Provider) in its discretion which, depending on the extent to which they are met, will determine the number or value of Performance Units/Shares that will be paid out to the Participant. The Administrator may set performance objectives based upon the achievement of Company-wide, divisional, or individual goals (including, but not limited to, continued employment or service), or any other basis determined by the Administrator in its discretion. The time period during which the performance objectives or other vesting provisions must be met will be called the “Performance Period.” Each Award of Performance Units/Shares will be evidenced by an Award Agreement that will specify the Performance Period and such other terms and conditions as the Administrator, in its sole discretion, determines.

(d) Earning of Performance Units/Shares. After the applicable Performance Period has ended, the holder of Performance Units/ Shares will be entitled to receive a payout of the number of Performance Units/Shares earned by the Participant over the Performance Period, to be determined as a function of the extent to which the corresponding performance objectives or other vesting provisions have been achieved. After the grant of a Performance Unit/Share, subject to the vesting limitations under Section 6(b), the Administrator, in its sole discretion, may reduce or waive any performance objectives or other vesting provisions for such Performance Unit/Share. Notwithstanding the foregoing, any outstanding Performance Units/Shares held by a Participant who dies while a Service Provider will accelerate upon the Participant’s death, with such acceleration assuming that all performance goals and other vesting criteria are deemed achieved at target performance levels and any additional service conditions satisfied.

(e) Form and Timing of Payment of Performance Units/Shares. Payment of earned Performance Units/Shares will be made as soon as practicable after the expiration of the applicable Performance Period and achievement of the performance criteria and other vesting provisions. The Administrator, in its sole discretion, may pay earned Performance Units/Shares in the form of cash, in Shares (which have an aggregate Fair Market Value equal to the value of the earned Performance Units/Shares at the close of the applicable Performance Period) or in a combination thereof.

9

(f) Cancellation of Performance Units/Shares. On the date set forth in the Award Agreement, all unearned or unvested Performance Units/Shares will be forfeited to the Company, and become available for grant under the Plan.

12. Compliance With Code Section 409A. Awards will be designed and operated in such a manner that they are either exempt from the application of, or comply with, the requirements of Section 409A such that the grant, payment, settlement or deferral will not be subject to the additional tax or interest applicable under Section 409A, except as otherwise determined in the sole discretion of the Administrator. The Plan and each Award Agreement under the Plan is intended to meet the requirements of Section 409A and will be construed and interpreted in accordance with such intent, except as otherwise determined in the sole discretion of the Administrator. To the extent that an Award or payment, or the settlement or deferral thereof, is subject to Section 409A the Award will be granted, paid, settled or deferred in a manner that will meet the requirements of Section 409A, such that the grant, payment, settlement or deferral will not be subject to the additional tax or interest applicable under Section 409A. In no event will the Company (or any Parent or Subsidiary of the Company, as applicable) reimburse a Participant for any taxes imposed or other costs incurred as a result of Section 409A.

13. Leaves of Absence/Transfer Between Locations. Unless the Administrator provides otherwise or as provided by written Company policies, vesting of Awards granted hereunder will be suspended during any unpaid leave of absence or as provided by written Company policies. A Service Provider will not cease to be an Employee in the case of (i) any leave of absence approved by the Company or (ii) transfers between locations of the Company or between the Company and its Affiliates. For purposes of Incentive Stock Options, no such leave may exceed three (3) months, unless reemployment upon expiration of such leave is guaranteed by statute or contract. If reemployment upon expiration of a leave of absence approved by the Company is not so guaranteed, then six (6) months and one day following the commencement of such leave any Incentive Stock Option held by the Participant will cease to be treated as an Incentive Stock Option and will be treated for tax purposes as a Nonstatutory Stock Option.

14. Transferability of Awards. Unless determined otherwise by the Administrator, an Award may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the Participant, only by the Participant. With the approval of the Administrator, a Participant may, in a manner specified by the Administrator, (a) transfer an Award to a Participant’s spouse or former spouse pursuant to a court-approved domestic relations order which relates to the provision of child support, alimony payments or marital property rights, and (b) transfer an Option by bona fide gift and not for any consideration, to (i) a member or members of the Participant’s immediate family, (ii) a trust established for the exclusive benefit of the Participant and/or member(s) of the Participant’s immediate family, (iii) a partnership, limited liability company of other entity whose only partners or members are the Participant and/or member(s) of the Participant’s immediate family, or (iv) a foundation in which the Participant and/or member(s) of the Participant’s immediate family control the management of the foundation’s assets. For purposes of this Section 14, “immediate family” will mean the Participant’s spouse, former spouse, children, grandchildren, parents, grandparents, siblings, nieces, nephews, parents-in-law, sons-in-law, daughters-in-law, brothers-in-law, sisters-in-law, including adoptive or step relationships and any person sharing the Participant’s household (other than as a tenant or employee).

15. Adjustments; Dissolution or Liquidation; Merger or Change in Control.

(a) Adjustments. In the event that any dividend or other distribution (whether in the form of cash, Shares, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split up, spin off, combination, repurchase, or exchange of Shares or other securities of the Company, or other change in the corporate structure of the Company affecting the Shares occurs, the Administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the Plan, will adjust the number and class of Shares that may be delivered under the Plan and/or the number, class, and price of Shares covered by each outstanding Award, and the numerical Share or value limits, as applicable, set forth in Sections 3 and 6.

(b) Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, the Administrator will notify each Participant as soon as practicable prior to the effective date of such proposed transaction. To the extent it has not been previously exercised, an Award will terminate immediately prior to the consummation of such proposed action.

(c) Change in Control. In the event of a merger of the Company with or into another corporation or other entity or a Change in Control, each outstanding Award will be treated as the Administrator determines subject to the restriction in the following paragraph, including, without limitation, that each Award be assumed or an equivalent option or right substituted by the successor corporation or a Parent or Subsidiary of the successor corporation (the “Successor Corporation”). The Administrator will not be required to treat all Awards or Participants similarly in the transaction.

10

In the event that the Successor Corporation does not assume or substitute for the Award (and for the avoidance of doubt, notwithstanding the vesting limitations under Section 6(b)), the Participant will fully vest in and have the right to exercise all of his or her outstanding Options and Stock Appreciation Rights, including Shares as to which such Awards would not otherwise be vested or exercisable, all restrictions on Restricted Stock and Restricted Stock Units will lapse, and, with respect to such Award with performance-based vesting, all performance goals or other vesting criteria will be deemed achieved based on actual performance measured through the last date that the Award remains outstanding (or such earlier date, as determined by the Administrator, in its sole discretion), with any performance period shortened proportionately and applicable performance goals or other vesting criteria adjusted proportionately to reflect the shortened performance period (or to the extent applicable, the value of the consideration to be received by the Company’s stockholders in connection with the merger or Change in Control), as determined by the Administrator, in its sole discretion. In addition, if an Option or Stock Appreciation Right is not assumed or substituted in the event of a Change in Control, the Administrator will notify the Participant in writing or electronically that the Option or Stock Appreciation Right will be exercisable for a period of time determined by the Administrator in its sole discretion, and the Option or Stock Appreciation Right will terminate upon the expiration of such period.

For the purposes of this subsection (c), an Award will be considered assumed if, following the Change in Control, the Award confers the right to purchase or receive, for each Share subject to the Award immediately prior to the Change in Control, the consideration (whether stock, cash, or other securities or property) received in the Change in Control by holders of Common Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding Shares); provided, however, that if such consideration received in the Change in Control is not solely common stock of the Successor Corporation or its Parent, the Administrator may, with the consent of the Successor Corporation, provide for the consideration to be received upon the exercise of an Option or Stock Appreciation Right or upon the payout of a Restricted Stock Unit, Performance Unit or Performance Share, for each Share subject to such Award, to be solely common stock of the Successor Corporation or its Parent equal in fair market value to the per share consideration received by holders of Common Stock in the Change in Control.

Notwithstanding anything in this Section 15(c) to the contrary, an Award that vests, is earned or paid-out upon the satisfaction of one or more performance goals will not be considered assumed if the Company or its successor modifies any of such performance goals without the Participant’s consent; provided, however, a modification to such performance goals only to reflect the Successor Corporation’s post-Change in Control corporate structure will not be deemed to invalidate an otherwise valid Award assumption.

(d) Outside Director Awards. With respect to Awards granted to an Outside Director, in the event of a Change in Control in which such Awards are assumed or substituted for, if on the date of or following such assumption or substitution the Participant’s status as a Director or a director of the Successor Corporation, as applicable, is terminated other than upon a voluntary resignation by the Participant (unless such resignation is at the request of the acquirer), then the Participant will fully vest in and have the right to exercise Options and/or Stock Appreciation Rights as to all of the Shares underlying such Award, including those Shares which would not otherwise be vested or exercisable, all restrictions on Restricted Stock and Restricted Stock Units will lapse, and, with respect to Awards with performance-based vesting, unless specifically provided otherwise under the applicable Award Agreement, a Company policy applicable to the Participant, or other written agreement between the Participant and the Company, all performance goals or other vesting criteria will be deemed achieved at one hundred percent (100%) of target levels and all other terms and conditions met.

16. Tax.

(a) Withholding Requirements. Prior to the delivery of any Shares or cash pursuant to an Award (or exercise thereof) or such earlier time as any tax withholding obligations are due, the Company will have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy U.S. federal, state, or local taxes, non-U.S. taxes, or other taxes (including the Participant’s FICA obligation) required to be withheld with respect to such Award (or exercise thereof).

(b) Withholding Arrangements. The Administrator, in its sole discretion and pursuant to such procedures as it may specify from time to time, may permit a Participant to satisfy such tax withholding obligation, in whole or in part by (without limitation) (i) paying cash, (ii) electing to have the Company withhold otherwise deliverable Shares having a fair market value equal to the minimum statutory amount required to be withheld or such greater amount as the Administrator may determine if such amount would not have adverse accounting consequences, as the Administrator determines in its sole discretion, (iii) delivering to the Company already-owned Shares having a fair market value equal to the statutory amount required to be withheld or such greater amount as the Administrator may determine, in each case, provided the delivery of such Shares will not result in any adverse accounting consequences, as the Administrator determines in its sole discretion, (iv) selling a sufficient number of Shares otherwise deliverable to the Participant through such means as the Administrator may determine in its sole discretion (whether through a broker or otherwise) equal to the

11

amount required to be withheld, or (v) any combination of the foregoing methods of payment. The amount of the withholding requirement will be deemed to include any amount which the Administrator agrees may be withheld at the time the election is made, not to exceed the amount determined by using the maximum federal, state or local marginal income tax rates applicable to the Participant with respect to the Award on the date that the amount of tax to be withheld is to be determined. The fair market value of the Shares to be withheld or delivered will be determined as of the date that the taxes are required to be withheld.

17. No Effect on Employment or Service. Neither the Plan nor any Award will confer upon a Participant any right with respect to continuing the Participant’s relationship as a Service Provider, nor will they interfere in any way with the Participant’s right or the right of the Company (or any Affiliate) to terminate such relationship at any time, with or without cause, to the extent permitted by Applicable Laws.

18. Date of Grant. The date of grant of an Award will be, for all purposes, the date on which the Administrator makes the determination granting such Award, or such other later date as is determined by the Administrator. Notice of the determination will be provided to each Participant within a reasonable time after the date of such grant.

19. Term of Plan. Subject to Section 24 of the Plan, the Plan will become effective upon its adoption by the Board. It will continue in effect for a term of ten (10) years from the date adopted by the Board, unless terminated earlier under Section 20 of the Plan.

20. Amendment and Termination of the Plan.

(a) Amendment and Termination. The Administrator may at any time amend, alter, suspend or terminate the Plan.

(b) Stockholder Approval. The Company will obtain stockholder approval of any Plan amendment to the extent necessary and desirable to comply with Applicable Laws.

(c) Effect of Amendment or Termination. No amendment, alteration, suspension or termination of the Plan will materially impair the rights of any Participant, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing and signed by the Participant and the Company. Termination of the Plan will not affect the Administrator’s ability to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination.

21. Conditions Upon Issuance of Shares.

(a) Legal Compliance. Shares will not be issued pursuant to the exercise of an Award unless the exercise of such Award and the issuance and delivery of such Shares will comply with Applicable Laws and will be further subject to the approval of counsel for the Company with respect to such compliance.

(b) Investment Representations. As a condition to the exercise of an Award, the Company may require the person exercising such Award to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required.

22. Inability to Obtain Authority. The inability of the Company to obtain authority from any regulatory body having jurisdiction or to complete or comply with the requirements of any registration or other qualification of the Shares under any U.S. federal or state law, any non-U.S. law, or the rules and regulations of the Securities and Exchange Commission, the stock exchange on which Shares of the same class are then listed, or any other governmental or regulatory body, which authority, registration, qualification or rule compliance is deemed by the Company’s counsel to be necessary or advisable for the issuance and sale of any Shares hereunder, will relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority, registration, qualification or rule compliance will not have been obtained.

23. Clawback. The Administrator may specify in an Award Agreement that the Participant’s rights, payments, and/or benefits with respect to an Award will be subject to reduction, cancellation, forfeiture, and/or recoupment upon the occurrence of certain specified events, in addition to any applicable vesting, performance or other conditions and restrictions of an Award. Notwithstanding any provisions to the contrary under this Plan, an Award granted under the Plan shall be subject to the Company’s clawback policy as may be established and/or amended from time to time. The Board may require a Participant to forfeit or return to and/or reimburse the Company all or a portion of the Award and/or Shares issued under the Award, any amounts paid under the Award, and any payments or proceeds paid or provided upon disposition of the Shares issued under the Award, pursuant to the terms of such Company policy or as necessary or appropriate to comply with Applicable Laws.

24. Stockholder Approval. The Plan will be subject to approval by the stockholders of the Company within twelve (12) months after the date the Plan is adopted by the Board. Such stockholder approval will be obtained in the manner and to the degree required under Applicable Laws.

12

EX-31.1

     EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(A) OF

THE SARBANES-OXLEY ACT OF 2002

I, Jure Sola, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Sanmina Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's Board of Directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

Date: May 19, 2023

/s/ JURE SOLA

Jure Sola

Chief Executive Officer (Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302(A) OF

THE SARBANES-OXLEY ACT OF 2002

I, Kurt Adzema, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Sanmina Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's Board of Directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

Date: May 19, 2023

/s/ KURT ADZEMA

Kurt Adzema

Chief Financial Officer (Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States of America Code (18 U.S.C. §1350), Jure Sola, Chief Executive Officer of Sanmina Corporation (the “Company”), hereby certifies that, to the best of his knowledge:

1. The Company's Quarterly Report on Form 10-Q for the period ended April 1, 2023, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and

2. The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

IN WITNESS WHEREOF, the undersigned has set his hand hereto as of May 19, 2023.

/s/ JURE SOLA

Jure Sola

Chief Executive Officer (Principal Executive Officer)

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

EX-32.2

EXHIBIT 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States of America Code (18 U.S.C. §1350), Kurt Adzema, Chief Financial Officer of Sanmina Corporation (the “Company”), hereby certifies that, to the best of his knowledge:

1. The Company's Quarterly Report on Form 10-Q for the period ended April 1, 2023, to which this Certification is attached as Exhibit 32.2 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and

2. The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

IN WITNESS WHEREOF, the undersigned has set his hand hereto as of May 19, 2023.

/s/ KURT ADZEMA

Kurt Adzema

Chief Financial Officer (Principal Financial Officer)

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

XML

Document and Entity Information Document - shares	6 Months Ended
	Apr. 01, 2023	May 03, 2023
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 01, 2023
Document Transition Report	false
Entity File Number	0-21272
Entity Registrant Name	Sanmina Corporation
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	77-0228183
Entity Address, Address Line One	2700 N. First St.
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95134
City Area Code	408
Local Phone Number	964-3500
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Title of 12(b) Security	Common Stock
Trading Symbol	SANM
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		58,168,859
Entity Central Index Key	0000897723
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Apr. 01, 2023	Oct. 01, 2022	Apr. 02, 2022
Current assets:
Cash and cash equivalents	$ 718,203	$ 529,857
Accounts receivable, net of allowances of approximately $8 million as of April 1, 2023 and October 1, 2022	1,208,808	1,138,894
Contract assets	486,290	475,721
Inventories	1,552,568	1,684,099
Prepaid expenses and other current assets	69,091	62,044
Total current assets	4,034,960	3,890,615
Property, plant and equipment, net	616,998	575,170
Deferred tax assets	196,191	209,554
Other	181,307	160,192
Total assets	5,029,456	4,835,531
Current liabilities:
Accounts payable	1,828,699	2,041,434
Accrued liabilities	282,414	281,599
Accrued payroll and related benefits	126,373	130,892
Short-term debt, including current portion of long-term debt	17,500	17,500
Total current liabilities	2,254,986	2,471,425
Long-term liabilities:
Long-term debt	320,779	329,237
Other	235,697	215,333
Total long-term liabilities	556,476	544,570
Contingencies
Stockholders' equity	2,217,994	1,819,536	$ 1,805,038
Total liabilities and stockholders' equity	$ 5,029,456	$ 4,835,531

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) $ in Millions	Apr. 01, 2023	Oct. 01, 2022
CONDENSED CONSOLIDATED BALANCE SHEETS
Accounts receivable, net of allowances	$ 8	$ 8

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
Net sales	$ 2,320,103	$ 1,915,070	$ 4,675,911	$ 3,671,396
Cost of sales	2,128,914	1,768,575	4,289,336	3,383,604
Gross profit	191,189	146,495	386,575	287,792
Operating expenses:
Selling, general and administrative	63,390	61,817	124,120	123,292
Research and development	6,394	5,472	11,993	10,249
Restructuring and other	804	2,932	1,435	4,346
Gain on sale of long-lived assets	0	0	0	(4,610)
Total operating expenses	70,588	70,221	137,548	133,277
Operating income	120,601	76,274	249,027	154,515
Interest income	2,539	349	5,472	658
Interest expense	(9,286)	(4,870)	(17,967)	(9,747)
Other income (expense), net	(2,768)	(1,408)	(9,480)	664
Interest and other, net	(9,515)	(5,929)	(21,975)	(8,425)
Income before income taxes	111,086	70,345	227,052	146,090
Provision for income taxes	25,779	21,724	46,631	41,292
Net income before noncontrolling interest	85,307	48,621	180,421	104,798
Less: Net income attributable to noncontrolling interest	5,686	0	8,786	0
Net income attributable to common shareholders	$ 79,621	$ 48,621	$ 171,635	$ 104,798
Net income attributable to common shareholders per share:
Basic	$ 1.37	$ 0.77	$ 2.96	$ 1.65
Diluted	$ 1.33	$ 0.76	$ 2.87	$ 1.60
Weighted average shares used in computing per share amounts:
Basic	58,269	62,845	57,999	63,622
Diluted	59,819	64,271	59,863	65,365

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Net income before noncontrolling interest	$ 85,307	$ 48,621	$ 180,421	$ 104,798
Other comprehensive income (loss), net of tax:
Change in foreign currency translation adjustments	1,060	(1,069)	7,243	(3,116)
Derivative financial instruments:
Change in net unrealized amount	2,938	7,776	7,407	9,740
Amount reclassified into net income before noncontrolling interest	(6,203)	337	(9,499)	2,400
Defined benefit plans:
Changes in unrecognized net actuarial losses and unrecognized transition costs	(157)	183	(908)	661
Amortization of actuarial losses and transition costs	217	242	562	480
Total other comprehensive income (loss)	(2,145)	7,469	4,805	10,165
Comprehensive income before noncontrolling interest	83,162	56,090	185,226	114,963
Less: Net income attributable to noncontrolling interest	5,686	0	8,786	0
Comprehensive income attributable to common shareholders	$ 77,476	$ 56,090	$ 176,440	$ 114,963

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Common Stock and Additional Paid in Capital	Treasury Stock	Accumulated Other Comprehensive Income	Accumulated Deficit	Parent	Noncontrolling Interest	Common Stock Shares Outstanding	Total
Balance, beginning of period at Oct. 02, 2021	$ 6,339,506	$ (1,047,202)	$ 40,690	$ (3,480,362)
Noncontrolling Interest in Joint Ventures at Oct. 02, 2021						$ 0
Noncontrolling Interest in Joint Ventures at Jan. 01, 2022						0
Number of shares, beginning of period at Oct. 02, 2021							108,734
Number of shares, end of period at Jan. 01, 2022							109,518
Increase (Decrease) in Stockholders' Equity
Repurchases of treasury stock		(46,198)
Balance, end of period at Jan. 01, 2022	6,349,588	$ (1,116,025)	43,386	(3,424,185)
Balance, beginning of period at Oct. 02, 2021	6,339,506	(1,047,202)	40,690	(3,480,362)
Increase (Decrease) in Stockholders' Equity
Issuances under stock plans	1,402
Stock-based compensation expense	18,362
Repurchases of treasury stock		$ (182,321)
Other comprehensive income (loss)			10,165
Net income attributable to common shareholders					$ 104,798			$ 104,798
Noncontrolling Interest in Joint Ventures at Oct. 02, 2021						0
Increase (Decrease) in Stockholders' Equity
Net income attributable to noncontrolling interest								0
Number of shares, beginning of period at Oct. 02, 2021							108,734
Increase (Decrease) in Stockholders' Equity
Issuances under stock plans							1,177
Number of shares, end of period at Apr. 02, 2022							109,911
Increase (Decrease) in Stockholders' Equity
Repurchases of treasury stock		(4,697)
Number of shares, end of period at Apr. 02, 2022		(49,124)
Balance, end of period at Apr. 02, 2022	6,359,270	$ (1,229,523)	50,855	(3,375,564)
Balance, beginning of period at Oct. 02, 2021	6,339,506	$ (1,047,202)	40,690	(3,480,362)
Noncontrolling Interest in Joint Ventures at Oct. 02, 2021						0
Noncontrolling Interest in Joint Ventures at Oct. 01, 2022						0
Number of shares, beginning of period at Oct. 02, 2021							108,734
Number of shares, end of period at Oct. 01, 2022							110,160
Increase (Decrease) in Stockholders' Equity
Repurchases of treasury stock		(52,766)
Balance, end of period at Oct. 01, 2022	6,381,348	$ (1,378,159)	56,325	(3,239,978)
Balance, beginning of period at Jan. 01, 2022	6,349,588	(1,116,025)	43,386	(3,424,185)
Increase (Decrease) in Stockholders' Equity
Issuances under stock plans	352
Stock-based compensation expense	9,330
Repurchases of treasury stock		$ (113,498)
Other comprehensive income (loss)			7,469
Net income attributable to common shareholders					48,621			48,621
Noncontrolling Interest in Joint Ventures at Jan. 01, 2022						0
Increase (Decrease) in Stockholders' Equity
Net income attributable to noncontrolling interest								0
Number of shares, beginning of period at Jan. 01, 2022							109,518
Increase (Decrease) in Stockholders' Equity
Issuances under stock plans							393
Number of shares, end of period at Apr. 02, 2022							109,911
Increase (Decrease) in Stockholders' Equity
Repurchases of treasury stock		(2,926)
Number of shares, end of period at Apr. 02, 2022		(49,124)
Balance, end of period at Apr. 02, 2022	6,359,270	$ (1,229,523)	50,855	(3,375,564)
Increase (Decrease) in Stockholders' Equity
Total stockholders' equity								1,805,038
Total stockholders' equity								1,819,536
Balance, beginning of period at Oct. 01, 2022	6,381,348	$ (1,378,159)	56,325	(3,239,978)
Noncontrolling Interest in Joint Ventures at Oct. 01, 2022						0
Noncontrolling Interest in Joint Ventures at Dec. 31, 2022						135,232
Number of shares, beginning of period at Oct. 01, 2022							110,160
Number of shares, end of period at Dec. 31, 2022							110,502
Increase (Decrease) in Stockholders' Equity
Repurchases of treasury stock		(52,902)
Balance, end of period at Dec. 31, 2022	6,471,299	$ (1,386,168)	63,275	(3,147,964)
Balance, beginning of period at Oct. 01, 2022	6,381,348	(1,378,159)	56,325	(3,239,978)
Increase (Decrease) in Stockholders' Equity
Issuances under stock plans	295
Stock-based compensation expense	24,143
Sale of noncontrolling interest	78,169
Repurchases of treasury stock		$ (21,507)
Other comprehensive income (loss)			4,805
Net income attributable to common shareholders					171,635			171,635
Noncontrolling Interest in Joint Ventures at Oct. 01, 2022						0
Increase (Decrease) in Stockholders' Equity
Sale of noncontrolling interest						132,132
Net income attributable to noncontrolling interest						8,786		8,786
Noncontrolling Interest in Joint Ventures at Apr. 01, 2023						140,918
Number of shares, beginning of period at Oct. 01, 2022							110,160
Increase (Decrease) in Stockholders' Equity
Issuances under stock plans							1,125
Number of shares, end of period at Apr. 01, 2023							111,285
Increase (Decrease) in Stockholders' Equity
Repurchases of treasury stock		(361)
Number of shares, end of period at Apr. 01, 2023		(53,127)
Balance, end of period at Apr. 01, 2023	6,483,955	$ (1,399,666)	61,130	(3,068,343)
Balance, beginning of period at Dec. 31, 2022	6,471,299	(1,386,168)	63,275	(3,147,964)
Increase (Decrease) in Stockholders' Equity
Issuances under stock plans	122
Stock-based compensation expense	12,534
Repurchases of treasury stock		$ (13,498)
Other comprehensive income (loss)			(2,145)
Net income attributable to common shareholders					$ 79,621			79,621
Noncontrolling Interest in Joint Ventures at Dec. 31, 2022						135,232
Increase (Decrease) in Stockholders' Equity
Net income attributable to noncontrolling interest						5,686		5,686
Noncontrolling Interest in Joint Ventures at Apr. 01, 2023						$ 140,918
Number of shares, beginning of period at Dec. 31, 2022							110,502
Increase (Decrease) in Stockholders' Equity
Issuances under stock plans							783
Number of shares, end of period at Apr. 01, 2023							111,285
Increase (Decrease) in Stockholders' Equity
Repurchases of treasury stock		(225)
Number of shares, end of period at Apr. 01, 2023		(53,127)
Balance, end of period at Apr. 01, 2023	$ 6,483,955	$ (1,399,666)	$ 61,130	$ (3,068,343)
Increase (Decrease) in Stockholders' Equity
Total stockholders' equity								$ 2,217,994

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income before noncontrolling interest	$ 180,421	$ 104,798
Adjustments to reconcile net income before noncontrolling interest to cash provided by (used in) operating activities:
Depreciation and amortization	57,818	55,032
Stock-based compensation expense	24,143	18,362
Deferred income taxes	13,558	9,173
Other, net	101	(1,903)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable	(66,479)	(79,308)
Contract assets	(10,569)	(67,092)
Inventories	136,447	(403,783)
Prepaid expenses and other assets	(25,381)	(11,334)
Accounts payable	(213,168)	362,191
Accrued liabilities	4,911	161,137
Cash provided by operating activities	101,802	147,273
CASH FLOWS PROVIDED BY (USED IN) INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(100,978)	(52,650)
Proceeds from sales of property, plant and equipment	990	8,025
Purchases of investments	(1,500)	(1,000)
Cash used in investing activities	(101,488)	(45,625)
CASH FLOWS PROVIDED BY (USED IN) FINANCING ACTIVITIES:
Repayments of long-term debt	(8,750)	(9,376)
Proceeds from revolving credit facility borrowings	1,471,700	202,800
Repayments of revolving credit facility borrowings	(1,471,700)	(202,800)
Net proceeds from stock issuances	295	1,402
Repurchases of common stock	(21,507)	(182,321)
Proceeds from sale of noncontrolling interest	215,799	0
Cash provided by (used in) financing activities	185,837	(190,295)
Effect of exchange rate changes	2,195	(1,486)
Increase (decrease) in cash and cash equivalents	188,346	(90,133)
Cash and cash equivalents at beginning of period	529,857	650,026
Cash and cash equivalents at end of period	718,203	559,893
Cash paid during the period for:
Interest, net of capitalized interest	15,264	7,533
Income taxes, net of refunds	28,247	17,052
Unpaid purchases of property, plant and equipment at the end of period	$ 34,973	$ 18,264

XML

Restatement of Condensed Consolidated Financial Statements

6 Months Ended

Apr. 01, 2023

Restatement of Condensed Consolidated Financial Statements

Restatement of Condensed Consolidated Financial Statements

Note 1. Restatement of Condensed Consolidated Financial Statements

Sanmina Corporation (the “Company”) identified misstatements in the unaudited condensed consolidated financial statements for the comparative periods of 2022 in conjunction with an independent investigation conducted by the Audit Committee of the Board of Directors, as further disclosed in the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on May 11, 2023. The comparative periods have been amended and restated to correct for such misstatements. More detailed information related to the amendment and restatement is contained in Amendment No. 1 to the Company’s Annual Report on Form 10-K for the fiscal year ended October 1, 2022 and Amendment No. 1 to the Company’s Form 10-Q for the quarter ended December 31, 2022 as filed with the Securities and Exchange Commission on May 19, 2023.

During the preparation of its unaudited consolidated financial statements for the fiscal quarter ended April 1, 2023, the Company determined that certain personnel in one of its divisions had failed to properly substantiate and update cost estimates for materials and other costs over the life of certain contracts. As a result, the Company conducted an independent investigation (the “Investigation”) under the direction of the Audit Committee of the Company’s Board of Directors (the “Audit Committee”). The division, like other Company divisions, has a stand-alone finance organization, which reports directly to the Company finance organization and indirectly to the management of the division. References in the findings below refer solely to this division unless otherwise noted. The Investigation found that:

● In connection with the preparation and review of quarterly contract cost and other estimates, an internal control in the Company’s accounting process for the division’s contracts with customers, certain division personnel made inappropriate and unsupported adjustments to reduce certain cost estimates and failed to appropriately evaluate and increase other cost estimates to reflect cost overruns and other costs associated with delays in completing certain contracts.

● The division had a culture that did not recognize or emphasize the importance of rigor in the division’s quarterly contract estimate review process or its significance to the Company’s internal control over financial reporting and accounting and financial reporting determinations with respect to the division’s contracts with customers. Instead, the division’s tone at the top and other control weaknesses enabled participants in the quarterly contract estimate review process to tolerate, place undue reliance on or otherwise fail to challenge unsupported adjustments and assumptions to contract cost estimates that had been made based on unsubstantiated optimism and/or a desire to avoid adverse outcomes.

● The division had an ineffective finance function that did not provide sufficient oversight on financial accounting and reporting matters or effectively challenge adjustments or other improper practices in the quarterly contract estimate review process.

● Certain division personnel lacked sufficient understanding of the division’s policies and procedures for the quarterly contract estimate review process as well as the relevant cost and contract accounting practices and requirements.

● Certain division personnel provided materially inaccurate and incomplete information to, including in response to inquiries from, Company management and the Company’s internal and independent auditors concerning contract cost estimates and related items.

The “Previously Reported” amounts in the following tables are amounts derived from the Form 10-Q for the period ended April 2, 2022. The amounts in columns labeled “Investigation Adjustments” represent the effect of adjustments resulting from an independent investigation conducted by the Audit Committee of the Board of Directors and the amounts in columns labeled “Other Adjustments” represent the effect of uncorrected misstatements in previously filed financial statements that were not material, individually or in the aggregate, to those previously filed financial statements. The effects of the restatement, including the related income tax effects, have been corrected in all impacted tables and footnotes throughout these condensed consolidated financial statements. The only impact to the Condensed Consolidated Statements of Comprehensive Income and Condensed Consolidated Statements of Stockholders’ Equity was to net income.

Investigation Adjustments correct misstatements that resulted primarily from 1) increases to estimated costs at completion of a contract that previously did not properly reflect estimated costs remaining to be incurred to complete a contract, 2) reductions in the

amount of transaction consideration expected to be received under a contract, and 3) segmentation of contracts that had previously been combined. The adjustments primarily affected net sales, cost of sales, contract assets and inventory.

Other Adjustments primarily correct balance sheet misstatements related to inventory cut-off and advance payments from customers.

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Statements of Income for the three and six months ended April 2, 2022.

	Three Months Ended								Six Months Ended
	April 2, 2022								April 2, 2022
	(Unaudited)								(Unaudited)
	Previously		Investigation		Other				Previously		Investigation		Other
	Reported		Adjustments		Adjustments		As Restated		Reported		Adjustments		Adjustments			As Restated
	(In thousands, except per share data)
Net sales	$	1,911,530	$	3,540	$	—	$	1,915,070	$	3,668,855	$	2,541	$	—	$	3,671,396
Cost of sales		1,759,083		9,492		—		1,768,575		3,371,919		11,685		—		3,383,604
Gross profit		152,447		(5,952)		—		146,495		296,936		(9,144)		—		287,792
Operating expenses:
Selling, general and administrative		61,817		—		—		61,817		123,292		—		—		123,292
Research and development		5,472		—		—		5,472		10,249		—		—		10,249
Restructuring and other		2,932		—		—		2,932		4,346		—		—		4,346
Gain on sale of long-lived assets		—		—		—		—		(4,610)		—		—		(4,610)
Total operating expenses		70,221		—		—		70,221		133,277		—		—		133,277
Operating income		82,226		(5,952)		—		76,274		163,659		(9,144)		—		154,515
Interest income		349		—		—		349		658		—		—		658
Interest expense		(4,870)		—		—		(4,870)		(9,747)		—		—		(9,747)
Other income (expense), net		(1,408)		—		—		(1,408)		664		—		—		664
Interest and other, net		(5,929)		—		—		(5,929)		(8,425)		—		—		(8,425)
Income before income taxes		76,297		(5,952)		—		70,345		155,234		(9,144)		—		146,090
Provision for income taxes		23,077		(1,353)		—		21,724		43,380		(2,088)		—		41,292
Net Income	$	53,220	$	(4,599)		—	$	48,621	$	111,854	$	(7,056)	$	—	$	104,798
Net income per share:
Basic	$	0.85	$	(0.08)	$	—	$	0.77	$	1.76	$	(0.11)	$	—	$	1.65
Diluted	$	0.83	$	(0.07)	$	—	$	0.76	$	1.71	$	(0.11)	$	—	$	1.60
Weighted average shares used in computing per share amounts:
Basic		62,845		—		—		62,845		63,622		—		—		63,622
Diluted		64,271		—		—		64,271		65,365		—		—		65,365

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Balance Sheet as of October 1, 2022.

	As of
	October 1, 2022
	(Unaudited)
	Previously		Investigation		Other
	Reported		Adjustments		Adjustments		As Restated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	529,857	$	—	$	—	$	529,857
Accounts receivable, net of allowances		1,138,894		—		—		1,138,894
Contract assets		503,674		(27,953)		—		475,721
Inventories		1,691,081		(21,705)		14,723		1,684,099
Prepaid expenses and other current assets		62,044		—		—		62,044
Total current assets		3,925,550		(49,658)		14,723		3,890,615
Property, plant and equipment, net		575,170		—		—		575,170
Deferred tax assets		198,588		10,966		—		209,554
Other		160,192		—		—		160,192
Total assets	$	4,859,500	$	(38,692)	$	14,723	$	4,835,531
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	2,029,534	$	—	$	11,900	$	2,041,434
Accrued liabilities		275,735		1,441		4,423		281,599
Accrued payroll and related benefits		130,892		—		—		130,892
Short-term debt, including current portion of long-term debt		17,500		—		—		17,500
Total current liabilities		2,453,661		1,441		16,323		2,471,425
Long-term liabilities:
Long-term debt		329,237		—		—		329,237
Other		215,333		—		—		215,333
Total long-term liabilities		544,570		—		—		544,570
Contingencies (Note 8)
Stockholders’ equity		1,861,269		(40,133)		(1,600)		1,819,536
Total liabilities and stockholders’ equity	$	4,859,500	$	(38,692)	$	14,723	$	4,835,531

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Statements of Cash Flows for the six month period ended April 2, 2022. There were no adjustments to cash flows provided by (used in) investing or financing activities for the six month period ended April 2, 2022.

	Six Months Ended
	April 2, 2022
	(Unaudited)
	Previously		Investigation		Other
	Reported		Adjustments		Adjustments		As Restated
	(In thousands)
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income before noncontrolling interest	$	111,854	$	(7,056)	$	—	$	104,798
Adjustments to reconcile net income before noncontrolling interest to cash provided by (used in) operating activities:
Depreciation and amortization		55,032		—		—		55,032
Stock-based compensation expense		18,362		—		—		18,362
Deferred income taxes		11,071		(1,898)		—		9,173
Other, net		(1,903)		—		—		(1,903)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable		(79,705)		—		397		(79,308)
Contract assets		(68,545)		4,804		(3,351)		(67,092)
Inventories		(403,396)		4,628		(5,015)		(403,783)
Prepaid expenses and other assets		(11,334)		—		—		(11,334)
Accounts payable		357,176		—		5,015		362,191
Accrued liabilities		158,661		(478)		2,954		161,137
Cash provided by operating activities	$	147,273	$	—	$	—	$	147,273

XML

Basis of Presentation

6 Months Ended

Apr. 01, 2023

Basis of Presentation

Basis of Presentation

Note 2. Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been omitted pursuant to those rules or regulations. The interim condensed consolidated financial statements are unaudited, but reflect all adjustments, consisting primarily of normal recurring adjustments, that are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended October 1, 2022, included in Amendment No. 1 on Form 10-K/A to the Company’s Annual Report on Form 10-K for such fiscal year filed with the SEC on May 19, 2023.

The unaudited condensed consolidated financial statements include all accounts of the Company, its wholly-owned subsidiaries and subsidiaries in which it has control. All intra-company accounts and transactions have been eliminated. Noncontrolling interest represents a noncontrolling investor’s interest in the results of operations of subsidiaries that the Company controls and consolidates.

The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates.

Results of operations for the second quarter of 2023 are not necessarily indicative of the results that may be expected for other interim periods or for the full fiscal year.

The Company operates on a 52 or 53 week year ending on the Saturday nearest September 30. Fiscal 2023 and 2022 are each 52-week years. All references to years relate to fiscal years unless otherwise noted.

XML

Revenue Recognition

6 Months Ended

Apr. 01, 2023

Revenue Recognition

Revenue Recognition

Note 3. Revenue Recognition

The Company is a leading global provider of integrated manufacturing solutions, components, products and repair, logistics and after-market services. For purposes of determining when to recognize revenue, and in what amount, the Company applies a 5-step model: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the Company satisfies a performance obligation. Each of these steps may involve the use of significant judgments, as discussed below.

Step 1 - Identify the Contract with a Customer

A contract is defined as an agreement between two parties that creates enforceable rights and obligations. The Company generally enters into a master supply agreement (“MSA”) with its customers that provides the framework under which business will be conducted, and pursuant to which a customer will issue purchase orders or other binding documents to specify the quantity, price and delivery requirements for products or services the customer wishes to purchase. The Company generally considers its contract with a customer to be a firm commitment, consisting of the combination of an MSA and a purchase order or any other similar binding document.

Step 2 - Identify the Performance Obligations in the Contract

A performance obligation is a promised good or service that is material in the context of the contract and is both capable of being distinct (customer can benefit from the good or service on its own or together with other readily available resources) and distinct within the context of the contract (separately identifiable from other promises). The Company reviews its contracts to identify promised goods or services and then evaluates such items to determine which of those items are performance obligations. The majority of the Company’s contracts have a single performance obligation since the promise to transfer an individual good or service is not separately identifiable from other promises in the contract. The Company’s performance obligations generally have an expected duration of one year or less.

Step 3 - Determine the Transaction Price

The Company’s contracts with its customers may include certain forms of variable consideration such as early payment discounts, volume discounts and shared cost savings. The Company includes an estimate of variable consideration when determining the transaction price and the appropriate amount of revenue to be recognized. This estimate is limited to an amount which will not result in a significant reversal of revenue in a future period. Factors considered in the Company’s estimate of variable consideration are the potential amount subject to these contract provisions, historical experience and other relevant facts and circumstances.

Step 4 - Allocate the Transaction Price to the Performance Obligations in the Contract

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. In the event that more than one performance obligation is identified in a contract, the Company is required to allocate a portion of the transaction price to each performance obligation. This allocation would generally be based on the relative standalone price of each performance obligation, which most often would represent the price at which the Company would sell similar goods or services separately.

Step 5 - Recognize Revenue When (or as) a Performance Obligation is Satisfied

The Company is required to assess whether control of a product or services promised under a contract is transferred to the customer at a point-in-time or over time as the product is being manufactured or the services are being provided. If the criteria in ASC 606 for recognizing revenue on an over time basis are not met, revenue must be recognized at the point-in-time determined by the Company at which its customer obtains control of a product or service.

The Company has determined that revenue for the majority of its contracts is required to be recognized on an over time basis. This determination is based on the fact that 1) the Company does not have an alternative use for the end products it manufactures for its customers and has an enforceable right to payment, including a reasonable profit, for work-in-progress upon a customer’s cancellation of a contract for convenience or 2) the Company’s customer simultaneously receives and consumes the benefits provided by the Company’s services. For these contracts, revenue is recognized on an over time basis using the cost-to-cost method (ratio of costs incurred to date to total estimated costs at completion) which the Company believes best depicts the transfer of control to the customer. At least 95% of the Company’s revenue is recognized on an over time basis, which is as products are manufactured or services are performed. Because of this, and the fact that there is no work-in-process or finished goods inventory associated with contracts for which revenue is recognized on an over-time basis, 99% or more of the Company’s inventory at the end of a given period is in the form of raw materials. For contracts for which revenue is required to be recognized at a point-in-time, the Company recognizes revenue when it has transferred control of the related goods, which generally occurs upon shipment or delivery of the goods to the customer.

Application of the cost-to-cost method for government contracts in the Company’s Defense and Aerospace division requires the use of significant judgments with respect to estimated materials, labor and subcontractor costs included in the total estimated costs at completion. Additionally, the Company evaluates whether contract modifications for claims have been approved and, if so, estimates the amount, if any, of variable consideration that can be included in the transaction price of the contract. This division is an operating segment whose results are combined with eleven other operating segments and reported under Components, Products and Services (“CPS”) for segment reporting purposes. During the first half of 2023, CPS revenue and gross profit were $830 million and $118 million, respectively.

Estimates of materials, labor and subcontractor costs expected to be incurred to satisfy a performance obligation are updated on a quarterly basis. These estimates consider costs incurred to date and estimated costs to be incurred over the remaining expected period of performance to satisfy a performance obligation. Such estimates are reviewed each quarter by a group of employees that includes representatives from numerous functions such as engineering, materials, contracts, manufacturing, program management, finance and senior management. If a change in estimate is deemed necessary, the impact of the change is recognized in the period of change. Additionally, contract modifications for claims are assessed each quarter to determine whether the claims have been approved. If it is determined that a claim has been approved, the amount of the claim, if any, that can be included in transaction price is estimated considering a number of factors such as the length of time expected to lapse until uncertainty about the claim has been resolved and the extent to which our experience with claims for similar contracts has predictive value.

Contract Assets

A contract asset is recognized when the Company has recognized revenue, but has not issued an invoice to its customer for payment. Contract assets are classified separately on the unaudited condensed consolidated balance sheets and transferred to accounts receivable when rights to payment become unconditional. Because of the Company’s short manufacturing cycle times, the transfer from contract assets to accounts receivable generally occurs within the next fiscal quarter.

Other

Taxes assessed by governmental authorities that are both imposed on and concurrent with a specific revenue-producing transaction, and are collected by the Company from a customer, are excluded from revenue.

Shipping and handling costs associated with outbound freight after control of a product has transferred to a customer are accounted for as fulfillment costs and are included in cost of sales.

The Company applies the following practical expedients or policy elections under ASC 606:

● The promised amount of consideration under a contract is not adjusted for the effects of a significant financing component because, at inception of a contract, the Company expects the period between when a good or service is transferred to a customer and when the customer pays for that good or service will generally be one year or less.

● The Company has elected not to disclose information about remaining performance obligations that have original expected durations of one year or less, which is substantially all of the Company’s remaining performance obligations.

● Incremental costs of obtaining a contract are not capitalized if the period over which such costs would be amortized to expense is less than one year.

Disaggregation of Revenue

In the following table, revenue is disaggregated by segment, market sector and geography.

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(In thousands)
Segments:
IMS	$	1,919,158	$	1,549,416	$	3,846,270	$	2,966,327
CPS		400,945		365,654		829,641		705,069
Total	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396
End Markets:
Industrial, Defense, Medical and Automotive	$	1,361,843	$	1,158,260	$	2,701,871	$	2,212,232
Communications Networks and Cloud Infrastructure		958,260		756,810		1,974,040		1,459,164
Total	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396
Geography:
Americas (1)	$	1,112,778	$	902,111	$	2,248,529	$	1,698,132
APAC		853,492		714,379		1,767,833		1,405,450
EMEA		353,833		298,580		659,549		567,814
Total	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396

(1) Mexico represents approximately 70% and 60% of the Americas revenue and the U.S. represents approximately 30% and 40% of the Americas revenue for the six months ended April 1, 2023 and April 2, 2022, respectively.

XML

Financial Instruments

6 Months Ended

Apr. 01, 2023

Financial Instruments

Financial Instruments

Note 4. Financial Instruments

Fair Value Measurements

Fair Value of Financial Instruments

The fair values of cash equivalents (represents 21% of cash and cash equivalents), accounts receivable, accounts payable and short-term debt approximate carrying values due to the short-term duration of these instruments. Additionally, the fair value of variable rate long-term debt approximates carrying value as of April 1, 2023.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

The Company’s primary financial assets and financial liabilities measured at fair value on a recurring basis are deferred compensation plan assets and defined benefit plan assets, which are both measured using Level 1 inputs. Deferred compensation plan assets were $38 million and $37 million as of April 1, 2023 and October 1, 2022, respectively. Defined benefit plan assets were $17 million as of October 1, 2022 and are measured at fair value only in the fourth quarter of each year. Other financial assets and financial liabilities measured at fair value on a recurring basis include foreign exchange contracts and interest rate swaps, which are both measured using Level 2 inputs. Foreign exchange contracts were not material as of April 1, 2023 or October 1, 2022. Interest rate swaps had values of $3 million and $6 million as of April 1, 2023 and October 1, 2022, respectively.

Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis

Other non-financial assets, such as goodwill and other long-lived assets, are measured at fair value as of the date such assets are acquired or in the period an impairment is recorded.

Offsetting Derivative Assets and Liabilities

The Company has entered into master netting arrangements with each of its derivative counterparties that allows net settlement of derivative assets and liabilities under certain conditions, such as multiple transactions with the same currency maturing on the same date. The Company presents its derivative assets and derivative liabilities on a gross basis on the unaudited condensed consolidated balance sheets. The amount that the Company had the right to offset under these netting arrangements was not material as of April 1, 2023 or October 1, 2022.

Derivative Instruments

Foreign Exchange Rate Risk

The Company is exposed to certain risks related to its ongoing business operations. The primary risk managed by using derivative instruments is foreign currency exchange risk.

Forward contracts on various foreign currencies are used to manage foreign currency risk associated with forecasted foreign currency transactions and certain monetary assets and liabilities denominated in non-functional currencies. The Company’s primary foreign currency cash flows are in certain Asian and European countries, Israel and Mexico.

The Company had the following outstanding foreign currency forward contracts that were entered into to hedge foreign currency exposures:

	As of
	April 1,		October 1,
	2023		2022
Derivatives Designated as Accounting Hedges:
Notional amount (in thousands)	$	126,383	$	123,172
Number of contracts		50		50
Derivatives Not Designated as Accounting Hedges:
Notional amount (in thousands)	$	434,005	$	531,558
Number of contracts		42		43

The Company utilizes foreign currency forward contracts to hedge certain operational (“cash flow”) exposures resulting from changes in foreign currency exchange rates. Such exposures generally result from (1) forecasted non-functional currency sales and (2) forecasted non-functional currency materials, labor, overhead and other expenses. These contracts are designated as cash flow hedges for accounting purposes and are generally one to two months in duration but, by policy, may be up to twelve months in duration.

For derivative instruments that are designated and qualify as cash flow hedges, the Company excludes time value from its assessment of hedge effectiveness and recognizes the amount of time value in earnings over the life of the derivative instrument. Gains or losses on the derivative not caused by changes in time value are recorded in Accumulated Other Comprehensive Income (“AOCI”), a component of equity, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The amount of gain or loss recognized in Other Comprehensive Income on derivative instruments and the amount of gain or loss reclassified from AOCI into income were not material for any period presented herein.

The Company enters into short-term foreign currency forward contracts to hedge currency exposures associated with certain monetary assets and liabilities denominated in non-functional currencies. These contracts have maturities of up to two months and are not designated as accounting hedges. Accordingly, these contracts are marked-to-market at the end of each period with unrealized gains and losses recorded in other income (expense), net, in the unaudited condensed consolidated statements of income. The amount of gains or losses associated with these forward contracts was not material for any period presented herein. From an economic perspective, the objective of the Company’s hedging program is for gains and losses on forward contracts to substantially offset gains and losses on the underlying hedged items. In addition to the contracts disclosed in the table above, the Company has numerous contracts that have been closed from an economic and financial accounting perspective and will settle early in the first month of the following quarter. Since these offsetting contracts do not expose the Company to risk of fluctuations in exchange rates, these contracts have been excluded from the above table.

Interest Rate Risk

The Company enters into forward interest rate swap agreements with independent counterparties to partially hedge the variability in cash flows due to changes in the Secured Overnight Financing Rate (“SOFR”), which is the benchmark interest rate associated with anticipated variable rate borrowings. These interest rate swaps have maturity dates of December 1, 2023 and September 27, 2027 and effectively convert a portion of the Company’s variable interest rate obligations to fixed interest rate obligations. These swaps are accounted for as cash flow hedges under ASC Topic 815, Derivatives and Hedging. Interest rate swaps with an aggregate notional amount of $600 million and $350 million were outstanding as of April 1, 2023 and October 1, 2022, respectively. The aggregate effective interest rate of these swaps as of April 1, 2023 was approximately 4.4%. The interest rate swaps portfolio had a value of $3 million and $6 million as of April 1, 2023 and October 1, 2022, respectively, of which the majority is included in prepaid expenses and other current assets and the remaining amount is included in other long-term liabilities on the unaudited condensed consolidated balance sheets.

XML

Debt

6 Months Ended

Apr. 01, 2023

Debt

Debt

Note 5. Debt

Long-term debt consisted of the following:

	As of
	April 1,		October 1,
	2023		2022
	(In thousands)
Term loan due 2027, net of issuance costs	$	338,279	$	346,737
Less: Current portion of Term Loan due 2027		17,500		17,500
Long-term debt	$	320,779	$	329,237

Term Loan maturities as of April 1, 2023 by fiscal year are as follows:

	(In Thousands)
Remainder of 2023	$	8,750
2024		13,125
2025		17,500
2026		21,875
2027		280,000
	$	341,250

Revolving Credit Facility

During the fourth quarter of 2022, the Company entered into a Fifth Amended and Restated Credit Agreement (the “Credit Agreement”), that provides for an $800 million revolving credit facility and a $350 million secured term loan (“Term Loan Due 2027”). Subject to the satisfaction of certain conditions, including obtaining additional commitments from existing and/or new lenders, the Company may increase the revolving commitment up to an additional $200 million. The Term Loan Due 2027 was fully drawn upon on the closing date.

Loans under the Credit Agreement bear interest, at the Company’s option, at either the SOFR or a base rate, in each case plus a spread determined based on the Company’s credit rating. Interest on the loans is payable quarterly in arrears with respect to base rate loans and at the end of an interest period (or at three-month intervals if the interest period exceeds three months) in the case of SOFR loans. The outstanding principal amount of all loans under the Credit Agreement, including, the Term Loan Due 2027, together with accrued and unpaid interest, is due on September 27, 2027. The Company is required to repay a portion of the principal amount of the Term Loan Due 2027 equal to 1.25% of the principal in quarterly installments.

On May 17, 2023, as a result of the Company’s failure to timely file its Form 10-Q for the quarter ended April 1, 2023, the Company was in technical default with respect to certain covenants within its Credit Agreement. Because the Company is filing this Form 10-Q on May 19, 2023, which is within the stated cure period of 15 calendar days, the Company is no longer in default.

Certain of the Company’s domestic subsidiaries are guarantors under the Credit Agreement. The Company and the subsidiary guarantors’ obligations under the Credit Agreement are secured by a lien on substantially all of their respective assets (excluding real property), including cash, accounts receivable and the shares of certain Company subsidiaries, subject to certain exceptions.

As of April 1, 2023, there were no borrowings and $13 million of letters of credit outstanding under the Credit Agreement.

Foreign Short-term Borrowing Facilities

As of April 1, 2023, certain foreign subsidiaries of the Company had a total of $74 million of uncommitted short-term borrowing facilities available, under which no borrowings were outstanding.

Debt Covenants

The Credit Agreement requires the Company to comply with certain financial covenants, namely a maximum consolidated leverage ratio and a minimum interest coverage ratio, in both cases measured on the basis of a trailing 12-month look-back period. In addition, the Company’s debt agreements contain a number of restrictive covenants, including restrictions on incurring additional debt, making investments and other restricted payments, selling assets and paying dividends, subject to certain exceptions. The Company was in compliance with these covenants as of April 1, 2023.

XML

Leases

6 Months Ended

Apr. 01, 2023

Leases

Leases

Note 6. Leases

The Company’s leases consist primarily of operating leases for buildings and land and have initial lease terms of up to 44 years. Certain of these leases contain an option to extend the lease term for additional periods or to terminate the lease after an initial non-cancelable term. Renewal options are considered in the measurement of the Company’s initial lease liability and corresponding right-of-use (“ROU”) assets only if it is reasonably certain that the Company will exercise such options. Leases with lease terms of twelve months or less are not recorded on the Company’s balance sheet.

ROU assets and lease liabilities recorded in the unaudited condensed consolidated balance sheet are as follows:

	As of
	April 1,			October 1,
	2023			2022
	(In thousands)
Other assets	$	98,541		$	79,495
Accrued liabilities	$	20,960		$	16,695
Other long-term liabilities		65,602			48,566
Total lease liabilities	$	86,562		$	65,261
Weighted average remaining lease term (in years)		11.02			15.74
Weighted average discount rate		3.68	%		2.40	%

Lease expense and supplemental cash flow information related to operating leases are as follows:

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
	(In thousands)
Operating lease expense (1)	$	8,198	$	5,860	$	17,565	$	11,770

	Six Months Ended
	April 1,		April 2,
	2023		2022
	(In thousands)
Cash paid for operating lease liabilities	$	11,629	$	9,752

(1) Includes immaterial amounts of short term leases, variable lease costs and sublease income.

Future lease payments under non-cancelable operating leases as of April 1, 2023, by fiscal year, are as follows:

	Operating
	Leases
	(In thousands)
Remainder of 2023	$	12,268
2024		22,789
2025		19,976
2026		15,759
2027		12,502
2028		3,498
Thereafter		9,030
Total lease payments		95,822
Less: imputed interest		9,260
Total	$	86,562

XML

Accounts Receivable Sale Program

6 Months Ended

Apr. 01, 2023

Accounts Receivable Sale Program

Accounts Receivable Sale Program

Note 7. Accounts Receivable Sale Program

The Company is a party to a Receivable Purchase Agreement (the “RPA”) with certain third-party banking institutions for the sale of trade receivables generated from sales to certain customers, subject to acceptance by, and a funding commitment from, the banks that are party to the RPA. Trade receivables sold pursuant to the RPA are serviced by the Company.

In addition to the RPA, the Company has the option to participate in trade receivables sales programs that have been implemented by certain of the Company’s customers, as in effect from time to time. The Company does not service trade receivables sold under these other programs.

Under each of the programs noted above, the Company sells its entire interest in a trade receivable for 100% of face value, less a discount. During the six months ended April 1, 2023 and April 2, 2022, the Company sold approximately $1.7 billion and $371 million, respectively, of accounts receivable under these programs. Upon sale, these receivables are removed from the unaudited condensed consolidated balance sheets and cash received is presented as cash provided by operating activities in the unaudited condensed consolidated statements of cash flows. Discounts on sold receivables were $12 million and $0.4 million for the six months ended April 1, 2023 and April 2, 2022, respectively. As of April 1, 2023 and October 1, 2022, $238 million and $194 million, respectively, of accounts receivable sold under the RPA and subject to servicing by the Company remained outstanding and had not yet been collected. The Company’s sole risk with respect to receivables it services is with respect to commercial disputes regarding such receivables. Commercial disputes include billing errors, returns and similar matters. To date, the Company has not been required to repurchase any receivable it has sold due to a commercial dispute. Additionally, the Company is required to remit amounts collected as servicer under the RPA on a weekly basis to the financial institutions that purchased the receivables. As of April 1, 2023 and October 1, 2022, $75 million and $49 million, respectively, had been collected but not yet remitted. This amount is classified in accrued liabilities on the unaudited condensed consolidated balance sheets.

XML

Contingencies

6 Months Ended

Apr. 01, 2023

Contingencies

Contingencies

Note 8. Contingencies

From time to time, the Company is a party to litigation, claims and other contingencies, including environmental, regulatory and employee matters and examinations and investigations by governmental agencies, which arise in the ordinary course of business. The Company records a contingent liability when it is probable that a loss has been incurred and the amount of loss is reasonably estimable in accordance with ASC Topic 450, Contingencies, or other applicable accounting standards. As of April 1, 2023 and October 1, 2022, the Company had estimated liabilities of $36 million and $38 million, respectively, for environmental matters, warranty, litigation and other contingencies (excluding reserves for uncertain tax positions), which the Company believes are adequate. However, there can be no assurance that the Company’s reserves will be sufficient to settle these contingencies. Such reserves are included in accrued liabilities and other long-term liabilities on the unaudited condensed consolidated balance sheets.

Legal Proceedings

Environmental Matters

The Company is subject to various federal, state, local and foreign laws and regulations and administrative orders concerning environmental protection, including those addressing the discharge of pollutants into the environment, the management and disposal of hazardous substances, the cleanup of contaminated sites, the materials used in products, and the recycling, treatment and disposal of hazardous waste. As of April 1, 2023, the Company had been named in a lawsuit and several administrative orders alleging certain of its current and former sites contributed to groundwater contamination. One such order demands that the Company and other alleged defendants remediate groundwater contamination at four landfills located in Northern California to which the Company may have sent wastewater in the past. The Company is participating in a working group of other alleged defendants to better understand its potential exposure in this action and has reserved its estimated exposure for this matter as of April 1, 2023. However, there can be no assurance that the Company’s reserve will ultimately be sufficient.

In June 2008, the Company was named by the Orange County Water District in a suit alleging that a predecessor company’s actions at a plant the Company sold in 1998 contributed to polluted groundwater managed by the plaintiff. The complaint seeks recovery of compensatory and other damages, as well as declaratory relief, for the payment of costs necessary to investigate, monitor, remediate, abate and contain contamination of groundwater. In April 2013, all claims against the Company were dismissed. The plaintiff appealed this dismissal and the Court of Appeal reversed the judgment in August 2017, remanding the case back to the Superior Court of California for trial. The trial against the Company and several other defendants commenced in April 2021 and the submission of evidence concluded in May 2022. On April 3, 2023, the Court published a statement of decision finding the Company and other remaining defendants liable for certain past investigation costs incurred by the plaintiff. The Company believes a loss in this matter is probable and has recorded an estimated loss. There will be subsequent proceedings to assess the Company’s and other defendants’ liability for the plaintiff’s future remediation and other costs. It is probable that the Company will record additional losses in connection with this matter, and it is reasonably possible that the amount of such additional losses will be material. However, at the current time, the Company is unable to estimate the amount of such additional losses or a range of losses. The Company intends to continue defending the case vigorously and to seek appellate review at the appropriate time.

Other Matters

In October 2018, a contractor who had been retained by the Company through a third party temporary staffing agency filed a lawsuit against the Company in the Santa Clara County Superior Court on behalf of himself and all other similarly situated Company contractors and employees in California, alleging violations of California Labor Code provisions governing overtime, meal and rest periods, wages, wage statements and reimbursement of business expenses. The complaint sought certification of a class of all non-exempt employees. Although the Company continued to deny any wrongdoing, on November 19, 2020, the Company reached an agreement to resolve all claims, including claims under California’s Private Attorneys General Act of 2004 (the “Settlement”), which also resulted in the dismissal of a suit alleging substantially similar claims filed in the Santa Clara County Superior Court in June 2021. The final amount of the judicially approved Settlement was approximately $4 million and was paid during the first quarter of fiscal 2022.

In December 2019, the Company sued a former customer, Dialight plc (“Dialight”), in the United States District Court for the Southern District of New York to collect approximately $10 million in unpaid accounts receivable and net obsolete inventory obligations. Later the same day, Dialight commenced its own action in the same court. Dialight’s complaint, which asserts claims for fraudulent inducement, breach of contract and willful misconduct, alleges that the Company fraudulently misrepresented its capabilities to induce Dialight to enter into a Manufacturing Services Agreement (the “Dialight MSA”), and then breached its obligations contained in the Dialight MSA relating to quality, on-time delivery and supply chain management. Dialight seeks compensatory and punitive damages that it contends exceed $200 million, but which the Company believes are vastly overstated and subject to a contractual limitation of liability that limits any Dialight recovery to less than $2 million. In an Opinion and Order dated March 14, 2023, the Court granted in part the Company's motion for partial summary judgment and dismissed Dialight's willful misconduct claim. The Company continues to vigorously prosecute its claims against Dialight. Further, the Company strongly disagrees with Dialight’s allegations and is defending against them vigorously. No trial date has been set in this matter.

In May 2023, the Company and its SCI Technology, Inc. subsidiary (“SCI”) received Civil Investigative Demands (“CIDs”) from the United States Department of Justice (“DOJ") pursuant to the civil False Claims Act (“FCA”). The stated purpose of the CIDs—a form of subpoena requiring responses to written interrogatories and the production of documents relating to certain contracts, projects, proposals and business activities of SCI going back to 2010—is to determine whether there is or has been a violation of the

FCA with respect to the provision of products and services to the government. These CIDs supplement several CIDs relating to the same subject matter served upon SCI and certain current and former SCI and Sanmina employees beginning in August 2020 pursuant to which SCI has been producing documents and information and the current and former employees have provided or will provide oral testimony. To date, neither the Company nor SCI has been served with a complaint in this matter. The Company has been, and is, cooperating with the DOJ and continues to produce documents and other information responsive to the CIDs. The Company is unable to predict the ultimate outcome in this matter, although a loss currently is not considered to be probable or estimable.

For each of the pending matters noted above, the Company is unable to reasonably estimate a range of possible loss at this time.

XML

Income Tax

6 Months Ended

Apr. 01, 2023

Income Tax

Income Tax

Note 9. Income Tax

The Company estimates its annual effective income tax rate at the end of each quarterly period. The estimate takes into account the geographic mix of expected pre-tax income (loss), expected total annual pre-tax income (loss), enacted changes in tax laws, implementation of tax planning strategies and possible outcomes of audits and other uncertain tax positions. To the extent there are fluctuations in any of these variables during a period, the provision for income taxes may vary.

The Company’s provision for income taxes for the three months ended April 1, 2023 and April 2, 2022 was $26 million (23% of income before taxes) and $22 million (31% of income before taxes), respectively. The tax rate was lower for the three months ended April 1, 2023 due to $5 million of favorable discrete items related to excess tax benefit from stock compensation and adjustments to tax reserves.

The provision for income taxes for the six months ended April 1, 2023 and April 2, 2022 was $47 million (21% of income before taxes) and $41 million (28% of income before taxes), respectively. The tax rate was lower for the six months ended April 1, 2023 due to various discrete items, including the recognition of an $8 million tax benefit that resulted from the release of certain foreign tax reserves due to lapse of time and expiration of statutes of limitations.

XML

Stockholders' Equity

6 Months Ended

Apr. 01, 2023

Stockholders' Equity

Stockholders' Equity

Note 10. Stockholders’ Equity

Accumulated Other Comprehensive Income

Accumulated other comprehensive income, net of tax as applicable, consisted of the following:

	As of
	April 1,		October 1,
	2023		2022
	(In thousands)
Foreign currency translation adjustments	$	71,172	$	63,929
Unrealized holding gains on derivative financial instruments		2,020		4,112
Unrecognized net actuarial losses and transition costs for benefit plans		(12,062)		(11,716)
Total	$	61,130	$	56,325

Stock Repurchase Program

During the six months ended April 1, 2023 and April 2, 2022, the Company repurchased 3,800 and 4.4 million shares of its common stock for $0.2 million and $169 million, respectively, under stock repurchase programs authorized by the Board of Directors. There were no repurchases during the three months ended April 1, 2023. These programs have no expiration dates and the timing of repurchases will depend upon capital needs to support the growth of the Company’s business, market conditions and other factors. Although stock repurchases are intended to increase stockholder value, they also reduce the Company’s liquidity. As of April 1, 2023, an aggregate of $164 million remained available under these programs.

In addition to the repurchases discussed above, the Company withheld 0.4 million and 0.3 million shares of its common stock during the six months ended April 1, 2023 and April 2, 2022, respectively, in settlement of employee tax withholding obligations due upon the vesting of restricted stock units. The Company paid $21 million and $13 million for the six months ended April 1, 2023 and April 2, 2022, respectively, to applicable tax authorities in connection with these repurchases.

XML

Business Segment, Geographic and Customer Information

6 Months Ended

Apr. 01, 2023

Business Segment, Geographic and Customer Information

Business Segment, Geographic and Customer Information

Note 11. Business Segment, Geographic and Customer Information

ASC Topic 280, Segment Reporting, establishes standards for reporting information about operating segments, products and services, geographic areas of operations and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker or decision making group in deciding how to allocate resources and in assessing performance.

The Company’s operations are managed as two businesses: Integrated Manufacturing Solutions (“IMS”) and CPS. The Company’s CPS business consists of multiple operating segments which do not meet the quantitative threshold for being presented individually as reportable segments. Therefore, financial information for these operating segments is presented in a single category entitled “CPS” and the Company has only one reportable segment - IMS.

The following table presents revenue and a measure of segment gross profit used by management to allocate resources and assess performance of operating segments:

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(In thousands)
Gross sales:
IMS	$	1,929,945	$	1,558,125	$	3,867,613	$	2,983,135
CPS		431,077		393,407		889,170		759,685
Intersegment revenue		(40,919)		(36,462)		(80,872)		(71,424)
Net sales	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396
Gross profit:
IMS	$	144,459	$	108,660	$	277,796	$	215,289
CPS		51,004		41,046		117,528		80,592
Total		195,463		149,706		395,324		295,881
Unallocated items (1)		(4,274)		(3,211)		(8,749)		(8,089)
Total	$	191,189	$	146,495	$	386,575	$	287,792

(1) For purposes of evaluating segment performance, management excludes certain items from its measure of gross profit. These items consist of stock-based compensation expense, amortization of intangible assets and litigation settlements

Net sales by geographic segment, determined based on the country in which a product is manufactured, were as follows:

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(In thousands)
Net sales:
Americas (1)	$	1,112,778	$	902,111	$	2,248,529	$	1,698,132
APAC		853,492		714,379		1,767,833		1,405,450
EMEA		353,833		298,580		659,549		567,814
Total	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396

(1) Mexico represents approximately 70% and 60% of the Americas revenue and the U.S. represents approximately 30% and 40% of the Americas revenue for the six months ended April 1, 2023 and April 2, 2022, respectively.

Percentage of net sales represented by ten largest customers	49	%	50	%	50	%	49	%
Number of customers representing 10% or more of net sales	1		2		1		2

XML

Earnings Per Share

6 Months Ended

Apr. 01, 2023

Earnings Per Share

Earnings Per Share

Note 12. Earnings Per Share

Basic and diluted per share amounts are calculated by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during the period, as follows:

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(In thousands, except per share data)
Numerator:
Net income attributable to common shareholders	$	79,621	$	48,621	$	171,635	$	104,798
Denominator:
Weighted average common shares outstanding		58,269		62,845		57,999		63,622
Effect of dilutive stock options and restricted stock units		1,550		1,426		1,864		1,743
Denominator for diluted earnings per share		59,819		64,271		59,863		65,365
Net income attributable to common shareholders per share:
Basic	$	1.37	$	0.77	$	2.96	$	1.65
Diluted	$	1.33	$	0.76	$	2.87	$	1.60

Weighted-average dilutive securities that were excluded from the above calculation because their inclusion would have had an anti-dilutive effect under ASC Topic 260, Earnings per Share, due to application of the treasury stock method were not material for any period presented.

XML

Stock-Based Compensation

6 Months Ended

Apr. 01, 2023

Stock-Based Compensation

Stock-Based Compensation

Note 13. Stock-Based Compensation

Stock-based compensation expense was recognized as follows:

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
	(In thousands)
Cost of sales	$	4,025	$	2,948	$	8,267	$	6,731
Selling, general and administrative		8,304		6,276		15,446		11,411
Research and development		205		106		430		220
Total	$	12,534	$	9,330	$	24,143	$	18,362

During the second quarter of 2023, the Company's stockholders approved the reservation of an additional 1.2 million shares of common stock for future issuance under the Company's 2019 Equity Incentive Plan. As of April 1, 2023, an aggregate of 6 million shares of common stock were authorized for future issuance under the Company’s stock plans, of which 3 million of such shares were issuable upon exercise of outstanding options and delivery of shares upon vesting of restricted stock units and 3 million shares of common stock were available for future grant.

Restricted and Performance Stock Units

The Company grants restricted stock units (“RSUs”) and restricted stock units with performance conditions (“PSUs”) to executive officers, directors and certain other employees. These units vest over periods ranging from one year to four years and/or upon achievement of specified performance criteria, with associated compensation expense recognized ratably over the vesting period.

The Company’s PSUs vest contingent on achievement of cumulative non-GAAP earnings per share measured over three fiscal years. If a minimum threshold is not achieved during the measurement period, the PSUs will be cancelled. If the minimum threshold is achieved or exceeded, the number of shares of common stock that will be issued will range from 70% to 130% of the number of PSUs granted, depending on the extent of performance. Additionally, the number of shares that vest may be adjusted up or down by up to 15% based on the Company’s total shareholder return relative to that of its peer group over this same period.

Activity with respect to the Company’s RSUs and PSUs was as follows:

			Weighted-
		Weighted-	Average
		Average Grant	Remaining	Aggregate
		Date	Contractual	Intrinsic
	Number of	Fair Value	Term	Value
	Shares	($)	(Years)	($)
	(In thousands)			(In thousands)
Outstanding as of October 1, 2022	3,280	37.11	1.35	155,049
Granted	922	60.07
Vested/Forfeited/Cancelled	(1,199)	35.25
Outstanding as of April 1, 2023	3,003	44.90	1.60	174,278
Expected to vest as of April 1, 2023	2,581	44.33	1.55	149,815

As of April 1, 2023, unrecognized compensation expense of $95 million is expected to be recognized over a weighted average period of 1.6 years.

XML

Strategic Transaction

6 Months Ended

Apr. 01, 2023

Strategic Transaction

Strategic Transaction

Note 14. Strategic Transaction

India Joint Venture

On October 3, 2022, the Company completed a joint venture transaction pursuant to a Share Subscription and Purchase Agreement (the “SSPA”) and a Joint Venture and Shareholders’ Agreement (the “Shareholders’ Agreement”) previously entered into with Reliance Strategic Business Ventures Limited (“RSBVL”), a wholly owned subsidiary of Reliance Industries Limited. Pursuant to the SSPA and the Shareholders’ Agreement, the parties established Sanmina SCI India Private Limited (“SIPL”), the Company’s existing Indian manufacturing entity, as a joint venture to engage in manufacturing in India of telecommunications equipment, data center and internet equipment, medical equipment, clean technology equipment and other high-tech equipment. This partnership leverages the Company’s advanced manufacturing experience and RSBVL’s expertise and leadership in the Indian business ecosystem. In addition to supporting the Company’s current customer base, the joint venture will create a state-of-the-art ‘Manufacturing Technology Center of Excellence’ that will serve as an incubation center to support the product development and hardware start-up ecosystem in India, as well as promote research and innovation of leading-edge technologies.

As a result of the transaction, RSBVL acquired shares of SIPL for approximately $216 million of cash such that RSBVL holds 50.1% of the outstanding shares of SIPL and the Company holds the remaining 49.9% of the outstanding shares of SIPL. In connection with RSBVL’s investment, Sanmina and RSBVL entered into a management services contract pursuant to which Sanmina has the unilateral ability to make the significant financial and operating decisions made in the ordinary course of SIPL’s business.

In accordance with ASC 810, Consolidation, the Company is required to consolidate entities in which it has a controlling financial interest. The Company determined the voting interest model was applicable under ASC 810 and concluded that, despite not having a majority ownership interest, the Company has a controlling financial interest in SIPL through the management services contract. Therefore, the Company has, by contract, the unilateral ability to control the significant decisions made in the ordinary course of SIPL’s business. Because the Company has a controlling financial interest in SIPL, the Company continues to consolidate SIPL. However, the Company periodically assesses whether any changes in facts and circumstances have occurred that could require the Company to deconsolidate SIPL.

The Company recognized a noncontrolling interest of $132 million and an increase in additional paid-in-capital of $84 million in the unaudited condensed consolidated financial statements in connection with the sale of shares of SIPL to RSBVL. SIPL’s cash and cash equivalents balance of $171 million as of April 1, 2023, is not available for general corporate purposes and must be retained in SIPL to fund SIPL’s operations.

XML

Subsequent Event

6 Months Ended

Apr. 01, 2023

Subsequent Event

Subsequent Event

Note 15. Subsequent Event

On May 18, 2023, the Company received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) as a result of its failure to file this Quarterly Report on Form 10-Q for the fiscal quarter ended April 1, 2023 (the “Form 10-Q”) with the SEC by the required due date of May 16, 2023. The Notice stated that, under the Nasdaq Listing Rules, the Company has 60 calendar days, or until July 17, 2023, to submit a plan to regain compliance with Nasdaq’s continued listing requirements.

On May 19, 2023 the Company filed Amendment No. 1 to the Company’s Annual Report on Form 10-K for the fiscal year ended October 1, 2022, Amendment No. 1 to the Company’s Form 10-Q for the quarter ended December 31, 2022 and this Form 10-Q with the SEC. As a result of these filings, the Company believes it has regained compliance with Nasdaq Listing Rule 5250(c)(1) and that no further action will be taken with respect to the Notice.

XML

Accounting Policies (Policies)

6 Months Ended

Apr. 01, 2023

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been omitted pursuant to those rules or regulations. The interim condensed consolidated financial statements are unaudited, but reflect all adjustments, consisting primarily of normal recurring adjustments, that are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended October 1, 2022, included in Amendment No. 1 on Form 10-K/A to the Company’s Annual Report on Form 10-K for such fiscal year filed with the SEC on May 19, 2023.

The unaudited condensed consolidated financial statements include all accounts of the Company, its wholly-owned subsidiaries and subsidiaries in which it has control. All intra-company accounts and transactions have been eliminated. Noncontrolling interest represents a noncontrolling investor’s interest in the results of operations of subsidiaries that the Company controls and consolidates.

Use of Estimates

The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates.

Results of operations for the second quarter of 2023 are not necessarily indicative of the results that may be expected for other interim periods or for the full fiscal year.

Fiscal Period

The Company operates on a 52 or 53 week year ending on the Saturday nearest September 30. Fiscal 2023 and 2022 are each 52-week years. All references to years relate to fiscal years unless otherwise noted.

XML

Restatement of Condensed Consolidated Financial Statements (Tables)

6 Months Ended

Apr. 01, 2023

Restatement of Condensed Consolidated Financial Statements

Schedule of impact of the financial statement adjustments on the Company's previously reported Condensed Consolidated Financial Statements

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Statements of Income for the three and six months ended April 2, 2022.

	Three Months Ended								Six Months Ended
	April 2, 2022								April 2, 2022
	(Unaudited)								(Unaudited)
	Previously		Investigation		Other				Previously		Investigation		Other
	Reported		Adjustments		Adjustments		As Restated		Reported		Adjustments		Adjustments			As Restated
	(In thousands, except per share data)
Net sales	$	1,911,530	$	3,540	$	—	$	1,915,070	$	3,668,855	$	2,541	$	—	$	3,671,396
Cost of sales		1,759,083		9,492		—		1,768,575		3,371,919		11,685		—		3,383,604
Gross profit		152,447		(5,952)		—		146,495		296,936		(9,144)		—		287,792
Operating expenses:
Selling, general and administrative		61,817		—		—		61,817		123,292		—		—		123,292
Research and development		5,472		—		—		5,472		10,249		—		—		10,249
Restructuring and other		2,932		—		—		2,932		4,346		—		—		4,346
Gain on sale of long-lived assets		—		—		—		—		(4,610)		—		—		(4,610)
Total operating expenses		70,221		—		—		70,221		133,277		—		—		133,277
Operating income		82,226		(5,952)		—		76,274		163,659		(9,144)		—		154,515
Interest income		349		—		—		349		658		—		—		658
Interest expense		(4,870)		—		—		(4,870)		(9,747)		—		—		(9,747)
Other income (expense), net		(1,408)		—		—		(1,408)		664		—		—		664
Interest and other, net		(5,929)		—		—		(5,929)		(8,425)		—		—		(8,425)
Income before income taxes		76,297		(5,952)		—		70,345		155,234		(9,144)		—		146,090
Provision for income taxes		23,077		(1,353)		—		21,724		43,380		(2,088)		—		41,292
Net Income	$	53,220	$	(4,599)		—	$	48,621	$	111,854	$	(7,056)	$	—	$	104,798
Net income per share:
Basic	$	0.85	$	(0.08)	$	—	$	0.77	$	1.76	$	(0.11)	$	—	$	1.65
Diluted	$	0.83	$	(0.07)	$	—	$	0.76	$	1.71	$	(0.11)	$	—	$	1.60
Weighted average shares used in computing per share amounts:
Basic		62,845		—		—		62,845		63,622		—		—		63,622
Diluted		64,271		—		—		64,271		65,365		—		—		65,365

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Balance Sheet as of October 1, 2022.

	As of
	October 1, 2022
	(Unaudited)
	Previously		Investigation		Other
	Reported		Adjustments		Adjustments		As Restated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	529,857	$	—	$	—	$	529,857
Accounts receivable, net of allowances		1,138,894		—		—		1,138,894
Contract assets		503,674		(27,953)		—		475,721
Inventories		1,691,081		(21,705)		14,723		1,684,099
Prepaid expenses and other current assets		62,044		—		—		62,044
Total current assets		3,925,550		(49,658)		14,723		3,890,615
Property, plant and equipment, net		575,170		—		—		575,170
Deferred tax assets		198,588		10,966		—		209,554
Other		160,192		—		—		160,192
Total assets	$	4,859,500	$	(38,692)	$	14,723	$	4,835,531
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	2,029,534	$	—	$	11,900	$	2,041,434
Accrued liabilities		275,735		1,441		4,423		281,599
Accrued payroll and related benefits		130,892		—		—		130,892
Short-term debt, including current portion of long-term debt		17,500		—		—		17,500
Total current liabilities		2,453,661		1,441		16,323		2,471,425
Long-term liabilities:
Long-term debt		329,237		—		—		329,237
Other		215,333		—		—		215,333
Total long-term liabilities		544,570		—		—		544,570
Contingencies (Note 8)
Stockholders’ equity		1,861,269		(40,133)		(1,600)		1,819,536
Total liabilities and stockholders’ equity	$	4,859,500	$	(38,692)	$	14,723	$	4,835,531

The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Statements of Cash Flows for the six month period ended April 2, 2022. There were no adjustments to cash flows provided by (used in) investing or financing activities for the six month period ended April 2, 2022.

	Six Months Ended
	April 2, 2022
	(Unaudited)
	Previously		Investigation		Other
	Reported		Adjustments		Adjustments		As Restated
	(In thousands)
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income before noncontrolling interest	$	111,854	$	(7,056)	$	—	$	104,798
Adjustments to reconcile net income before noncontrolling interest to cash provided by (used in) operating activities:
Depreciation and amortization		55,032		—		—		55,032
Stock-based compensation expense		18,362		—		—		18,362
Deferred income taxes		11,071		(1,898)		—		9,173
Other, net		(1,903)		—		—		(1,903)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable		(79,705)		—		397		(79,308)
Contract assets		(68,545)		4,804		(3,351)		(67,092)
Inventories		(403,396)		4,628		(5,015)		(403,783)
Prepaid expenses and other assets		(11,334)		—		—		(11,334)
Accounts payable		357,176		—		5,015		362,191
Accrued liabilities		158,661		(478)		2,954		161,137
Cash provided by operating activities	$	147,273	$	—	$	—	$	147,273

XML

Revenue Recognition (Tables)

6 Months Ended

Apr. 01, 2023

Revenue Recognition

Schedule of revenue disaggregation

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(In thousands)
Segments:
IMS	$	1,919,158	$	1,549,416	$	3,846,270	$	2,966,327
CPS		400,945		365,654		829,641		705,069
Total	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396
End Markets:
Industrial, Defense, Medical and Automotive	$	1,361,843	$	1,158,260	$	2,701,871	$	2,212,232
Communications Networks and Cloud Infrastructure		958,260		756,810		1,974,040		1,459,164
Total	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396
Geography:
Americas (1)	$	1,112,778	$	902,111	$	2,248,529	$	1,698,132
APAC		853,492		714,379		1,767,833		1,405,450
EMEA		353,833		298,580		659,549		567,814
Total	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396

XML

Financial Instruments (Tables)

6 Months Ended

Apr. 01, 2023

Financial Instruments

Schedule of outstanding foreign currency forward contracts

	As of
	April 1,		October 1,
	2023		2022
Derivatives Designated as Accounting Hedges:
Notional amount (in thousands)	$	126,383	$	123,172
Number of contracts		50		50
Derivatives Not Designated as Accounting Hedges:
Notional amount (in thousands)	$	434,005	$	531,558
Number of contracts		42		43

XML

Debt (Tables)

6 Months Ended

Apr. 01, 2023

Debt

Schedule of Long-term debt

	As of
	April 1,		October 1,
	2023		2022
	(In thousands)
Term loan due 2027, net of issuance costs	$	338,279	$	346,737
Less: Current portion of Term Loan due 2027		17,500		17,500
Long-term debt	$	320,779	$	329,237

Schedule of Term Loan maturities

	(In Thousands)
Remainder of 2023	$	8,750
2024		13,125
2025		17,500
2026		21,875
2027		280,000
	$	341,250

XML

Leases (Tables)

6 Months Ended

Apr. 01, 2023

Leases

Schedule of ROU assets and lease liabilities

	As of
	April 1,			October 1,
	2023			2022
	(In thousands)
Other assets	$	98,541		$	79,495
Accrued liabilities	$	20,960		$	16,695
Other long-term liabilities		65,602			48,566
Total lease liabilities	$	86,562		$	65,261
Weighted average remaining lease term (in years)		11.02			15.74
Weighted average discount rate		3.68	%		2.40	%

Schedule of Lease expense and supplemental cash flow

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
	(In thousands)
Operating lease expense (1)	$	8,198	$	5,860	$	17,565	$	11,770

	Six Months Ended
	April 1,		April 2,
	2023		2022
	(In thousands)
Cash paid for operating lease liabilities	$	11,629	$	9,752

(1) Includes immaterial amounts of short term leases, variable lease costs and sublease income.

Schedule of Lease payments under non-cancelable operating leases

	Operating
	Leases
	(In thousands)
Remainder of 2023	$	12,268
2024		22,789
2025		19,976
2026		15,759
2027		12,502
2028		3,498
Thereafter		9,030
Total lease payments		95,822
Less: imputed interest		9,260
Total	$	86,562

XML

Stockholders' Equity (Tables)

6 Months Ended

Apr. 01, 2023

Stockholders' Equity

Schedule of accumulated other comprehensive income (loss)

	As of
	April 1,		October 1,
	2023		2022
	(In thousands)
Foreign currency translation adjustments	$	71,172	$	63,929
Unrealized holding gains on derivative financial instruments		2,020		4,112
Unrecognized net actuarial losses and transition costs for benefit plans		(12,062)		(11,716)
Total	$	61,130	$	56,325

XML

Business Segment, Geographic and Customer Information (Tables)

6 Months Ended

Apr. 01, 2023

Business Segment, Geographic and Customer Information

Schedule of segment gross profit used by management

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(In thousands)
Gross sales:
IMS	$	1,929,945	$	1,558,125	$	3,867,613	$	2,983,135
CPS		431,077		393,407		889,170		759,685
Intersegment revenue		(40,919)		(36,462)		(80,872)		(71,424)
Net sales	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396
Gross profit:
IMS	$	144,459	$	108,660	$	277,796	$	215,289
CPS		51,004		41,046		117,528		80,592
Total		195,463		149,706		395,324		295,881
Unallocated items (1)		(4,274)		(3,211)		(8,749)		(8,089)
Total	$	191,189	$	146,495	$	386,575	$	287,792

(1) For purposes of evaluating segment performance, management excludes certain items from its measure of gross profit. These items consist of stock-based compensation expense, amortization of intangible assets and litigation settlements

Schedule of net sales by geographic segment, determined based on the country

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(In thousands)
Net sales:
Americas (1)	$	1,112,778	$	902,111	$	2,248,529	$	1,698,132
APAC		853,492		714,379		1,767,833		1,405,450
EMEA		353,833		298,580		659,549		567,814
Total	$	2,320,103	$	1,915,070	$	4,675,911	$	3,671,396

(1) Mexico represents approximately 70% and 60% of the Americas revenue and the U.S. represents approximately 30% and 40% of the Americas revenue for the six months ended April 1, 2023 and April 2, 2022, respectively.

Percentage of net sales represented by ten largest customers	49	%	50	%	50	%	49	%
Number of customers representing 10% or more of net sales	1		2		1		2

XML

Earnings Per Share (Tables)

6 Months Ended

Apr. 01, 2023

Earnings Per Share

Schedule of basic and diluted per share

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
			(Restated)				(Restated)
	(In thousands, except per share data)
Numerator:
Net income attributable to common shareholders	$	79,621	$	48,621	$	171,635	$	104,798
Denominator:
Weighted average common shares outstanding		58,269		62,845		57,999		63,622
Effect of dilutive stock options and restricted stock units		1,550		1,426		1,864		1,743
Denominator for diluted earnings per share		59,819		64,271		59,863		65,365
Net income attributable to common shareholders per share:
Basic	$	1.37	$	0.77	$	2.96	$	1.65
Diluted	$	1.33	$	0.76	$	2.87	$	1.60

XML

Stock-Based Compensation (Tables)

6 Months Ended

Apr. 01, 2023

Stock-Based Compensation

Schedule of stock-based compensation expense recognized

	Three Months Ended				Six Months Ended
	April 1,		April 2,		April 1,		April 2,
	2023		2022		2023		2022
	(In thousands)
Cost of sales	$	4,025	$	2,948	$	8,267	$	6,731
Selling, general and administrative		8,304		6,276		15,446		11,411
Research and development		205		106		430		220
Total	$	12,534	$	9,330	$	24,143	$	18,362

Schedule of activity with respect to the Company's restricted stock units and PSU

			Weighted-
		Weighted-	Average
		Average Grant	Remaining	Aggregate
		Date	Contractual	Intrinsic
	Number of	Fair Value	Term	Value
	Shares	($)	(Years)	($)
	(In thousands)			(In thousands)
Outstanding as of October 1, 2022	3,280	37.11	1.35	155,049
Granted	922	60.07
Vested/Forfeited/Cancelled	(1,199)	35.25
Outstanding as of April 1, 2023	3,003	44.90	1.60	174,278
Expected to vest as of April 1, 2023	2,581	44.33	1.55	149,815

XML

Restatement of Condensed Consolidated Financial Statements - Condensed Consolidated Statements of Income (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Restatement of Condensed Consolidated Financial Statements
Net sales	$ 2,320,103	$ 1,915,070	$ 4,675,911	$ 3,671,396
Cost of sales	2,128,914	1,768,575	4,289,336	3,383,604
Gross profit	191,189	146,495	386,575	287,792
Operating expenses:
Selling, general and administrative	63,390	61,817	124,120	123,292
Research and development	6,394	5,472	11,993	10,249
Restructuring and other	804	2,932	1,435	4,346
Gain on sale of long-lived assets	0	0	0	(4,610)
Total operating expenses	70,588	70,221	137,548	133,277
Operating income	120,601	76,274	249,027	154,515
Interest income	2,539	349	5,472	658
Interest expense	(9,286)	(4,870)	(17,967)	(9,747)
Other income (expense), net	(2,768)	(1,408)	(9,480)	664
Interest and other, net	(9,515)	(5,929)	(21,975)	(8,425)
Income before income taxes	111,086	70,345	227,052	146,090
Provision for income taxes	25,779	21,724	46,631	41,292
Net Income	85,307	48,621	180,421	104,798
Less: Net income attributable to noncontrolling interest	5,686	0	8,786	0
Net income attributable to common shareholders	$ 79,621	$ 48,621	$ 171,635	$ 104,798
Net income per share:
Basic	$ 1.37	$ 0.77	$ 2.96	$ 1.65
Diluted	$ 1.33	$ 0.76	$ 2.87	$ 1.60
Weighted average shares used in computing per share amounts:
Basic	58,269	62,845	57,999	63,622
Diluted	59,819	64,271	59,863	65,365
Previously Reported
Restatement of Condensed Consolidated Financial Statements
Net sales		$ 1,911,530		$ 3,668,855
Cost of sales		1,759,083		3,371,919
Gross profit		152,447		296,936
Operating expenses:
Selling, general and administrative		61,817		123,292
Research and development		5,472		10,249
Restructuring and other		2,932		4,346
Gain on sale of long-lived assets				(4,610)
Total operating expenses		70,221		133,277
Operating income		82,226		163,659
Interest income		349		658
Interest expense		(4,870)		(9,747)
Other income (expense), net		(1,408)		664
Interest and other, net		(5,929)		(8,425)
Income before income taxes		76,297		155,234
Provision for income taxes		23,077		43,380
Net Income		$ 53,220		$ 111,854
Net income per share:
Basic		$ 0.85		$ 1.76
Diluted		$ 0.83		$ 1.71
Weighted average shares used in computing per share amounts:
Basic		62,845		63,622
Diluted		64,271		65,365
Investigation Adjustments
Restatement of Condensed Consolidated Financial Statements
Net sales		$ 3,540		$ 2,541
Cost of sales		9,492		11,685
Gross profit		(5,952)		(9,144)
Operating expenses:
Operating income		(5,952)		(9,144)
Income before income taxes		(5,952)		(9,144)
Provision for income taxes		(1,353)		(2,088)
Net Income		$ (4,599)		$ (7,056)
Net income per share:
Basic		$ (0.08)		$ (0.11)
Diluted		$ (0.07)		$ (0.11)

XML

Restatement of Condensed Consolidated Financial Statements - Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Apr. 01, 2023	Oct. 01, 2022	Apr. 02, 2022
Current assets:
Cash and cash equivalents	$ 718,203	$ 529,857
Accounts receivable, net of allowances	1,208,808	1,138,894
Contract assets	486,290	475,721
Inventories	1,552,568	1,684,099
Prepaid expenses and other current assets	69,091	62,044
Total current assets	4,034,960	3,890,615
Property, plant and equipment, net	616,998	575,170
Deferred tax assets	196,191	209,554
Other	181,307	160,192
Total assets	5,029,456	4,835,531
Current liabilities:
Accounts payable	1,828,699	2,041,434
Accrued liabilities	282,414	281,599
Accrued payroll and related benefits	126,373	130,892
Short-term debt, including current portion of long-term debt	17,500	17,500
Total current liabilities	2,254,986	2,471,425
Long-term liabilities:
Long-term debt	320,779	329,237
Other	235,697	215,333
Total long-term liabilities	556,476	544,570
Contingencies
Stockholders' equity	2,217,994	1,819,536	$ 1,805,038
Total liabilities and stockholders' equity	$ 5,029,456	4,835,531
Previously Reported
Current assets:
Cash and cash equivalents		529,857
Accounts receivable, net of allowances		1,138,894
Contract assets		503,674
Inventories		1,691,081
Prepaid expenses and other current assets		62,044
Total current assets		3,925,550
Property, plant and equipment, net		575,170
Deferred tax assets		198,588
Other		160,192
Total assets		4,859,500
Current liabilities:
Accounts payable		2,029,534
Accrued liabilities		275,735
Accrued payroll and related benefits		130,892
Short-term debt, including current portion of long-term debt		17,500
Total current liabilities		2,453,661
Long-term liabilities:
Long-term debt		329,237
Other		215,333
Total long-term liabilities		544,570
Stockholders' equity		1,861,269
Total liabilities and stockholders' equity		4,859,500
Investigation Adjustments
Current assets:
Contract assets		(27,953)
Inventories		(21,705)
Total current assets		(49,658)
Deferred tax assets		10,966
Total assets		(38,692)
Current liabilities:
Accrued liabilities		1,441
Total current liabilities		1,441
Long-term liabilities:
Stockholders' equity		(40,133)
Total liabilities and stockholders' equity		(38,692)
Other Adjustments
Current assets:
Inventories		14,723
Total current assets		14,723
Total assets		14,723
Current liabilities:
Accounts payable		11,900
Accrued liabilities		4,423
Total current liabilities		16,323
Long-term liabilities:
Stockholders' equity		(1,600)
Total liabilities and stockholders' equity		$ 14,723

XML

Restatement of Condensed Consolidated Financial Statements - Condensed Consolidated Statements of Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income before noncontrolling interest	$ 85,307	$ 48,621	$ 180,421	$ 104,798
Adjustments to reconcile net income before noncontrolling interest to cash provided by (used in) operating activities:
Depreciation and amortization			57,818	55,032
Stock-based compensation expense	$ 12,534	9,330	24,143	18,362
Deferred income taxes			13,558	9,173
Other, net			101	(1,903)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable			(66,479)	(79,308)
Contract assets			(10,569)	(67,092)
Inventories			136,447	(403,783)
Prepaid expenses and other assets			(25,381)	(11,334)
Accounts payable			(213,168)	362,191
Accrued liabilities			4,911	161,137
Cash provided by operating activities			$ 101,802	147,273
Previously Reported
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income before noncontrolling interest		53,220		111,854
Adjustments to reconcile net income before noncontrolling interest to cash provided by (used in) operating activities:
Depreciation and amortization				55,032
Stock-based compensation expense				18,362
Deferred income taxes				11,071
Other, net				(1,903)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable				(79,705)
Contract assets				(68,545)
Inventories				(403,396)
Prepaid expenses and other assets				(11,334)
Accounts payable				357,176
Accrued liabilities				158,661
Cash provided by operating activities				147,273
Investigation Adjustments
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income before noncontrolling interest		$ (4,599)		(7,056)
Adjustments to reconcile net income before noncontrolling interest to cash provided by (used in) operating activities:
Deferred income taxes				(1,898)
Changes in operating assets and liabilities, net of amounts acquired:
Contract assets				4,804
Inventories				4,628
Accrued liabilities				(478)
Other Adjustments
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable				397
Contract assets				(3,351)
Inventories				(5,015)
Accounts payable				5,015
Accrued liabilities				$ 2,954

XML

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Disaggregation of Revenue [Line Items]
Percent of Net Sales Transferred Over Time			95.00%
Raw Materials, net of reserves, as a percentage of total Inventory	99.00%		99.00%
Number of Other Operating Segment Excluding DAS			11
Net sales	$ 2,320,103	$ 1,915,070	$ 4,675,911	$ 3,671,396
Gross profit	191,189	146,495	386,575	287,792
Operating Segments
Disaggregation of Revenue [Line Items]
Gross profit	195,463	149,706	395,324	295,881
Americas
Disaggregation of Revenue [Line Items]
Net sales	1,112,778	902,111	2,248,529	1,698,132
EMEA
Disaggregation of Revenue [Line Items]
Net sales	353,833	298,580	659,549	567,814
APAC
Disaggregation of Revenue [Line Items]
Net sales	$ 853,492	$ 714,379	$ 1,767,833	$ 1,405,450
Mexico
Disaggregation of Revenue [Line Items]
Percentage of net sales to americas net sales	70.00%	60.00%	70.00%	60.00%
United States
Disaggregation of Revenue [Line Items]
Percentage of net sales to americas net sales	30.00%	40.00%	30.00%	40.00%
Industrial, Medical, Defense and Automotive
Disaggregation of Revenue [Line Items]
Net sales	$ 1,361,843	$ 1,158,260	$ 2,701,871	$ 2,212,232
Communications Networks and Cloud Infrastructure
Disaggregation of Revenue [Line Items]
Net sales	958,260	756,810	1,974,040	1,459,164
IMS Third Party Revenue
Disaggregation of Revenue [Line Items]
Net sales	1,919,158	1,549,416	3,846,270	2,966,327
CPS Third Party Revenue
Disaggregation of Revenue [Line Items]
Net sales	400,945	365,654	829,641	705,069
CPS | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	431,077	393,407	889,170	759,685
Gross profit	$ 51,004	$ 41,046	$ 117,528	$ 80,592

XML

Financial Instruments (Details) - USD ($) $ in Millions	6 Months Ended
	Apr. 01, 2023	Oct. 01, 2022
Financial Instruments
Cash equivalents	21.00%
Fair value, inputs, level 1 | Fair value, recurring
Financial Instruments
Assets for plan benefits, defined benefit plan		$ 17
Deferred compensation plan assets	$ 38	37
Fair value, inputs, level 2 | Fair value, recurring | Derivatives Designated as Accounting Hedges: | Interest rate swap
Financial Instruments
Interest rate cash flow hedge asset at fair value	$ 3	$ 6

XML

Financial Instruments (Outstanding foreign currency forward contracts) (Details) $ in Thousands	6 Months Ended
	Apr. 01, 2023 USD ($) contract	Oct. 01, 2022 USD ($)	Apr. 02, 2022 USD ($) contract
Derivatives Designated as Accounting Hedges:
Financial Instruments
Notional amount	$ 126,383		$ 123,172
Number of contracts | contract	50		50
Derivatives Designated as Accounting Hedges: | Foreign Exchange Forward [Member]
Financial Instruments
Maximum length of time hedged	12 months
Derivatives Designated as Accounting Hedges: | Interest rate swap
Financial Instruments
Notional amount	$ 600,000	$ 350,000
Effective interest rate	4.40%
Derivatives Designated as Accounting Hedges: | Interest rate swap | Maximum
Financial Instruments
Maturity date	Sep. 27, 2027
Derivatives Designated as Accounting Hedges: | Interest rate swap | Minimum
Financial Instruments
Maturity date	Dec. 01, 2023
Derivatives Not Designated as Accounting Hedges:
Financial Instruments
Notional amount	$ 434,005		$ 531,558
Number of contracts | contract	42		43
Derivatives Not Designated as Accounting Hedges: | Foreign Exchange Forward [Member]
Financial Instruments
Maximum remaining maturity	2 months
Fair value, inputs, level 2 | Derivatives Designated as Accounting Hedges: | Interest rate swap | Fair value, recurring
Financial Instruments
Notional amount	$ 3,000	6,000
Interest rate cash flow hedge asset at fair value	$ 3,000	$ 6,000

XML

Debt - Long-term debt (Details) - USD ($) $ in Thousands	Apr. 01, 2023	Oct. 01, 2022
Debt
Long-term debt	$ 320,779	$ 329,237
Term loan due 2027
Debt
Term loan due 2027, net of issuance costs	338,279	346,737
Less: Current portion of Term Loan due 2027	17,500	$ 17,500
Long-term Debt, Fiscal Year Maturity [Abstract]
Remainder of 2023	8,750
2024	13,125
2025	17,500
2026	21,875
2027	280,000
Long-term Debt, Gross	$ 341,250

XML

Debt (Details) - USD ($) $ in Millions	6 Months Ended
	Apr. 01, 2023	Dec. 31, 2022
Foreign Line of Credit
Debt
Maximum borrowing capacity	$ 74
Long-term line of credit	0
Letters of credit outstanding, amount	13
Fifth amended and restated credit agreement
Debt
Maximum borrowing capacity		$ 800
Long-term line of credit	$ 0
Term loan		350
Additional credit line		$ 200
Line of credit facility, expiration date	Sep. 27, 2027
Term loan due 2027 | Fifth amended and restated credit agreement
Debt
Repayment percentage for long-term debt	1.25%

XML

Leases (ROU assets and lease liabilities) (Details) - USD ($) $ in Thousands	Apr. 01, 2023	Oct. 01, 2022
Leases
Other assets	$ 98,541	$ 79,495
Accrued liabilities	20,960	16,695
Other long-term liabilities	65,602	48,566
Total	$ 86,562	$ 65,261
Weighted average remaining lease term (in years)	11 years 7 days	15 years 8 months 26 days
Weighted average discount rate	3.68%	2.40%

XML

Leases (Lease expense and supplemental cash flow) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Leases
Operating lease expense	$ 8,198	$ 5,860	$ 17,565	$ 11,770
Cash paid for operating lease liabilities			$ 11,629	$ 9,752

XML

Leases (Details)	Apr. 01, 2023
Maximum
Leases
Term of contract	44 years

XML

Leases (Lease payments under non-cancelable operating leases) (Details) - USD ($) $ in Thousands	Apr. 01, 2023	Oct. 01, 2022
Leases
Remainder of 2023	$ 12,268
2024	22,789
2025	19,976
2026	15,759
2027	12,502
2028	3,498
Thereafter	9,030
Total lease payments	95,822
Less: imputed interest	9,260
Total	$ 86,562	$ 65,261

XML

Accounts Receivable Sale Program (Details) - USD ($) $ in Millions	6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Oct. 01, 2022
Accounts Receivable Sale Program
Face value of receivable sold, percentage	100.00%
Accounts receivable sold during the period	$ 1,700.0	$ 371.0
Amount Receivable On Discount Sales	12.0	$ 0.4
RPA
Accounts Receivable Sale Program
Accounts receivable sold and outstanding	238.0		$ 194.0
Amount collected but not remitted to financial institutions	$ 75.0		$ 49.0

XML

Contingencies (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jan. 01, 2022	Apr. 01, 2023	Oct. 01, 2022
Contingencies
Loss Contingency Accrual		$ 36	$ 38
Collectability of Receivable and Excess and Obsolete Inventory
Contingencies
Loss Contingency, Damages Sought, Value		10
Violation of Labor Code
Contingencies
Loss Contingency, Damages Paid, Value	$ 4
Performance of Manufacturing Service Agreement
Contingencies
Loss Contingency, Damages Sought, Value		200
Performance of Manufacturing Service Agreement | Maximum
Contingencies
Loss Contingency, Estimate of Possible Loss		$ 2

XML

Income Tax (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Income Tax
Provision for income taxes	$ 25,779	$ 21,724	$ 46,631	$ 41,292
Effective Income Tax Rate	23.00%	31.00%	21.00%	28.00%
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations	$ 5,000		$ 8,000

XML

Stockholders' Equity (Details) - USD ($) $ in Thousands	Apr. 01, 2023	Oct. 01, 2022
Stockholders' Equity
Foreign currency translation adjustments	$ 71,172	$ 63,929
Unrealized holding gains on derivative financial instruments	2,020	4,112
Unrecognized net actuarial losses and transition costs for benefit plans	(12,062)	(11,716)
Total	$ 61,130	$ 56,325

XML

Stockholders' Equity - Stock Repurchase Program (Details) - USD ($) $ in Millions	6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Stockholders' Equity
Shares repurchased	3,800	4,400,000
Cash paid for share repurchases	$ 0.2	$ 169.0
Stock repurchase program, remaining authorized repurchase amount	$ 164.0
Share-based payment arrangement, shares withheld for tax withholding obligation	400,000	300,000
Amount of tax withholding for share-based compensation	$ 21.0	$ 13.0

XML

Business Segment, Geographic and Customer Information - Revenue and a Measure of Segment Gross Profit (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023 USD ($)	Apr. 02, 2022 USD ($)	Apr. 01, 2023 USD ($) segment	Apr. 02, 2022 USD ($)
Business Segment, Geographic and Customer Information
Net sales	$ 2,320,103	$ 1,915,070	$ 4,675,911	$ 3,671,396
Gross profit	191,189	146,495	$ 386,575	287,792
Number of reportable segments | segment			1
Operating Segments
Business Segment, Geographic and Customer Information
Gross profit	195,463	149,706	$ 395,324	295,881
Operating Segments | IMS
Business Segment, Geographic and Customer Information
Net sales	1,929,945	1,558,125	3,867,613	2,983,135
Gross profit	144,459	108,660	277,796	215,289
Operating Segments | CPS
Business Segment, Geographic and Customer Information
Net sales	431,077	393,407	889,170	759,685
Gross profit	51,004	41,046	117,528	80,592
Intersegment revenue
Business Segment, Geographic and Customer Information
Net sales	(40,919)	(36,462)	(80,872)	(71,424)
Unallocated items
Business Segment, Geographic and Customer Information
Gross profit	$ (4,274)	$ (3,211)	$ (8,749)	$ (8,089)

XML

Business Segment, Geographic and Customer Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Business Segment, Geographic and Customer Information
Net sales	$ 2,320,103	$ 1,915,070	$ 4,675,911	$ 3,671,396
Percentage of net sales represented by ten largest customers	49.00%	50.00%	50.00%	49.00%
Number of customers representing 10% or more of net sales	1	2	1	2
Americas
Business Segment, Geographic and Customer Information
Net sales	$ 1,112,778	$ 902,111	$ 2,248,529	$ 1,698,132
APAC
Business Segment, Geographic and Customer Information
Net sales	853,492	714,379	1,767,833	1,405,450
EMEA
Business Segment, Geographic and Customer Information
Net sales	$ 353,833	$ 298,580	$ 659,549	$ 567,814
Mexico
Business Segment, Geographic and Customer Information
Percentage of net sales to americas net sales	70.00%	60.00%	70.00%	60.00%
United States
Business Segment, Geographic and Customer Information
Percentage of net sales to americas net sales	30.00%	40.00%	30.00%	40.00%

XML

Business Segment, Geographic and Customer Information - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 2,320,103	$ 1,915,070	$ 4,675,911	$ 3,671,396
Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	1,112,778	902,111	2,248,529	1,698,132
APAC
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	853,492	714,379	1,767,833	1,405,450
EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 353,833	298,580	$ 659,549	567,814
Previously Reported
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales		1,911,530		3,668,855
Investigation Adjustments
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales		$ 3,540		$ 2,541

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Weighted average shares used in computing per share amount:
Net income attributable to common shareholders	$ 79,621	$ 48,621	$ 171,635	$ 104,798
Weighted average common shares outstanding	58,269	62,845	57,999	63,622
Effect of dilutive stock options and restricted stock units	1,550	1,426	1,864	1,743
Denominator for diluted earnings per share	59,819	64,271	59,863	65,365
Net income attributable to common shareholders per share:
Basic	$ 1.37	$ 0.77	$ 2.96	$ 1.65
Net income attributable to common shareholders per share:
Diluted	$ 1.33	$ 0.76	$ 2.87	$ 1.60

XML

Stock-Based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Stock-Based Compensation
Stock-based compensation expense	$ 12,534	$ 9,330	$ 24,143	$ 18,362
Cost of sales
Stock-Based Compensation
Stock-based compensation expense	4,025	2,948	8,267	6,731
Selling, general and administrative
Stock-Based Compensation
Stock-based compensation expense	8,304	6,276	15,446	11,411
Research and development
Stock-Based Compensation
Stock-based compensation expense	$ 205	$ 106	$ 430	$ 220

XML

Stock-Based Compensation - Shares Authorized for Future Issuance and Available for Grant (Details) shares in Millions	Apr. 01, 2023 shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance	6.0
Stock options and unvested restricted stock units outstanding	3.0
Share-based compensation arrangement by share-based payment award, number of shares available for grant	3.0
2019 Equity Incentive Plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance	1.2

XML

Stock-Based Compensation - Additional Information (Details)	6 Months Ended
	Apr. 01, 2023
Minimum
Stock-Based Compensation
Vesting period	1 year
Maximum
Stock-Based Compensation
Vesting period	4 years
Performance Shares
Stock-Based Compensation
Potential adjustment to PSUs	15.00%
Performance Shares | Minimum
Stock-Based Compensation
Potential payout percentage	70.00%
Performance Shares | Maximum
Stock-Based Compensation
Potential payout percentage	130.00%

XML

Stock-Based Compensation - Restricted Stock (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended	12 Months Ended
	Apr. 01, 2023	Oct. 01, 2022
Number of Shares
Outstanding, ending	3,280
Granted	922
Vested/Forfeited/Cancelled	(1,199)
Outstanding, ending	3,003	3,280
Expected to vest	2,581
Weighted- Average Grant Date Fair Value
Outstanding, beginning	$ 37.11
Granted	60.07
Vested/Forfeited/Cancelled	35.25
Outstanding, ending	44.90	$ 37.11
Expected to vest	$ 44.33
Weighted- Average Remaining Contractual Term (Years)
Outstanding	1 year 7 months 6 days	1 year 4 months 6 days
Expected to vest	1 year 6 months 18 days
Aggregate Intrinsic Value
Outstanding	$ 174,278	$ 155,049
Expected to vest	$ 149,815

XML

Stock-Based Compensation - Unrecognized Stock Based Compensation Expense (Details) $ in Millions	6 Months Ended
	Apr. 01, 2023 USD ($)
Stock-Based Compensation
Unrecognized compensation expense	$ 95
Weighted average period of recognition (years)	1 year 7 months 6 days

XML

Strategic Transactions (Details) - USD ($) $ in Thousands		6 Months Ended
	Oct. 03, 2022	Apr. 01, 2023	Apr. 02, 2022	Oct. 01, 2022
Strategic Transaction
Proceeds from sale of noncontrolling interest		$ 215,799	$ 0
Cash and cash equivalents		718,203		$ 529,857
Joint Venture with Reliance
Strategic Transaction
Proceeds from sale of noncontrolling interest	$ 216,000
Noncontrolling interest in joint ventures	132,000
APIC attributable to parent from joint venture transaction	$ 84,000
Cash and cash equivalents		$ 171,000
Joint Venture with Reliance | RSVL
Strategic Transaction
Business acquisition, percentage of voting interests acquired	50.10%
Joint Venture with Reliance | Sanmina
Strategic Transaction
Business acquisition, percentage of voting interests acquired	49.90%

XML

Label	Element	Value
Treasury Stock [Member]
Treasury Stock, Shares, Acquired	us-gaap_TreasuryStockSharesAcquired	(44,427,000)